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Abstract 
Chiral Microemulsion Electrokinetic Chromatography 
Melissa Danielle Mertzman 
Dr. Joe P. Foley 
 
 
 
Electrokinetic chromatography (EKC) has proven to be an invaluable tool for providing 
chiral separations.  Its merits include fast, high efficiency, high resolution separations, 
which produce very little waste, consume minimal chemicals and are significantly more 
cost effective than its key competitors.  EKC using chiral microemulsions (MEEKC) 
offers the additional advantages of increased solubility for analytes and additives as well 
as the ability to custom tune chiral resolution via elution window and retention factor 
optimization.  Herein, the chiral resolution of various pharmaceutical compounds was 
explored using a microemulsion comprised of the chiral surfactant 
dodecoxycarbonylvaline (DDCV), 1-butanol as a co-surfactant, and ethyl acetate as a 
lipophilic phase (oil).  
 
Chapter 2 considers the effect of the lipophilic phase at a constant volume percentage or 
at a constant molarity. 
 
Chapter 3 reports the use of cyclodextrins, in combination with both a chiral (DDCV) and 
an achiral (sodium dodecyl sulfate) microemulsion, as a secondary pseudostationary 
phase. Importantly, the impact of background electrolyte (BGE) is critically assessed.   
 
Chapter 4 explores the effects of changing the surfactant concentration and/or phase ratio, 
BGE and applied voltage and Chapter 5 examines the thermodynamic quantities of 
 
 xx
transfer between the enantiomers and the DDCV microemulsion.  Finally, in Chapter 6 
DDCV microemulsion, butanol-modified micellar and micellar aggregates are compared 
using the same preparation technique and instrumental conditions. 
 
While the identity of the oil played only a minor role in analytical performance, 
surfactant concentration, BGE, applied voltage and the presence of a secondary 
pseudostationary phase all played major roles.  Optimized method conditions provided 
resolution for all enantiomeric pairs (in some cases doubling in value upon optimization), 
superior retention and efficiencies that increased anywhere from 5 to 25 times their 
original values.  In addition, van’t Hoff analyses showed favorable enthalpic 
contributions to retention and selectivity, variable entropic contributions and an overall 
favorable Gibb’s free energy of transfer between the analytes and the DDCV 
microemulsion.  Finally, DDCV microemulsion and butanol-modified micelles behaved 
similarly using 2% DDCV, whereas greater differences were noted in comparison to the 
micellar phase.  Further, when the comparison was performed using 4% DDCV, only the 
microemulsion resulted in a stable aggregate system. 
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Chapter 1: Introduction to Chiral Separations, Capillary Electrophoresis and 
Microemulsion Electrokinetic Chromatography 
 
1.1 Chiral Separations - History and Motivation 
 
There are moments in science when a conceptually simple and seemingly eloquent 
experiment yields results that change the world forever.   Such a moment occurred in 
1848 when Louis Pasteur noticed a subtle difference in the three-dimensional shapes of a 
series of tartaric acid crystals [1]. Leading up to that moment, the works of his own 
teacher, Jean-Baptiste Biot and crystallographer René-Just Haüy had already been 
cemented in Pasteur’s mind.  In 1809 Haüy first set fourth the concept of hemihedrism, or 
the idea that certain facets of a crystal exhibit asymmetry and produce 
nonsuperimposable mirror image species [2].  In 1838, Biot probed the existence of 
optical activity [3], but had not yet determined the phenomenological origin or the reason 
some molecules were optically active while others were not.  Using a microscope, 
Pasteur noticed that the crystalline molecules he examined seemed to be mirror images of 
one another, such that he was able to segregate them into two physically distinct piles. 
Pasteur later found that when he separately dissolved each of the crystal types and passed 
polarized light through the resulting solutions, one solution rotated the light to the right 
(dextrorotatory-(+)) and the other solution rotated it to the left (levorotatory-(-)).  Each 
solution displayed the same magnitude of optical rotation, however the rotation occurred 
in opposite directions.  Furthermore, he found that a solution of equal quantities of each 
crystal (or racemic mixture) displayed no resulting optical activity due to the cancellation 
of the combined equal and opposite rotations.  He understood, even then, that the ability 
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to rotate plane polarized light was related to molecular asymmetry and that the molecular 
structures of (+)- and (-)- tartaric acids were somehow related as an object to its non-
superimposable mirror image [4]. 
 
It would take another twenty-four years before the three-dimensional nature of molecules 
like these was further understood.  Ultimately, the concurrent works of van’t Hoff and Le 
Bel in 1874 revealed the tetrahedral bonding arrangement of the carbon atom [5].  
Understandably, a tetrahedral configuration allowed for the arrangement in space of two 
nonsuperimposable mirror images, or enantiomers.  It was from that point forward that 
the science of stereochemistry was truly born [6]. In 1893 Lord Kelvin fittingly coined 
these molecules “chiral” (derived from the Greek word “cheir” or hand), because like the 
human hand, a chiral molecule is not superimposable with its mirror image [7].  Since 
that time, chirality has been cemented as defining a molecule with no element of 
symmetry except at most an axis of rotation [4].  
 
Importantly, the understanding that biological and metabolic processes were 
enantiospecific began to arise.  In addition to his experiments with optical rotation, 
Pasteur performed experiments showing that one enantiomer of tartaric acid could be 
used by microorganisms for nutrition, but the other could not.  He went on to further 
highlight the fact that all naturally occurring amino acids are levorotatory where, in 
contrast, all naturally occurring sugars are dextrorotatory [8]. It became increasingly 
understood that biological processes depended not only on the atoms comprising a 
molecule but also on the three-dimensional manner in which the atoms are arranged in 
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space. A three-dimensional arrangement either allows or disallows a “lock-and-key” fit 
between a molecule and a given biological receptor.  This concept has many implications.  
Enantiomeric pairs are known to taste or smell different from one another (i.e. (R)-(+) 
limonene has an orange odor, while (S)-(-)-limonene has the odor of lemons).  Of even 
greater consequence is the metabolism of pharmaceutical compounds within the human 
body.  Often times only one of the pharmaceutical enantiomers is efficacious, whereas 
the other enantiomer is either non-efficacious or worse yet, toxic.  A particularly haunting 
example supporting this is thalidomide, a drug commonly given to women in the 1960’s 
to treat nausea and insomnia. The (R)- enantiomer of thalidomide was the desired 
efficacious enantiomer, whereas the (S)- enantiomer was teratogenic. Prescription of this 
drug without regard for enantiomeric activity resulted in as many as 20,000 to 30,000 
birth defects worldwide [9]. 
 
Initially, the biological consequences of chiral compounds were regarded in a manner 
that was somewhat matter-of-fact.  Scientists understood the existence of chirality, 
however the thought of synthesizing and/or analyzing one enantiomer over another 
seemed insurmountable.  Indeed, enantiomeric pairs are indistinguishable via 
conventional physical methodologies.  They have the same molecular weight, boiling 
point, melting point, density, etc. making differentiation extremely difficult. Fortunately, 
improvements in synthetic and analytical technologies combined with increasing 
regulation by the Food and Drug Administration has served to drive scientific processes 
towards single enantiomer production and characterization.  In fact, the current world-
 
 4
wide market for chiral chemicals reached $6.63 billion in 2000 and is expected to grow 
13.2% annually to $16.0 billion in 2007 [10]. 
 
1.1.1 Direct versus Indirect Methods of Chiral Separation 
 
There are two methods of distinction between enantiomeric pairs, (i) the direction in 
which they rotate polarized light and (ii) the manner with which they interact with other 
chiral species.  The latter can additionally be segregated into two distinct methods of 
chiral differentiation, indirect or direct.  Indirect separation involves derivatizing a chiral 
species with an additional chiral chemical agent, such that it is converted from an 
enantiomer to a diastereomer.  While enantiomers are physically identical, diastereomers 
are not.  In this regard the resulting differences in physical properties can be utilized to 
separate the diasteriomeric pair.  Unfortunately, the indirect method has many 
disadvantages:  (1) additional steps during an analysis will increase the chances for error, 
(2) the analyte must have an active functional group to derivatize, (3) the derivatizing 
reaction must be complete and must not degrade the analyte in anyway, (4) the 
derivatizing agent must be optically pure, (5) it is often impossible to recover the starting 
enantiomers after analysis [11].   There are situations where derivatization is necessary, 
but the increased success rate found using direct chiral analysis has made indirect 
analysis the less preferred technique of the two. 
 
Similarly, the direct method of separation involves the formation of diastereomers to 
achieve chiral differentiation.  In contrast, however, the diastereomers formed are via 
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temporary interactions and not via chemical bonds.  For these purposes, a chiral agent is 
incorporated into the separation process, typically in the form of a chiral stationary or 
pseudostationary phase, for the enantiomers to interact with.  The best description of this 
process is Dalgleish’s “3-point rule of interaction” [12].  In essence, when a pair of 
enantiomers interacts with an enantiomerically pure resolving agent, both enantiomers 
will share two common points of interaction.  In contrast, only one of the two 
enantiomers will interact through a third preferential point which will result in the overall 
chiral discrimination.  The various types of interactions are listed in Table 1.1, and range 
in strength from weakly associative van der Waals (or inclusion) interactions to strongly 
associative electrostatic interactions.  
 
1.1.2 Chiral Separations via High Performance Liquid Chromatography, Gas 
Chromatography and Supercritical Fluid Chromatography 
 
Chromatographic methods of chiral separation have become firmly established as 
favorable and efficient techniques for chiral differentiation. Improvements in 
instrumentation, as well as the increasing breadth of commercially available chiral 
stationary phases (CSPs), have set these techniques apart from their previously 
unfavorable status over two decades ago [13]. In general, chromatographic methods rely 
on common separation principles and similar technologies, however their range of 
applications and performance qualities vary.   
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Table 1.1. Important intermolecular interactions in direct chiral separation. 
 
 
 
Intermolecular Force Relative Strength 
van der Waals (or inclusion) weak 
π-π complexation strong 
dipole stacking medium 
steric interactions weak 
hydrogen bonding strong 
electrostatic (anionic/cationic) very strong 
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The first analytical scale chromatographic chiral separation was reported by Gil-Av et al. 
in 1966 [14]. Gil-Av and co-workers employed gas chromatography on a 100 m column 
with an optically active coating to separate a series of derivatized amino acid esters.  
Chiral stationary phase selectors in gas chromatography (GC) were originally employed 
as involatile, neat liquids. The lack of thermal stability, however, resulted in the 
subsequent chemical bonding of these phases to polysiloxanes to enhance chemical 
selectivity and chromatographic efficiency [15].  At present, there are three basic types of 
GC stationary phases: (1) chiral amino acid derivatives, (2) chiral metal coordination 
compounds and (3) cyclodextrin derivatives.  GC offers the advantages of fast and 
efficient analyses as well as a wide range of detector compatibility, however the 
resolution and/or enantioselectivity obtained is typically lower than that observed via 
other chromatographic techniques.  In fact, enantioselectivity in GC is rare above 200° C, 
limiting the temperatures that can be employed in chiral analyses. Additional 
disadvantages are the limited number of chiral stationary phases available, and also the 
requirement of analyte volatility and thermal stability (both chemically and 
enantiomerically).  
 
The stationary phases used for high performance liquid chromatography (HPLC) include 
brush-type (or Pirkle), helical polymers, cavity phases, protein phases and ligand-
exchange phases [16].  Furthermore, in HPLC there is the added flexibility of choosing 
between reversed-phase, normal phase or the increasingly popular polar organic mobile 
phases.  In general, the most widely used detection format in HPLC is UV/VIS.  As a 
result, HPLC is typically chosen for use over GC if the analytes possess a UV 
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chromophore and/or exhibit insufficient volatility or thermal stability to warrant GC 
analysis.   In terms of performance, HPLC is known for wider compound applicability, as 
well as higher selectivity and resolution than GC, but significantly lower efficiencies, 
longer analysis times, higher operational cost, and higher waste production. 
 
Supercritical fluid chromatography (SFC) employs many of the same stationary phases 
used in HPLC, however the choice of mobile phase is much more limited.  SFC combines 
the high resolution and selectivity noted with HPLC with the higher efficiencies observed 
in GC.  It also offers the GC benefit of an expanded choice of detection format.  
Unfortunately, the majority of supercritical fluids utilized are non-polar (mainly CO2), 
often making HPLC or GC the more preferred methodologies. 
 
1.2 Electrophoretic Separations 
 
1.2.1 The Origin and History 
 
Capillary electrophoresis (CE) has become an increasingly popular separation technique, 
in part because it offers the higher efficiencies noted with GC concurrent with the high 
resolution and enantioselectivity observed with HPLC. The simplest form of CE, 
capillary zone electrophoresis (CZE), separates analytes based on relative size and charge 
and their resulting migration characteristics under an applied electric field.  The historical 
developments that have helped shape this technique are summarized in Table 1.2. The 
pioneering works of Faraday, Hemholtz, Hittorf, Nernst and Kohlrausch established a  
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Table 1.2.  Historical milestones in the development of capillary electrophoresis  [17] 
 
Year Author’s Name Contribution 
1791 Faraday Laws of electrolysis 
1877 Helmholtz Solvent layer close to an inside wall and the surface of a charged particle acquires an opposite charge 
1856 Hittorf Definition of transport numbers for ions 
1897 Nernst Properties of small ions 
1897 Kohlrausch 
Kohlrausch function describing the order of 
electrophoretic migration of ions and their relative 
concentrations 
1930 Tiselius Thesis-the moving boundary method of studying the electrophoresis of proteins 
1923 Kendall and Crittenden 
Rare earth metal separation by “ion migration method.”  
First isotachophoresis. 
1939 Svenson 
1945 Longsworth Development of zone and displacement electrophoresis 
1948 Tiselius Nobel Prize for development of  
1950 Haglund and Tiselius 
Electrophoresis tube filled with glass beads, powder 
material 
1955 Smithies Gel electrophoresis 
1958 Hjerten Electrophoretic analyses in free solution 
1967 Martin and Everaerts 
Displacement electrophoresis in glass tubes with 
hydroxyethylcellulose 
1967 Hjerten Elimination of the electroosmosis effects by coating of tubes 
1969 Giddings Nondiffusional model of concentration distribution in free zone electrophoresis 
1969 Virtanen Glass capillaries 0.2-0.5 mm I.D. were used 
1970 Everaerts and Hoving-Keulemans Capillary isotachophoresis, ITP equipment 
1970 Arlinger and Routs Developments in detectors-UV 
1972 Verheggen et al. Conductivity detector 
1979 Mikkers et al. High voltage in narrow-bore Teflon tubes 
1981 Jorgenson and Lukacs 
Use of 75 µm open tubular glass capillaries; high 
performance capillary electrophoresis (HPCE) 
1984 Terabe et al. 
Combination of electrophoretic and chromatographic 
modes.  Micellar electrokinetic chromatography 
(MEKC) 
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firm theoretical foundation with respect to the movement and behavior of charged 
species.  It was Tiselius, however, who provided the first true insight into the potential 
usefulness of electrophoresis as an analytical technique with his novel “moving 
boundary” analysis of serum proteins in 1937 [18].  His research consisted of using 
ultraviolet light to photograph moving protein boundaries in a quartz U-tube.  
Unfortunately, his initial approach was plagued with problems caused by the resulting 
high Joule heat generation.  Moreover, the technique was further limited by incomplete 
separation of the proteins, relatively large sample volume requirements and the necessity 
of operating with low electrical fields to further minimize Joule heat [19].  Later, a more 
refined version of his apparatus incorporated the use of circulating cold water to cool the 
U-tube and he was ultimately awarded the Nobel Prize in 1948 for his pioneering 
research in electrophoretic separations.  Importantly, the work of Tiselius highlighted the 
need for anticonvective media, resulting in the use of paper, starch, agarose and 
ultimately polyacrylamide (or PAGE) gels [19].    Today, PAGE gels are still of vital 
importance in biochemical analysis.  
 
In 1958, Hjertén and co-workers made the first steps towards modern-day capillary 
electrophoresis.   His initial experiments employed a slowly rotating, 1-3 mm inner 
diameter (I.D.) quartz capillary as a separation channel; the sample was injected using a 
microsyringe and the separated zones were scanned by a UV photometer moving along 
the axis of the separation tube [20].  In 1974, Virtanen refined the arrangement by using a 
tube with an even narrower I.D. (0.2 mm) to further eliminate problems due to 
convection [21].  He also went on to derive expressions for calculating the dispersion 
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coefficients due to Joule heat and electroosmotic flow in closed capillaries [20].  In 1979, 
Mikkers et al. changed from a quartz to a Teflon capillary, and achieved the separation of 
organic and inorganic ions in less than ten minutes [22]. 
 
The first truly modern CE experiments were conducted by Jorgensen and Lukacs in 1981 
[23-26].  Importantly, unlike their previous counterparts, Jorgensen and Lukacs used 
electroosmotic flow to their advantage rather than attempting to suppress it.  Their 
research also introduced the use of even smaller I.D. (100 µm) fused silica capillaries.  
Overall, this instrument was simpler in design, consisting of the capillary, electrode 
buffer reservoirs, a high voltage power supply and a fluorimetric detector.  Furthermore, 
this presented the first “on-column” detection format.  A detection window was burned 
into the polyimide coating around the capillary so that light could pass through the 
capillary and analytes could be detected. 
 
While this bounty of research served to refine the instrument technology to its current 
status today, there was still one key issue in CE yet to be solved.  Capillary 
electrophoresis provided excellent separation for charged species, however the technique 
in its current state could not separate neutral compounds.  Indeed, neutral compounds 
have no electrophoretic mobility and are only carried along with the bulk electroosmotic 
flow to the capillary outlet where they are simultaneously detected.  In 1984, Terabe 
realized a solution to this problem by employing anionic micellar surfactant aggregates as 
pseudostationary phases (PSPs) [27].   This arrangement (electrokinetic chromatography, 
or EKC) mated both chromatographic and electrophoretic thought processes and 
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resultantly provided separations for a wide variety of compounds.  Since that time, the 
repertoire of pseudostationary phases has expanded to include anionic, neutral, cationic 
and mixed micelles and microemulsions, vesicles, cyclodextrins, crown ethers and 
polymers. 
 
1.2.2 Theory and Principles Governing Electrophoretic Separations 
 
Figure 1.1 displays a typical CE instrument.  The components include a capillary, power 
supply, electrodes, buffer vials and a detector.  The capillaries are commonly narrow bore 
(< 100 µm) bare fused silica, ranging in length from 32 to 75 cm and externally coated 
with polyimide to add flexibility to the normally brittle glass (Figure 1.2).  The polyimide 
coating is easily burned away to create an optically transparent, on-column detection 
window.  The high voltage power supply can deliver up to 30 kV in either normal or 
reversed polarity mode.  Under normal polarity, the anode is located at the point of 
sample injection (capillary entrance) and the cathode is located towards the capillary 
outlet, near the detector.  The potential is established via two platinum electrodes.  
Injection of sample onto the capillary can be performed via one of three methods: (1) 
applying pressure, (2) applying vacuum (or siphoning), or (3) applying voltage.  The 
most common detection format is UV/VIS, however fluorescence is also commonly 
employed.  Once the sample is introduced, a voltage is applied, generating a bulk flow 
from anode to cathode under normal polarity conditions.  Separation is carried out by 
both the bulk flow and by the electrophoretic migration of the ions being separated.  The 
analytes resultantly migrate based on their charge/frictional drag ratio until they are 
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Figure 1.1: Schematic of basic capillary electrophoresis components. 
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Figure 1.2: Schematic of typically capillary dimensions.
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eventually carried past the detection window.  In the normal polarity mode of operation, 
the elution order is cations, neutrals and anions, respectively. 
 
To understand the dynamic processes involved in CE, it is important to appreciate which 
variables affect the electrophoretic migration of the analytes as well as the bulk, 
electroosmotic flow (EOF).  The electrophoretic mobility of a given analyte is the 
quotient of its charge versus its frictional drag.  Through application of Stoke’s equation, 
this mobility can be expressed as noted in equation 1.1: 
µep = q6πηr  (1.1) 
where q is the charge of the molecule, r is the hydrated radius and η is the viscosity of the 
solution.  Understandably then, a small, highly charged molecule will migrate quite 
rapidly, whereas the converse is true for a large molecule of lesser charge.  Importantly, 
the velocity of an analyte is additionally dependent on the applied electric field, as 
described in equation 1.2: 
vep = µep • E = µep • VLt
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟  (1.2) 
where E is the applied electric field, or the voltage applied (V) over the total length of the 
column (Lt).  The greater the electric field, the faster the analytes will traverse the 
column.  The magnitude of the electric field that can be applied is limited, however, by 
the amount of Joule heat generated by ions in the background electrolyte (BGE).  All ions 
present in the BGE migrate in a manner governed by the equation 1.1.  This migration 
generates heat (termed Joule heat) due to the frictional drag of their movement in 
solution.  Importantly, the capillary temperature gradients resulting from Joule heat create 
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convective, parabolic and/or non-uniform flow, and at extreme temperatures, even out-
gassing.   Since these effects severely degrade analytical performance, analyses are 
typically conducted at Joule heat levels of ≤ 1.5 W/m (at the onset of nonlinearity of an 
Ohm’s Law Plot (I vs. V)).  
 
One of the most integral aspects of CE is the bulk, electroosmotic flow (EOF) of 
electrolyte solution through the capillary.  EOF allows for the simultaneous analysis of 
both anions and cations, and similarly the detection of neutrals.  Without bulk flow, 
anions and cations would migrate to opposite ends of the capillary and neutrals would 
simply not migrate at all.  Electroosmotic flow is quite unique in comparison to pressure-
driven parabolic flow in that it is generated at the capillary surface.  The capillary surface 
is comprised of ionizable silanol groups (Si-OH), which acquire a net negative charge 
above pH 3 (Si-O-). The pH of the electrolyte solution determines the extent of ionization 
and the resulting overall charge.  The negatively charged wall attracts cations present in 
solution, and a “fixed” non-stoichiometric, cationic layer is formed (Figure 1.3).  Since 
this layer does not neutralize all of the available negatively charged sites, a second, more 
loosely held (diffuse) layer is formed, further away from the capillary surface than the 
first.  Once the electric field is applied, cations in the diffuse layer will be attracted to the 
cathode resulting a net migrational movement of the diffuse cations in the direction of the 
cathode.  Further, since the cations are highly solvated they drag a solvation sphere, as 
well as the surrounding water that is hydrogen bonded to the solvation sphere, with them. 
This results in an overall bulk flow of BGE from anode to cathode.
 
  
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Representation of electroosmotic flow (EOF) and the electrical double layer.
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Electroosmotic flow is governed by the dielectric constant of the buffer (ε), the buffer 
viscosity (η), the electric field (E) and the zeta potential (ζ), as noted in equation 1.3 
[28]: 
veo = εζ4πη E  (1.3) 
Key variables that affect EOF include buffer composition (including the presence or 
absence of organic solvents), buffer concentration or ionic strength, applied voltage, 
temperature and BGE pH.  Increasing the applied voltage increases the EOF by 
increasing the electric field.  Similarly, increasing the pH of the BGE results in the 
presence of more ionized silanoates and a subsequent EOF increase by increasing the zeta 
potential.  Understandably, the converse is true upon reducing the pH, especially below a 
value of 2 where EOF reduces to almost zero.  Buffer concentration and ionic strength 
directly impact the double-layer thickness at the capillary wall, resulting in a more rapid 
potential decay and ensuing decrease in zeta potential and EOF.  Further, temperature, 
buffer concentration and also the presence of organic solvents affect the viscosity at the 
capillary wall, in turn affecting the dielectric constant and ultimately the EOF. 
 
As mentioned earlier, one of the most unique properties of EOF is that it is generated at 
the capillary walls (Figure 1.4). This provides a unique flat flow profile and compared to 
typical pressure-induced (or hydrodynamic) flows, results in less broadening of the 
analyte zones and the resulting higher separation efficiencies for which CE is known.
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Figure 1.4: Comparison of (A) Hydrodynamic flow profile and (B) Electroosmotic flow 
profile [29]. 
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1.2.3 Non-Electrokinetic Chromatographic Modes of Separation in Capillary 
Electrophoresis 
 
The simplest form of capillary electrophoretic separation is capillary zone 
electrophoresis, or CZE, however the field of CE has given birth to a variety of 
electrophoretic techniques with an equally wide variety of applications.  CZE is 
predominantly used for the separation of simple molecules based on size and charge. 
Non-aqueous capillary electrophoresis (NACE) is somewhat similar to CZE except that it 
utilizes non-aqueous (organic) solvents instead of predominantly aqueous media.  As a 
result, NACE is typically chosen for use with analytes and/or additives for which aqueous 
solubility is limited. 
 
In contrast, capillary isoelectric focusing (CIEF) has established a niche for the 
separation of proteins (or amphoteric molecules) based on differences in isoelectric point. 
CIEF involves the establishment of a pH gradient across the capillary (in the absence of 
EOF), such that proteins migrate until they reach the pH at which they are neutral 
(isoelectric point) and stop migrating.  The resulting electroneutrality focuses the proteins 
in place, after which they are pushed through the column via a slight pressure application 
until they reach the point of detection.   
 
Capillary gel electrophoresis (CGE) incorporates the use of size selective packing 
materials (typically gel polymer networks) to separate large molecules based on size and 
charge.  As the molecules traverse the column, they become tangled in the size-selective 
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network of packing material.  The smaller molecules resultantly elute first and the larger 
molecules, having greater difficulty fitting through the pore network, elute later.  
 
Capillary electrochromatography (CEC) employs stationary phases used in reversed-
phase HPLC chromatographic columns in conjunction with a CE capillary format and 
voltage driven separation.  In this fashion, the analytes are separated based on both 
electrophoretic and chromatographic differences, however, the chromatographic 
separation medium in this case is stationary, unlike its electrokinetic chromatography 
(EKC) counterpart. 
 
1.2.4 Electrokinetic Chromatography 
 
In 1984, Terabe revolutionized the CE world by incorporating an anionic micellar 
surfactant aggregate as a “pseudostationary phase” (PSP) in capillary electrophoresis [27, 
30].  Based on the relevance to the research presented herein, electrokinetic 
chromatography, or EKC, will be discussed in greater detail than the previous modes of 
CE separation.  First, general EKC principles will be covered, followed by a brief 
introduction into micellar and vesicular surfactant aggregates and ultimately the theory 
behind microemulsion electrokinetic chromatography and its value in chiral separations.  
 
Electrokinetic chromatography supplies a secondary chromatographic separation 
mechanism.  Similar to reversed-phase HPLC, an analyte migrating through the capillary 
will exhibit preferences for either the hydrophilic aqueous phase or hydrophobic PSP, 
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such that the more time the analyte partitions into (or is retained by) the PSP, the longer it 
takes for it to elute past the detector.  Different analytes will exhibit greater or lesser 
preferences for a given PSP, and thus differences in selectivity evolve.   Since the 
introduction of EKC, the variety of additives incorporated as PSPs has greatly expanded, 
including but not limited to vesicles, microemulsions, polymeric micelles, cyclodextrins, 
crown ethers, macrocycle antibiotics, calixerenes, and proteins [31, 32]. 
 
The key difference between EKC and HPLC is with respect to the migratory nature of the 
chromatographic selector.  In HPLC, the chromatographic selector is fixed, having been 
chemically bound within the column.  Hence the name “stationary” phase.  In contrast, 
the chromatographic selector in EKC is not stationary.   EKC relies on differences in 
mobility between the analyte and PSP, where the PSP moves at a slower rate and/or in 
the opposite direction.  This fairly simple mechanism enables the separation of neutral 
analytes based on differences in intermolecular attractive/repulsive forces.  Further, even 
charged analytes benefit from the orthogonal selectivity mechanism.  
 
The partitioning process can be described similar to that of HPLC (equation 1.4): 
P = S[ ]psp
S[ ]aq  (1.4) 
where P is the partition coefficient and [S]psp and [S]aq are the concentration of the solute 
in the PSP and aqueous phase respectively.  Further, the partition coefficient can be 
related to the retention factor via incorporation of the phase ratio β (or volume ratio of the 
PSP and aqueous phase respectively)  as noted in equation 1.5: 
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k = P •β = npsp
naq
 (1.5) 
where npsp and naq are the moles of solute in the PSP and aqueous phase respectively.  
Taking the net solute velocity and distributed mole fractions into account, the weighted 
average of the net solute velocity can be determined via equation (1.6): 
vav = Xaqvaq + X pspvpsp   (1.6) 
where Xaq, Xpsp, νaq and νpsp are the mole fractions and velocities of the solute in the 
aqueous and pseudostationary phases, respectively.  Using the relationship in equation 
1.5, the average velocity in equation 1.6 can similarly be related to the retention factor as 
noted in equation 1.7: 
vav = 11+ k vep + veo( )+ k1+ k vpsp( ) (1.7) 
Importantly, charged species will exhibit a velocity comprised of contributions due to 
both electroosmotic flow and electrophoretic mobility (veo + vep ), whereas neutral 
species (having no electrophoretic velocity) will exhibit contributions from the former, 
only.  The migration time of a given analyte can then be described by equation 1.8, a 
rearrangement of equation 1.7: 
tr = Lvav
= 1+ k
1+ µr + tot psp
⎛ 
⎝ 
⎜ ⎜ 
⎞ 
⎠ 
⎟ ⎟ k
⎡ 
⎣ 
⎢ 
⎢ 
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⎤ 
⎦ 
⎥ 
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⎥ 
⎥ 
⎥ 
to  (1.8) 
where µr = µep /µeo or the quotient of the electrophoretic mobility of the analyte and the 
electroosmotic flow, tpsp is the retention time of the PSP and t0 signifies the time of a 
neutral, unretained marker (methanol).  Typically, however, it is migration time that is 
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experimentally observed and retention factors which are subsequently calculated.  To 
facilitate this, equation 1.8 is rearranged to yield equation 1.9: 
k = tr 1+ µr( )− t0
t0 − t0tpsp
⎛ 
⎝ 
⎜ ⎜ 
⎞ 
⎠ 
⎟ ⎟ tr
 (1.9) 
Separations are often compared via resolution, efficiency, selectivity and elution range 
(or separation window).  The dependence of chromatographic resolution, or the 
separation between two given peaks, is commonly expressed via equation 1.10: 
Rs = N4 α −1( )
k1
1+ kav
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟  (1.10) 
where N is the efficiency (provided the efficiencies of the two peaks are similar), α is the 
selectivity and k is the retention factor of either the first eluted compound (“1”) or the 
average retention (“av”).  While the calculation of resolution in EKC is similar, minor 
adjustments must be made to compensate for the fact that the elution range (tpsp/to) is 
finite when using a pseudostationary phase.  Subsequently, in EKC resolution is 
expressed via equation 1.11: 
Rs = N4 α −1( )
k1
1+ kav
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟ 
1+ µr − t0 tpsp
1+ µr + t0 t psp( )k
⎛ 
⎝ 
⎜ ⎜ 
⎞ 
⎠ 
⎟ ⎟  (1.11) 
where µr is the relative electrophoretic mobility of the solutes, which reduces to µr = 0 for 
neutral analytes. 
 
The efficiency of a given separation results from the culmination of an entire series of 
band broadening (dispersive) processes.  The collective variances sum to yield the overall 
band broadening as noted in equation 1.12: 
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σ total2 = σ diff2 + σ temp2 + σ inj2 + σ ads2 + σ det2 ....... (1.12) 
where the subscripts denote dispersion due to diffusion, temperature gradients, injection, 
adsorption and detection respectively.  The collective dispersion can then be related to the 
efficiency by taking the length of the separation medium into account: 
N = Ld
2
σ total2  (1.13) 
where Ld is the length of the capillary to the detector.  Since one of the largest 
contributions to band broadening in CE is longitudinal diffusion (σ2diff) and longitudinal 
diffusion is directly proportional to time as described by Einstein’s equation (1.14): 
σ diff2 = 2Dtr  (1.14) 
(where D is the solute diffusion coefficient), the greater the amount of time an analyte 
spends on column, the lower the efficiency.  More commonly, however, efficiencies are 
obtained using the migration time of the analyte (tr) and the width of the chromatographic 
peak at half-height (W50) as noted in equation 1.15: 
N = 5.54 tr
W50
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟ 
2
 (1.15) 
The selectivity observed for two different peaks is simply the quotient of individual 
retention factors: 
α = k2
k1
  (1.16) 
where the subscripts “2” and “1” denoted the second and first eluting peaks respectively.  
A selectivity value of 1.00 denotes a lack of differentiation between the two analytes, 
whereas the converse is true of selectivity values greater than 1.00.  Importantly, 
selectivity does not include any measure of zone broadening.  As a result, two peaks 
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exhibiting a moderate selectivity difference will not be resolved if the efficiency is 
inadequate, yet two peaks with minor selectivity and higher efficiency may be easily 
resolved. 
 
Another metric to consider is the elution range (ER), often referred to in HPLC as the 
separation window.  The elution range is described in equation 1.17: 
ER = t psp
t0
= µeoµpsp  (1.17) 
where tpsp and t0 are the migration times of the PSP and a neutral, unretained marker, and 
µeo and µpsp are the electroosmotic mobility and net mobility of the pseudostationary 
phase.  Importantly, t0 defines the earliest time at which a neutral analyte could elute and 
tpsp defines the latest an analyte would elute if it were infinitely retained by the PSP.  By 
definition, this yields a “window” of time in which the separation has to occur.  
Understandably, the larger the separation window, the more peaks that can be separated 
in a given analysis.  
 
The final metric to consider is the peak capacity (nc), or the number of peaks that can be 
fit side by side in a given area: 
nc =1+ N4 ln
tpsp
to
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟ 
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟   (1.18) 
Importantly, equation 1.18 reveals that a deterioration in efficiency and/or a smaller than 
adequate elution range will reduce the number of peaks that can be separated within a 
given analysis. 
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Out of all the surfactant aggregate systems, micelles are the simplest in composition and 
also the most thoroughly understood.  The essential driving force behind their, or any 
surfactant aggregate formation, is the hydrophobic effect.  The “surface active agents” 
(surfactants) that they are comprised of possess both a polar, hydrophilic head group and 
a non-polar, hydrophic tail.  While solvation of the polar head groups in aqueous 
surroundings is accomplished quite readily, the solvation of the tail group is one of 
uncomfortably ordered rigidity.  From that standpoint, it can be readily understood that 
surfactant monomers present in solution will try to aggregate to achieve a more 
energetically stable state.  Once the surfactant concentration is raised above a certain 
critical value (the critical micelle concentration or cmc), enough surfactant is present for 
these spherical aggregates to form.  The resulting structure is characterized by an 
outwardly facing, spherical envelope of polar head groups, with the hydrophobic tails 
concealed safely inside (Figure 1.5A).  The surfactant packing, and thus the cmc, are 
determined based on the size and characteristics of the head and tail groups and also the 
properties of the surrounding aqueous phase. 
 
The most commonly used surfactant for these purposes is sodium dodecyl sulfate (SDS).  
SDS is anionic, and under normal polarity conditions SDS micelles will try to migrate 
away from the detector, towards the anode.  Therefore, any analyte that is retained by the 
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Figure 1.5: Representative cross-sections comparing various surfactant aggregates (A) Micelle.  (B) Vesicle.  (C) Microemulsion.
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SDS micelle will be retarded from reaching the detector, allowing separation to occur.  In 
addition to SDS, cationic and neutral surfactants and also mixtures of different 
surfactants [33, 34] have all been successfully incorporated into micellar format.  
 
While micelles are simple to create, and small in size (3 to 5 nm), vesicles are more 
complex to create and significantly larger (80 nm to 1 µm).  Vesicles are formed from 
either (1) double-tailed surfactants, or (2) non-stoichiometric combinations of oppositely 
charged single-tailed surfactants. The resulting structure can be either unilamellar or 
multilamellar in nature, surrounding one or more internal cavitites of solvent (Figure 
1.5B).  Vesicles are attractive pseudostationary phases because they offer larger elution 
ranges than those noted with micelles and those that form bilayer structures provide a tool 
with which to study biological membrane processes.   
 
Microemulsions, in contrast to the previous two aggregate systems, are not solely 
surfactant-based.  Importantly, a microemulsion is comprised of surfactant, a water-
immiscible oil phase, and often a co-surfactant.  First discovered in 1948 [35], these 
systems uniquely combine oil and water into a single, optically transparent, 
thermodynamically stable liquid (Figure 1.5C).  Unlike their emulsion counterparts, when 
a stable microemulsion is formed it will remain as one uniform phase almost indefinitely.  
Also unlike emulsions, the small size of the microemulsion droplets (< 10 nm) [36] 
allows for optical transparency. Microemulsions were initially used in a variety of non-
analytical applications, and so it was not until 1991 that Watarai first integrated them as 
PSPs in microemulsion electrokinetic chromatography (MEEKC) [37].  While MEEKC 
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was initially somewhat slow to catch on, it has since greatly expanded, with 130 of its 
173 publications occurring in the past four years alone. Microemulsion electrokinetic 
chromatography has been successfully applied to the separation of pharmaceuticals [38-
41], nucleosides [42], biphenyl nitrile compounds [43], steroids [44], natural products 
[45] and also in log Pow determinations [46, 47]. 
 
It is the oil core of the microemulsion that provides many of its unique characteristics, 
resulting in an aggregate that is more swollen (larger), less rigid, and also more amenable 
to both hydrophobic and hydrophilic analytes than its micellar counterpart.  Additionally, 
unlike MEKC, increasing the surfactant concentration in MEEKC increases the net 
charge on the microemulsion droplet.  This results in an aggregate that is better able to 
migrate in opposition to the EOF and further increases the elution range of the system.  In 
contrast, increasing the surfactant concentration in MEKC serves only to (1) increase the 
number of micelles in solution and/or (2) increase the viscosity of the solution.  While 
increasing the number of micelles will result in a slight increase in elution range, the 
effect is not nearly as dramatic as what has previously been observed using MEEKC [36, 
47, 48].  
 
The oils traditionally used as the lipophilic component of a microemulsion are short-
chained hydrocarbons such as hexane, heptane or octane [37, 41, 49, 50].  The 
disadvantage in using these oils is that they require a relatively large concentration of 
surfactant in order to reduce the interfacial tension sufficiently to allow droplet formation 
[51].  Since the surfactant monomers are ionized, increasing their concentration results in 
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a net increase in the current and Joule heat of the system, such that lower operation 
voltages are required.  The lower the voltage, the longer the analysis time and the lower 
the efficiency of the separation. 
 
An alternative to these “high-interfacial tension” oils was first proposed by Mahuzier and 
Altria in 2001 [51].  Rather than use the traditional hydrocarbon oils, a relatively water-
imiscible, polar organic liquid (ethyl acetate) was used.  Since that time, the repertoire of 
“low-interfacial tension” oils has been expanded to include organic compounds such as 
dibutylether, butyl acetate [52], diisopropyl ether and 1-octanone[53].  Importantly, 
employing a low-interfacial tension oil requires less surfactant to form a stable 
microemulsion.  This allows for operation using higher applied voltages, resulting in 
much more rapid analysis times and higher overall efficiencies.   
 
Also of great importance is the choice of co-surfactant.  Typically employed co-
surfactants are short-chained and linear such that they can readily insert into the 
surfactant monolayer, ease electrostatic repulsion and promote aggregate formation.  The 
most commonly used co-surfactant is 1-butanol [36-39, 48, 49, 51, 54-57], however 1-
propanol, methanol, tetrahydrofuran and 2-ethoxyethanol have also been used [52, 53].  
Based on these studies and others, it has been largely established that the co-surfactant 
identity plays an important role in selectivity in MEEKC.  
 
Other important variables to consider in MEEKC include the identity and concentration 
of the surfactant, pH of the BGE and, as reported herein, the identity of the BGE.  The 
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identity of the surfactant will affect the charge state of the microemulsion and the 
selectivity, based on the available functional groups.  Further, the pH of the BGE will 
determine the extent of the EOF (based on the dissociation of the capillary silanols) as 
well as the charge state of any ionizable groups (e.g. the surfactant and/or analytes).  
 
1.2.5 Chiral Separations via Electrokinetic Chromatography and Microemulsion 
Electrokinetic Chromatography 
 
The first chiral separation employing CE was reported by Gassman in 1985 [58].  While 
enantiomers cannot be separated in CE based on charge/frictional drag ratio (because 
they are identical) they can be separated via temporary diasteriomeric interactions with a 
chiral additive, using a direct separation approach.  Many different additives have been 
used in support of this, including, but not limited to, chiral micelles, cyclodextrins, 
macrocycle antibiotics, proteins, chiral CEC packings, chiral crown ethers or sometimes 
even combinations of more than one additive/selector  [10, 11, 59-61].  The most widely 
used of these selectands by far are micelles and cyclodextrins.  Cyclodextrins are 
macrocycle oligosaccharides that are synthesized by the enzymatic digestion of starch 
[32].  These large, basket-shape molecules are available in three different cavity sizes, α, 
β, and γ, corresponding to 6, 7 or 8 glucopyranose units respectively.  Furthermore, in 
addition to “native” cyclodextrins, there are also derivitized cyclodextrins that offer a 
wide array of functional groups and possible charge states to chose from. 
 
Importantly, in order for separation to occur, the binding constants of each enantiomer 
with the chiral selectand should differ.  A difference in binding constant will result in one 
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enantiomer being retarded to a greater extent than the other, with the subsequent 
differences in mobility yielding the desired separation.  This relationship is best described 
by the model developed by Wren and Rowe [62-64], displayed in equation 1.18: 
∆µ = C[ ](µ1 − µ2)(K1 − K2)
1+ C[ ](K1 + K2) + K1K2 C[ ]2  (1.18) 
where [C] is the concentration of the chiral selector, K1 and K2 are the respective 
equilibrium constants for enantiomer “1” and “2”, and µ1 and µ2 are the mobility of the 
free enantiomer and the complexed enantiomer, respectively.  Finally, ∆µ is the resulting 
difference in mobility.  This equation highlights the dependence of selectivity not only on 
relative binding constants, but also on the concentration of chiral selector present in 
solution.  Thus, when developing a chiral CE method there are two key parameters to 
consider: (1) the identity of the chiral selector and resulting extent to which the 
functionality of the selector may compliment the functionality of the analyte (which 
governs the equilibrium constant), (2) the concentration of selector that should be used to 
achieve optimal chiral resolution. 
 
Capillary electrophoresis has become widely popular as a chiral separation technique 
largely due to the ease with which chiral selectors can be interchanged to achieve a 
desired separation.  Working with a chiral selector that is chemically bound inside a 
column (truly stationary) requires the limitation that a lack of success with that selector 
will necessitate the purchase of a new column.  Further, even if a particular phase works 
well for a given separation, many of the chiral stationary phases are mechanically and/or 
chemically fragile, limiting the amount of overall use.  Unfortunately, chiral columns are 
often quite expensive and successive purchases become cost prohibitive.  
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Another disadvantage encountered with typical chromatographic methods is the difficulty 
in changing the elution order between an enantiomeric pair [10, 60, 61].  In chiral 
analysis, it is often the case that one enantiomer is present in excess, while the other may 
only be present in trace quantities.  In this situation, it is important to elute the smaller of 
the two peaks first, such that more accurate, quantitative integration may be obtained.  
The most viable method for reversing elution order is to change the selectivity of the 
selectand, either by using an entirely different phase, or by using a packing material 
comprised of the opposite enantiomer of the previous phase.  Since packing materials are 
typically available in only one of their enantiomeric forms, the decision often favors the 
former of the two.  
 
In contrast, working with chiral additives in EKC is relatively facile.  In chiral EKC, 
switching between chiral selectands/additives is as easy as flushing your column with a 
new solution.  Furthermore, the variety of chiral additives is the largest available and 
many of them (although not all) are relatively inexpensive.  Even if the cost of a given 
selectand is high, the quantities employed in CE are so minimal that it is still a more 
economically practical option.  Moreover, elution order can be reversed in a number of 
ways, including changing the selectand enantiomer. 
 
One key disadvantage noted with these methods is their lack of applicability towards 
more hydrophobic analytes, for which solubility in predominantly aqueous surroundings 
is precluded. Non-aqueous capillary electrophoresis (NACE) was conceived to attempt to 
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address this issue, however operation under NACE conditions is quite difficult due to the 
large, and often unpredictable shifts in pKa’s of analytes and buffer additives, and also 
the impact that these solvents have on EOF.  Ultimately, a more practical, and resultantly 
more successful alternative to NACE is microemulsion electrokinetic chromatography. 
 
Chiral MEEKC, as a subset of MEEKC, is still largely unexplored.  The first published 
account reported a chiral microemulsion based on a chiral oil, (2R, 3R)-di-n-butyl 
tartrate, an achiral surfactant (sodium dodecyl sulfate) and an achiral co-surfactant (1-
butanol) [65].  Since it has become increasingly established that the lipophillic phase in 
MEEKC exerts only a minor influence on selectivity, this approach is understandably not 
ideal.  It is similarly limited with respect to more hydrophilic analytes that may not 
penetrate the microemulsion droplet as deeply, and thus not interact to as great an extent 
with the oil.   
 
In contrast, in 2002 Pascoe and Foley reported a chiral microemulsion based on a chiral 
surfactant, dodecoxycarbonylvaline (DDCV), a low interfacial tension, achiral oil (ethyl 
acetate), 1-butanol as the co-surfactant and a zwitterionic background buffer (ACES) 
[54].  The DDCV microemulsion achieved chiral separations with each of the nine 
pharmaceutical compounds investigated, exhibiting enantioselectivities in the range of 
1.06 – 1.30.  DDCV is an anionic surfactant comprised of the amino acid valine and a 
C12-hydrocarbon chain.  It is the valine portion of the monomer that imparts its chiral 
nature.  The polar functionality of the monomer is provided by the carbamate and 
carboxylic acid moieties, with the chiral center located on the α-carbon.  DDCV 
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(Figure1.6) is also unique in that it is commercially available in each of the 
enantiomerically pure forms, (R)-DDCV and (S)-DDCV.  The option of switching the 
surfactant enantiomers permits easy elution order reversal for a given chiral separation. It 
was also noted that the DDCV microemulsion offered an enhanced elution range [54] 
over that previously observed with DDCV micelles [66].  
 
More recently, Shamsi et al. expanded on the use of chiral surfactants in MEEKC, by 
investigating polymeric microemulsions [67]. The general lack of exploration in chiral 
MEEKC is surprising for two reasons.  First, the ability to increase the elution window in 
MEEKC can enable the separation of a greater number of enantiomers within a given 
analysis.  Furthermore, this added flexibility also allows the capability to custom tune 
retention, and possibly increase the resolution between enantiomers.  This was 
specifically shown to be the case in non-chiral MEKC/MEEKC comparisons [39, 68].  
Finally, should the area of chiral MEEKC prove successful, the increased solubility 
ranges could have wide implications in the chiral analyses of hydrophobic compounds for 
which CE is not currently a preferred methodology.  
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Figure 1.6: (R)- and (S)- stereoisomers of Dodecoxycarbonylvaline (DDCV). 
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Chapter 2: Effect of Low-Interfacial-Tension Oil Substitution in Chiral 
Microemulsion Electrokinetic Chromatography 
 
 
2.1  Introduction 
 
 
Chiral separations in EKC are invoked by using additives as simple as cyclodextrins, 
crown ethers and carbohydrates, or via thermodynamically stable aggregate systems such 
as chiral micelles or chiral microemulsions.  While micelles and microemulsions are 
comparable in many ways, there are important differences to consider.  A micelle is an 
aggregate of surfactant monomers that forms spontaneously, under predominantly 
aqueous conditions, when the surfactant concentration is raised above a certain level.  
The concentration at which this occurs is referred to as the critical micelle concentration 
or cmc.  In addition to surfactant, oil-in-water microemulsions require a water-immiscible 
oil and frequently utilize a co-surfactant in a ratio such that the various entities form a 
single, optically transparent and thermodynamically stable phase.  It is the presence of the 
oil core that gives microemulsions many of their unique properties when compared with 
micelles.  Microemulsions are slightly larger than micelles, they are somewhat better at 
separating very hydrophobic compounds in a voltage-driven setting and there are more 
parameters that can be manipulated in their preparation.  Variations in the concentration 
and identity of surfactant, co-surfactant and oil, as well as the pH and identity of the 
background electrolyte have all proven to be important parameters in microemulsion 
electrokinetic chromatography (MEEKC) [1-8].  However, because there are more 
parameters involved in the preparation of a microemulsion, the composition is also much 
more complex to optimize than that of a micelle.  In addition, the stability of the 
microemulsion system can be more sensitive to the sample solvent and/or matrix.  In 
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MEEKC it is well noted that the analytical sample must be dissolved in the 
microemulsion to maintain the integrity of the separation, whereas this is not as critical 
with micellar electrokinetic chromatography (MEKC) [8].  A suggested reason for this is 
that the presence of a non-microemulsion sample solvent front is enough to disrupt the 
integrity of the adjacent microemulsion equilibria [9].  In addition, it has been our 
experience that microemulsion separations are more sensitive to capillary conditioning 
than a typical MEKC analysis.  While in most cases it is preferential to continually 
restore the fused silica capillary surface using either an acidic or basic medium, we have 
found that separations are more reproducible in MEEKC when only an intermittent fresh 
microemulsion rinse is employed after the initial conditioning of the new capillary. 
 
Even though the number of MEEKC publications has greatly increased within the past 
five years, chiral microemulsions have been evaluated the least in this capacity[10].  In 
fact, at the time of these findings there had only been two published reports.  The first 
chiral microemulsion was based on a chiral oil, (2R, 3R)-di-n-butyl tartrate, an achiral 
surfactant (sodium dodecyl sulfate) and an achiral co-surfactant (1-butanol) [11].  The 
second chiral microemulsion was based on a chiral surfactant, dodecoxycarbonylvaline 
(DDCV), a low interfacial tension, achiral oil (ethyl acetate), 1-butanol as the co-
surfactant and a zwitterionic background buffer (ACES) [10]. 
 
The DDCV microemulsion achieved chiral separations with each of the nine 
pharmaceutical compounds investigated, exhibiting enantioselectivities in the range of 
1.06 – 1.30. It was also noted that the DDCV microemulsion offered an enhanced elution 
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range [10] over that previously observed with DDCV micelles [12].  In addition, the 
incorporation of the ACES low-conductivity buffer and the ethyl acetate oil permitted a 
higher separation voltage, resulting in shorter analysis times [13, 14].  The advantage of 
using low interfacial tension oils, such as ethyl acetate, is that less surfactant is required 
for the microemulsion to form.  Typical surfactant concentrations in MEEKC employing 
traditional hydrocarbon oils are in the range of 80 – 100 mM, however, the use of ethyl 
acetate in this particular microemulsion required a surfactant concentration of only 30 
mM.   
 
While the DDCV microemulsion produced rapid and highly selective enantioseparations, 
the peak shapes were asymmetric and the efficiency values obtained were lower than 
previously noted using DDCV micelles.  The incorporation of tetrapropylammonium 
hydroxide (TPAH) as a mobility-matching counter-ion reduced the asymmetry, but was 
unable to eliminate it altogether.  The goal of this work was to evaluate the use of other 
low-interfacial tension oils, in combination with the DDCV microemulsion system to 
characterize their effect on peak efficiency, resolution and enantioselectivity.  There have 
been several publications focusing on the effects of changing oils with traditional 
microemulsion hydrocarbon chain oils and a few publications that have touched on the 
effect of interchanging low-interfacial tension oils [5-7, 15]. It has become increasingly 
more accepted that substitutions in the type of oil used typically result in only minor 
changes in the selectivity of the microemulsion system.  The oil can, however, alter the 
retention factors (k) of the analytes and as a result could have an effect on efficiency. The 
oils chosen for this evaluation were methyl acetate, methyl propionate and methyl 
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formate.  All three lipophilic liquids meet the criteria of having limited miscibility with 
water and exhibiting some polar character in their overall structure.  Moreover, to the best 
of our knowledge they have not previously been evaluated in this capacity.  These oils 
were examined at two different concentrations: in the same volume percentage as the 
ethyl acetate in the previous DDCV microemulsion [10] (0.5% (v/v)), and also in the 
same molar concentration as the ethyl acetate in the DDCV microemulsion (0.051 M).  
Fourteen chiral compounds were employed to test the enantioselective properties of the 
microemulsion systems: pseudoephedrine, ephedrine, methylephedrine, metoprolol, 
norphenylephrine, indapamide, synephrine, atenolol, octopamine, epinephrine, arterenol, 
propranolol, chlorpheniramine and verapamil (Figure 2.1).  At pH 7.0, all analytes were 
positively charged, with the exception of indapamide, which was neutral. 
 
 
2.2 Materials and Methods 
 
 
2.2.1  Instrumentation 
 
 
All separations were performed on an Agilent 3DCE electrophoresis system (Agilent 
Technologies, Waldbronn, Germany) at a constant temperature of 25° C.  The detection 
wavelength was 215 nm, although detection wavelengths of 236, 254 and 280 nm were 
also stored and monitored.  Each microemulsion was evaluated on a fresh, fused silica 
capillary (Ld = 23.6 cm, Lt = 32 cm, I.D. = 50 µm) (Polymicro Technologies, Phoenix 
AZ, USA).  The fresh capillaries were rinsed with 1 M NaOH for 10 minutes, 0.1 M 
NaOH for 5 minutes, HPLC grade water for 3 minutes and voltage-conditioned with 
microemulsion overnight to insure reproducible migration times.  Sample injection was  
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performed hydrodynamically by applying 25 mbar of pressure for 2 seconds.  All sample 
injections were performed in quadruplicate.  The applied voltage in all cases except the 
0.50% (v/v) methyl formate microemulsion was 17 kV; for the latter microemulsion the 
applied voltage was 15 kV.  The voltages applied resulted in Joule heat values of 1.56 
W/m.  This is different from the Joule heat values of 1.7 W/m typically employed in the 
previous set of experiments [10].   Analytical data from the Agilent 3DCE were collected 
and processed on a Hewlett Packard Kayak XA system using ChemStation software (v. 
A.08.03). 
 
 
2.2.2  Reagents 
 
 
Dodecoxycarbonylvaline (DDCV), marketed under the name EnantioselectTM, was 
provided by Waters Corporation (Milford, MA, USA).  Ethyl acetate, methyl acetate, 
methyl propionate and methyl formate were purchased from Aldrich (Milwaukee, WI, 
USA).  1-Butanol was purchased from Sigma (St. Louis, MO, USA).  N-2-acetomido-2-
aminoethanesulfonic acid (ACES), phenyldodecane, butyrophenone and 
tetrapropylammonium hydroxide (TPAH) were purchased from Aldrich (Milwaukee, WI, 
USA).  Pseudoephedrine, ephedrine, methylephedrine, norphenylephrine, atenolol and 
propranolol were purchased from Aldrich (Milwaukee,WI, USA).  Metoprolol, 
indapamide, synephrine, octopamine, epinephrine, arterenol, chlorpheniramine and 
verapamil were purchased from Sigma (St. Louis, MO, USA). 
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2.2.3  Microemulsion Preparation 
 
 
For each microemulsion preparation enough DDCV and ACES were weighed to achieve 
a final concentration of 1.00% (w/v) and 0.91% (w/v) respectively.  The DDCV and 
ACES were dissolved in a volume of HPLC grade water that was approximately 75% of 
the final volume.  The resulting solutions were then pH adjusted to 7.0 by the addition of 
tetrapropylammonium hydroxide.  1.2% (v/v) 1-butanol and the appropriate amount of 
low interfacial tension oil were then added and the solution was sonicated for 30 minutes.  
For the constant volume percentage experiments, the percentage of low interfacial tension 
oil used was 0.50% (Table 2.1).  This resulted in molar concentrations of 0.051 for ethyl 
acetate, 0.047 for methyl propionate, 0.063 for methyl acetate and 0.081 for methyl 
formate.  For the constant molarity experiments, the molar concentration was 0.051 M; 
corresponding volume percentages used for each oil were 0.50% (v/v) for ethyl acetate, 
0.32% (v/v) for methyl formate, 0.40% (v/v) for methyl acetate, and 0.54% (v/v) for 
methyl propionate.  Once sonicated, the microemulsions were transferred to a volumetric 
flask, cooled to room temperature, diluted to the mark with HPLC grade water, mixed 
well and allowed to rest for a minimum of one hour prior to use. 
 
 
2.2.4  Sample Preparation 
 
 
Each pharmaceutical enantiomer was dissolved in the appropriate microemulsion at a 
concentration of 0.5 mg/mL, with the exception of indapamide.  For solubility reasons, 
the indapamide enantiomers were prepared at a concentration of 0.25 mg/mL.  A 
negligible amount of methanol was added to each sample to serve as a t0 marker.  The tme  
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Table 2.1.  Microemulsion compositions expressed in volume percentage of oil and molar 
concentration of oila) 
 
Volume Percentage of Low 
Interfacial Tension Oil 
Molar Concentration of Low 
Interfacial Tension Oil 
Experiment 
0.50% (v/v) Ethyl Acetate 0.051 Control 
0.32% (v/v) Methyl Formate 0.051 Constant Molar Concentration 
0.50% (v/v) Methyl Formate 0.081 Constant Volume Percentage 
0.40% (v/v) Methyl Acetate 0.051 Constant Molar Concentration 
0.50% (v/v) Methyl Acetate 0.063 Constant Volume Percentage 
0.54% (v/v) Methyl Propionate 0.051 Constant Molar Concentration 
0.50% (v/v) Methyl Propionate 0.047 Constant Volume Percentage 
a) Other microemulsion components include 0.91% (w/v) (50 mM) ACES (pH 7.0), 1.0% 
(w/v) DDCV (30 mM) and 1.2% (v/v) 1-butanol (131 mM). 
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marker (migration time of the microemulsion) was prepared by dissolving 3 µL of 
octanophenone in 6.5 mL of the appropriate microemulsion for the ethyl acetate, methyl 
acetate and methyl propionate microemulsions.  For the methyl formate microemulsions, 
octanophenone destabilized the solutions; as a result, butyrophenone was used instead.  
Valerophenone, hexanophenone, heptanophenone, and phenyldodecane were also 
evaluated as tme markers, however in each case the methyl formate microemulsion 
disintegrated.  A negligible amount of methanol was also added to each tme marker 
solution to serve as a t0 marker. 
 
 
2.2.5  Calculations 
 
 
Each set of results was evaluated for peak efficiency (N), resolution (Rs), retention factor 
(k) and enantioselectivity (αenant).  Because the resolution was less than baseline in some 
cases, both resolution and efficiency were calculated using the respective half-height 
equations via ChemStation software (v. A.08.03).  The less-than-baseline resolution 
nearly always precluded the ChemStation's statistical moment method or the Foley-
Dorsey equation[16] which requires the peak width and asymmetry factor at 10%.  An 
analogous equation based on the peak width and asymmetry factor at 50% [16] was not 
utilized because the ChemStation software does not provide an asymmetry factor at 50%. 
Rs = 1.18(tr(b ) − tr(a ))
W0.5(b ) + W0.5(a )
    (2.1) 
N = 5.54 tr
W0.5
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟ 
2
    (2.2) 
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where W0.5 is the peak width at half-height (min), tr is the peak retention time (min), and 
"a" and "b" denote peaks one and two respectively.  The electroosmotic flow (µeo) was 
calculated using the equation: 
µeo = Ld Ltt0V     (2.3) 
where Ld and Lt are the length to the detector and total column length respectively, t0 
signifies the retention time of methanol and V is the applied voltage.  When calculating 
retention factors in EKC, both the electrophoretic mobility of the analytes and the 
retention characteristics must be taken into account.  The electrophoretic mobility of the 
analytes (µep) in the microemulsion was estimated by obtaining the electrophoretic 
mobilities under CZE conditions (ACES buffer, pH 7.0) and applying a correction factor 
to adjust for viscosity differences between the CZE buffer and the microemulsion.  The 
viscosity correction factor was calculated for each of the microemulsions investigated.  
The retention factor of each enantiomer was then calculated by the equation: 
k = tr 1− µr( )− t0
t0 − µ eo − µep, meµeo
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟ tr
   (2.4) 
where µep,me is calculated using equation (2.3) with the substitution of tme for t0, and the 
relative electrophoretic mobility (µr) is defined as the ratio µep,analyte/µeo.  From the 
retention factors, the enantioselectivity can then be determined: 
αenant = k2k1      (2.5) 
where k2 and k1 are the retention factors of the second and first eluting peaks 
respectively. 
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2.3  Results and Discussion 
 
 
2.3.1  Microemulsion Stability 
 
 
Each microemulsion was evaluated by adding the low-interfacial tension oil in both the 
same volume percentage and the same molar concentration as the ethyl acetate in the 
previous DDCV microemulsion.  This allowed a comparison of the different oil 
properties without performing a full phase diagram analysis of each formulation.  All of 
the microemulsions investigated (Table 2.1) were thermodynamically stable with the 
exception of the methyl formate systems.  Interestingly, the methyl formate formulation 
initially gave the illusion of forming a microemulsion.  The surfactant, co-surfactant and 
oil readily combined to form an optically transparent solution which exhibited 
chromatographic stability for three days.  After three days, however, the chromatographic 
properties began to falter.  This was signified by a gradual loss in resolution, a gain in 
migration time and a 100 – 300 mAU increase in baseline noise over all of the 
wavelengths that were monitored.  Oddly enough, throughout all of this the resulting 
current remained stable.  At 6-7 days, the solutions became turbid and separated into their 
individual components, further signifying that they were not true microemulsions.  In 
contrast, the microemulsions composed of ethyl acetate, methyl acetate and methyl 
propionate exhibited an exceptional stability of at least 2-3 months.  The stability is most 
likely longer than this, but this was the longest period of time that they were each 
observed.  
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The baseline exhibited by the 0.32% (v/v) methyl formate microemulsion was also 
unique (Figure 2.2).  While, in many cases enhanced resolution and enantioselectivity 
were observed with this formulation, the enhanced results were obtained in the presence 
of an aberrant baseline.  Depending on where the enantiomers eluted relative to the 
baseline hump, their resolution was affected.  In some cases this resulted in inflated 
values for enantioselectivity and resolution, and in other cases it caused the enantiomers 
to be completely unresolved.  The aberrant baseline was reproducible over two separate 
microemulsion and sample set preparations, on two different capillaries, using two 
different instruments and on multiple different days.  While the cause of the disturbance 
is unknown, it may be due to the existence of more than one physical phase within this 
particular formulation.  Because the microemulsion/background electrolyte (BGE) 
contains low concentrations of several UV absorbing species the variation in the ratio of 
the microemulsion components in an additional phase (with varying migration 
characteristics) could alter the absorbance profile of the baseline.  Baseline disturbances 
and system peaks are often the result of concentration vacancies that occur between the 
sample and BGE zones within the capillary [17].  It has been noted that if a species is 
present in both the BGE and sample in different concentrations, the resulting migrating 
vacancy will most likely manifest in the form of a baseline disturbance or system peak 
[18].  
 
 
2.3.2  Electrophoretic Parameters and Elution Range 
 
 
In the previous DDCV microemulsion study, the migration time of the microemulsion 
was estimated using the iterative computation method which is based on maximizing the
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Figure 2.2: Enantiomeric separation of (±)- pseudoephedrine illustrating the anomalous baseline provided by the methyl 
formate constant molarity microemulsion.  Detection wavelength: 215 ± 5 nm, capillary dimensions: Ld = 23.6 cm, Lt = 32 
cm, I.D. = 50 µm, injection: hydrodynamic (25 mbar for 2 seconds), voltage: 17 kV.  
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correlation coefficient (r2) of a regression line of log k vs. alkyl chain length (number of –
CH2- units) of a series of alkylphenones [10].  While this method has proven to be 
reliable and reproducibly linear in many other EKC analyses [19], it has occasionally 
displayed non-linear behavior with this particular microemulsion system.  For that 
reason, a tme marker was used instead.  Phenyldodecane, sudan III, biphenyl and 
octanophenone were all evaluated for this purpose.  Octanophenone was retained the 
longest of the tme markers that were investigated, without destabilizing the 
microemulsion.  Phenyldodecane, which was previously employed as a tme by Ivanova et 
al. [20], was not retained as strongly as octanophenone.  Sudan III and biphenyl were also 
evaluated, however both exhibited limited solubility in the microemulsion.  As a result of 
changing the method with which the tme was obtained, we found that the elution range 
had actually been underestimated in the previous publication.  Instead of 8.0, a value of 
11.4 was obtained (Table 2.2). 
 
Another item to note is that butyrophenone was employed as the tme marker for the 
methyl formate microemulsion systems due to the latter's instability (previously 
discussed in Sample Preparation). While butyrophenone did provide reproducible values 
without destabilizing the microemulsion, it may also underestimate the actual magnitude 
of the elution range.  Not surprisingly, therefore, methyl formate yielded the smallest 
elution range under both constant volume percentage and constant molarity conditions.  
Ethyl acetate yielded the largest elution range overall, with the order of elution ranges 
increasing in the manner: 0.32% (v/v) methyl formate < 0.50% (v/v) methyl formate < 
0.54% (v/v) methyl propionate < 0.40% (v/v) methyl acetate < 0.50% (v/v) methyl  
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Table 2.2: Electrophoretic parameters and elution range for DDCV microemulsions 
employing both constant volume percent and constant molar concentration of oil 
 
Microemulsion µeo (104)d) 
cm2/Vs 
µeo ηf)(104) 
cm2/Vs 
µep,me (104)a),e) 
cm2/Vs 
µep,me ηf)(104) 
cm2/Vs 
tme/teo = 
µeo/µnete)  
Ethyl Acetate 2.990 ± 0.039 3.32 -2.780 ± 0.011 -3.09 11.38 ± 0.19 
Methyl Formateb) 3.429 ± 0.006 3.66 -2.196± 0.019 -2.33 4.51 ± 0.11 
Methyl Acetateb) 3.058 ± 0.013 3.18 -2.919 ± 0.019 -3.04 9.06 ± 0.10 
Methyl 
Propionateb)
3.159 ± 0.010 3.29 -2.985 ± 0.007 -3.10 10.45 ± 0.12 
Methyl Formatec) 2.778 ± 0.007 3.06 -2.003 ± 0.005 -2.20 3.72 ± 0.00 
Methyl Acetatec) 3.614 ± 0.009 3.72 -2.941 ± 0.004 -3.03 5.07 ± 0.04 
Methyl Propionatec) 3.533 ± 0.018 3.81 -2.780 ± 0.018 -3.00 4.60 ± 0.06 
a) Octanophenone was used as a tme marker for methyl acetate, methyl propionate and 
ethyl acetate microemulsions.  Butyrophenone was used as a tme marker for the methyl 
formate microemulsion.  b) 0.50% (v/v).  c) Constant molar concentration as noted in 
Table 2.1.  d) Values based on the average of 56 injections.  e) Values based on the average 
of four injections.  f) η is the ratio: ηMEEKC/ηCZE. 
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acetate < 0.50% (v/v) methyl propionate < 0.50% (v/v) ethyl acetate.  With the exception 
of methyl formate, the elution ranges seem fairly consistent for the remaining 0.50% 
(v/v) microemulsions.  The methyl propionate microemulsions displayed the most drastic 
change in elution range when switching from 0.50% (v/v) to 0.54% (v/v) by shifting from 
a value of 10.45 to a value of 4.60.   
 
The values for both the electroosmotic flow (µeo) generated and the electrophoretic 
mobilities (µep,me) of the microemulsion were viscosity-corrected to account for any 
differences that the varying microemulsion compositions might interject (Table 2.2).  The 
slight differences noted in these values from system to system were statistically 
significant but displayed no discernable trends.   
 
 
2.3.3  Enantioselectivity, Resolution and Efficiency 
 
 
Representative electropherograms displaying the chiral separation of (±)-ephedrine using 
each of the microemulsion systems are displayed in Figures 2.3 and 2.4.  Compared to the 
other microemulsions, the methyl formate microemulsions displayed enhanced 
enantioselectivity for pseudoephedrine, ephedrine, methylephedrine, metoprolol, 
norphenylephrine (in the constant molarity experiment), and indapamide (Table 2.3).  
Beyond those compounds, the methyl formate formulations were unable to provide any 
enantioselectivity, with the exception of atenolol in the 0.32% (v/v) experiment.  The 
enhanced enantioselectivity, in the case of the 0.50% (v/v) methyl formate experiments, 
cannot be attributed to an abnormal baseline as might perhaps be the case with the 
constant molarity experiment.  The baseline for the 0.50% (v/v) methyl formate 
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Figure 2.3: Representative constant volume percent chromatograms for the separation of (±)-ephedrine employing 0.50% (v/v) 
(A) methyl formate, (B) methyl acetate, (C) methyl propionate and (D) ethyl acetate (control) microemulsions.  Other 
conditions as noted in Figure 2.2, with the exception of the voltage for the methyl formate analysis (15 kV). 
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Figure 2.4: Representative constant molarity chromatograms for the separation of (±)-ephedrine employing 0.051 M (A) methyl 
formate, (B) methyl acetate, (C) methyl propionate and (D) ethyl acetate (control) microemulsions.  Other conditions as noted in 
Figure 2.2. 
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Table 2.3.  Effect of oil substitution on enantioselectivity 
Compound Ethyl Acetate Methyl Formatea) Methyl Acetatea) Methyl Propionatea) Methyl Formateb) Methyl Acetateb) Methyl Propionateb)
pseudoephedrine 1.177 ± 0.011 1.190 ± 0.031 1.158 ± 0.001 1.159 ± 0.000 1.269 ± 0.002 1.163 ± 0.001 1.179 ± 0.002 
ephedrine 1.089 ± 0.001 1.124 ± 0.001 1.083 ± 0.001 1.082 ± 0.001 1.153 ± 0.001 1.085 ± 0.001 1.091 ± 0.001 
methylephedrine 1.088 ± 0.001 1.116 ± 0.001 1.083 ± 0.001 1.084 ± 0.001 1.148 ± 0.001 1.082 ± 0.003 1.091 ± 0.001 
metoprolol 1.067 ± 0.001 1.182 ± 0.005 1.061 ± 0.001 1.061 ± 0.001 1.660 ± 0.030 1.062 ± 0.001 1.072 ± 0.000 
norphenylephrine 1.080 ± 0.001 1.074 ± 0.006 1.072 ± 0.001 1.072 ± 0.000 1.103 ± 0.000 1.074 ± 0.002 1.078 ± 0.000 
indapamide 1.061 ± 0.002 1.154 ± 0.001 1.054 ± 0.000 1.054 ± 0.000 1.356 ± 0.016 1.055 ± 0.000 1.063 ± 0.003 
synephrine 1.052 ± 0.000 NR  1.033 ± 0.274 1.035 ± 0.000 NR 1.032 ± 0.001 1.061 ± 0.002 
atenolol 1.033 ± 0.000 NR 1.025 ± 0.001 1.029 ± 0.001 1.104 ± 0.013 1.018 ± 0.005 NR 
octopamine 1.041 ± 0.002 NR 1.031 ± 0.001 1.035 ± 0.001 NR 1.019 ± 0.001 1.053 ± 0.006 
epinephrine 1.040 ± 0.001 NR 1.029 ± 0.002 1.019 ± 0.006 NR 1.017 ± 0.003 1.023 ± 0.100 
arterenol 1.029 ± 0.001 NR 1.024 ± 0.002 1.009 ± 0.006 NR 1.011 ± 0.001 1.003 ± 0.002 
propranolol       NR NR NR NR NR NR NR
chlorpheniramine        NR NR NR NR NR NR NR
verapamil        NR NR NR NR NR NR NR
Average of 
Compounds 1 - 6 
 
1.09 
 
1.14 
 
1.09 
 
1.09 
 
1.28 
 
1.09 
 
1.10 
NR = not resolved.  a) 0.50% (v/v).  b) 0.051 M. 
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experiment was very uniform (Figure 2.3A).  Whether these differences are due to the 
fact that this is not a true microemulsion or are caused by some unique property of methyl 
formate that the other oils do not possess is unknown at this time.  Methyl formate is the 
least hydrophobic and most water soluble of all the oils investigated and it is possible that 
this might result in some unique characteristics when incorporated into a microemulsion-
like formulation.   
 
The enantioselectivities obtained for pseudoephedrine, ephedrine, methylephedrine, 
metoprolol, norphenylephrine, and indapamide were comparable among the ethyl acetate, 
methyl acetate and methyl propionate microemulsions.  In contrast, the 
enantioselectivities for synephrine, atenolol, octopamine and epinephrine, were different 
among the ethyl acetate, methyl acetate and methyl propionate microemulsions.  The 
latter compounds tended to be more difficult to separate via these chiral microemulsions, 
and as a result may have provided an insight to some of the more subtle differences 
between the various formulations.  In the constant volume percentage (0.50%) 
experiments, ethyl acetate provided the greatest enantioselectivity overall.  When 
evaluating the constant molarity enantioselectivity results, ethyl acetate exhibited the 
most consistent ability to separate the enantiomers of these compounds.  Again, methyl 
formate, with the exception of atenolol in the constant molarity experiment, provided no 
separation of this latter group of compounds. 
 
Arterenol, propranolol, verapamil and chlorpheniramine exhibited the lowest 
enantioselectivities with each of the microemulsions investigated.  Arterenol exhibited a 
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slight degree of enantioselectivity (1.01 – 1.03) using four of the seven microemulsion 
systems.  Verapamil, chlorpheniramine and propranolol, however, were never separated 
under any of the conditions evaluated.  In addition, they were very strongly retained by 
the microemulsion.  While all of the other compounds investigated eluted within 8 
minutes, the migration times for verapamil, chlorpheniramine and propranolol fell within 
the range of 14 – 30 minutes, depending on the microemulsion system employed.  This 
resulted in retention factors (k) in the range of 30 – 400, greatly above the optimal range.  
In EKC, as the retention factors exceed a certain optimum value (kopt), the resolution 
begins to suffer [21].  For elution ranges between 2-10, the k values of neutral analytes 
must be within the range 0.7 < k < 6.8 to obtain 90% of the maximum resolution 
obtainable at kopt [22].  While the upper cutoff for cationic species is somewhat higher 
than that of neutral species, it is still greatly exceeded by the retention factors for 
verapamil, chlorpheniramine and propranolol. 
 
The results for resolution (Table 2.4) followed the same general trend as those noted with 
enantioselectivity, with the exception that ethyl acetate provided slightly greater 
resolution for the indapamide and norphenylephrine enantiomers compared to the methyl 
acetate and methyl propionate microemulsions. 
 
In terms of efficiency, the methyl formate 0.50% (v/v) formulation yielded slightly higher 
efficiencies for the enantiomers that were separated (Table 2.5).  With the exception of 
methyl formate, the overall separation efficiency decreases as elution range increases.  
The increase in elution range was accompanied by an increase in the migration time of 
  
  
 
Table 2.4.  Effect of l oil substitution on resolution a)
Compound Ethyl Acetate Methyl Formateb) Methyl Acetateb) Methyl Propionateb) Methyl Formatec) Methyl Acetatec) Methyl Propionatec)
pseudoephedrine         2.87 2.40 2.76 2.53 2.43 2.15 2.64
ephedrine        1.74 1.33 1.66 1.72 1.75 1.33 1.40
methylephedrine        1.65 1.30 1.57 1.64 1.65 1.20 1.18
metoprolol        1.35 0.97 1.32 1.24 1.47 0.81 0.82
norphenylephrine        1.26 0.80 1.04 0.99 1.07 0.86 1.01
indapamide        0.96 0.90 1.04 0.91 1.16 0.83 0.74
synephrine        0.80 NR 0.52 0.52 NR 0.44 0.73
atenolol        0.62 NR 0.51 0.58 1.50 0.40 0.00
octopamine        0.59 NR 0.48 0.53 NR 0.27 0.69
epinephrine        0.56 NR 0.54 0.30 NR 0.31 0.35
arterenol        0.44 NR 0.45 0.19 NR 0.18 0.06
propranolol        NR NR NR NR NR NR NR
chlorpheniramine        NR NR NR NR NR NR NR
verapamil        NR NR NR NR NR NR NR
NR = not resolved. a) Standard deviation (n = 4) in all cases is ≤ 0.10. b) 0.50% (v/v).  c) 0.051 M.
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the analytes, thus allowing more longitudinal diffusion to occur.  As a result, lower 
efficiencies were observed.  For methyl acetate and methyl propionate, when the 
concentration changed from constant volume to constant molarity a decrease in elution 
range, increase in peak efficiency, and slight decrease in the resolution of the enantiomers 
was observed.  While methyl formate again does not follow the same trend as the true 
microemulsion systems, it must be noted that with the decrease in elution range for the 
0.32% (v/v) methyl formate system versus the 0.50% (v/v) system the poor baseline was 
also introduced.  The cause of the aberrant baseline, or perhaps simply the baseline itself, 
is most likely the cause of the decrease in efficiency.   
 
The average efficiency was calculated utilizing only those compounds that were 
separated by each of the microemulsions (Table 2.5).  These compounds included 
pseudoephedrine, ephedrine, methylephedrine, metoprolol, norphenylephrine and 
indapamide.  The averages obtained ranged from 14000 to 20000.  While the average 
separation efficiency of the ethyl acetate microemulsion was slightly lower than three of 
the other six microemulsion formulations, it must also be noted that the ethyl acetate 
microemulsion was able to separate more compounds than any of the other systems.  
Since the increases or decreases in efficiencies noted during this experiment were not 
large in magnitude, the capability of separating more compounds becomes the more 
important factor to consider.
  
 Table 2.5.  Effect of oil substitution on efficiency a)
Compound/Peak 
Number 
Ethyl 
Acetate 
Methyl 
Formateb)
Methyl 
Acetateb)
Methyl 
Propionateb)
Methyl 
Formatec)
Methyl 
Acetatec)
Methyl 
Propionatec)
Pseudoephedrine  
1 
 
15000 
 
21000 
 
15000 
 
17000 
 
13000 
 
17000 
 
19000 
2        13000 17000 13000 14000 10000 14000 16000
Ephedrine 
1 
 
18000 
 
24000 
 
16000 
 
18000 
 
17000 
 
21000 
 
24000 
2        16000 18000 14000 16000 15000 16000 19000
Methylephedrine 
1 
 
20000 
 
25000 
 
16000 
 
16000 
 
15000 
 
22000 
 
20000 
2        16000 18000 14000 15000 14000 14000 14000
Metoprolol 
1 
 
18000 
 
26000 
 
16000 
 
15000 
 
17000 
 
21000 
 
23000 
2        14000 15000 12000 11000 14000 10000 11000
Norphenylephrine 
1 
 
15000 
 
19000 
 
13000 
 
16000 
 
14000 
 
17000 
 
18000 
2     11000 14000 8000 9000 9243 9000 11000
Indapamide 
1 
 
11000 
 
19000 
 
15000 
 
18000 
 
16000 
 
26000 
 
13000 
2        11000 31000 17000 21000 20000 26000 14000
Synephrine 
1 
 
22000 
 
n/a 
 
n/a 
 
17000 
 
n/a 
 
n/a 
 
n/a 
2        15000 n/a n/a 13000 n/a n/a n/a
Atenolol 
1 
 
n/a 
 
n/a 
 
n/a 
 
n/a 
 
21000 
 
n/a 
 
n/a 
2        n/a n/a n/a n/a 38000 n/a n/a
Octopamine 
1 
 
15000 
 
n/a 
 
n/a 
 
n/a 
 
n/a 
 
n/a 
 
n/a 
2        15000 n/a n/a n/a n/a n/a n/a
Average of 
Compounds 1-6 
 
15000 
 
20000 
 
14000 
 
15000 
 
14000 
 
17000 
 
17000 
a) Standard deviations (n = 4) ranged from 200 to 6000, with an average value of 1200.   b) 0.50% (v/v).  c) Constant 
molar concentration as noted in Table 2.1. 
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2.4  Concluding Remarks 
 
 
Microemulsion electrokinetic chromatography provides unique separation capabilities 
with a wide range of opportunities for method optimization. Varying the low interfacial 
tension oil used in conjunction with chiral microemulsion electrokinetic chromatography 
is a viable method of eliciting subtle changes in enantioselectivity, resolution and 
efficiency.  While differences in all of these areas were noted with the use of methyl 
acetate, methyl propionate and methyl formate oils, they were seldom beneficial with 
respect to the original ethyl acetate system.  In addition, it was noted that these 
differences were more dependent on the concentration of oil than the type of oil used. 
Ethyl acetate yielded the largest elution range and, given the similar enantioselectivities 
and efficiencies, was able to separate more compounds overall; eight out of fourteen test 
compounds were separated using the ethyl acetate microemulsion versus the six out of 
fourteen compounds typically separated by the other microemulsions. While ethyl acetate 
was the forerunner in terms of enantioselectivity, even greater chiral discrimination and 
broader compound applicability are still desirable.  Additional method parameters such as 
chiral surfactant concentration and/or different chiral surfactants and chiral additives will 
need to be investigated to increase both enantioselectivity and efficiency if MEEKC is to 
become a more universal method of chiral analysis. 
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Chapter 3: Chiral Cyclodextrin-Modified Microemulsion Electrokinetic 
Chromatography 
 
 
3.1  Introduction 
 
 
Since the introduction of microemulsion electrokinetic chromatography (MEEKC) in 
1991 [1], there have been approximately 150 publications on the subject, a majority 
having been published within the past three years.  While comparisons between MEEKC 
and MEKC are largely warranted, there are important benefits to MEEKC that can make 
it a more attractive technique for a variety of applications.  The presence of the oil core in 
microemulsions results in an aggregate that is both larger in size and better able to 
solubilize a wide array of analytes and additives.  It has additionally been theorized that 
this structure offers increased fluidity, aiding in analyte penetration and mass transfer [2, 
3]. Furthermore, there are a greater number of parameters that can be manipulated when 
preparing a microemulsion.  Variations in the concentration and identity of surfactant, co-
surfactant and oil, as well as the pH and identity of the background electrolyte have all 
proven to be important parameters in MEEKC [3-9].  Lastly, and of great importance, is 
the ability to alter the elution range of the separation by changing the surfactant 
concentration and subsequently altering the charge density of the aggregate [3, 10].  This 
is not an option available in MEKC, where elution ranges are largely fixed.  
 
The lack of exploration in chiral MEEKC is surprising for two reasons.  First, increasing 
the elution window in MEEKC can enable the separation of a greater number of 
enantiomers within a given analysis.  Furthermore, this added flexibility permits custom 
tuning of the resolution.  This has been observed in non-chiral MEKC/MEEKC 
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comparisons [6, 11].  Finally, should the area of chiral MEEKC prove successful, the 
increased solubility range could have wide implications in the chiral analyses of 
hydrophobic compounds. 
 
The goal of any chiral analysis is to provide high separation selectivity, in a rapid and 
efficient manner, and in a format that is applicable to a wide array of analytes.  The 
aforementioned DDCV-based chiral microemulsion fulfilled many of those requirements.  
Most notably, when compared to an analogous DDCV-based micellar system [12], the 
microemulsion separations exhibited equal or slightly larger enantioselectivities, a greater 
than 2-fold increase in the elution range, and analysis times that were more than 3-fold 
lower [13].  Unfortunately, while separations using the DDCV microemulsion were 
successful, the efficiencies noted were consistently lower than those observed with the 
MEKC system.  Furthermore, to truly compete with the current state of chiral technology 
(namely SFC, GC and HPLC) the chiral resolution should be further improved.   
 
One way to increase the resolving power of a given EKC system is to incorporate a 
second pseudostationary phase (PSP).  For these purposes, various combinations of 
micelles, cyclodextrins, antibiotics, bile salts and crown ethers have all been explored 
[14-20].  The dual partitioning of an analyte between two different PSPs, as well as the 
analyte's electrophoretic migration characteristics, will increase the selectivity provided 
that the two selector mechanisms are complementary.  Conversely, if the selector 
mechanisms are antagonistic, the resolution will be reduced. In particular, cyclodextrins 
(CDs) have been utilized the most in this capacity, a technique often referred to as CD-
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modified EKC (or CD-EKC).  One of the attractive features of using cyclodextrins is that 
they are available in cationic, neutral or anionic forms, depending on the type and extent 
of derivation. Additionally, the functionality of the derivation often plays a key role in 
defining the stereoselective association between the analyte and CD.  In general, CD-
analyte complexation constants are determined primarily based on the size, geometry, 
hydrophobicity and hydrogen-bonding properties of the analyte [21].  One of the most 
popular variations of derivatized cyclodextrins is sulfated-β-cyclodextrin (s-β-CD).  β-
CDs, in general have exhibited the most complimentary cavity size for a wide variety of 
analytes.  Furthermore, sulfating β-CD serves to increase its aqueous solubility, as well as 
impart an anionic charge over a wide pH range. In fact, the use of s-CDs has become so 
popular that they were recently the subject of a comprehensive review [22]. 
 
While CDs have been combined with MEKC (CD-MEKC) to achieve chiral separations, 
their use with MEEKC (CD-MEEKC) has been rare and limited to achiral separations.  
In 1999, Quirino et al. employed β-CDs in conjunction with MEEKC in an on-line 
sample concentration EKC analysis [23].  More recently, CDs were employed by Tao et 
al. as an organic modifier in an MEEKC system [24].  Neither of these CD-MEEKC 
approaches was developed to separate enantiomers, and to the best of our knowledge 
there are currently none to date.  Again, since MEEKC offers increased solubility for 
hydrophobic compounds this is an area that warrants greater understanding.  
Hydrophobic compounds for which separations were either difficult or unachievable 
using conventional MEKC have been successfully separated via MEEKC [25, 26] and we 
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believe this will be the case with respect to chiral MEEKC and chiral CD-MEEKC as 
well.   
 
In this work, the results of investigations of various microemulsions with cyclodextrin 
additives are presented.  Two different microemulsions are explored: an ethyl acetate 
sodium dodecyl sulfate microemulsion developed by Mahuzier et al. [27], and a chiral 
DDCV microemulsion developed in our laboratory [13].  Each microemulsion is paired 
separately with a neutral CD (hydroxypropyl-β-CD) and an anionic CD (sulfated-β-CD).  
Furthermore, given that DDCV surfactant is available in both the pure R- and pure S- 
form, the stereoselective recognition can be reversed by simply switching the enantiomer 
with which the microemulsion is formulated. Thus, the CDs could be combined 
individually with both the R- and the S- form of the microemulsion to determine which 
combinations proved to be complementary and which proved to be antagonistic.  
 
 
3.2  Materials and Methods 
 
 
3.2.1  Instrumentation 
 
 
All separations were performed on an Agilent 3DCE electrophoresis system (Agilent 
Technologies, Waldbronn, Germany) at a constant temperature of 25° C.  The detection 
wavelength was 215 nm (data acquisition rate of 5 Hz), although detection wavelengths 
of 236, 254 and 280 nm were also monitored and stored.  Each microemulsion was 
evaluated on a fresh, fused silica capillary (Ld = 23.6 cm, Lt = 32 cm, I.D. = 50 µm) 
(Polymicro Technologies, Phoenix AZ, USA).  The fresh capillaries were rinsed with 1 
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M NaOH for 10 minutes, 0.1 M NaOH for 5 minutes, and HPLC-grade water for 3 
minutes.  Sample injection was performed hydrodynamically by applying 25 mbar of 
pressure for 2 seconds.  All sample injections were performed in quadruplicate.  For the 
first series of experiments (Section 3.1) the applied voltages ranged from 11 to 17 kV, 
such that Joule heating never exceeded 1.56 W/m.  For the second set of experiments 
(Section 3.3.2) the applied voltages ranged from 8.5 to 17 kV, and the Joule heat never 
exceeded 2.5 W/m.  Analytical data from the Agilent 3DCE were collected and processed 
on a Hewlett Packard Kayak XA system using ChemStation software (v. A.08.03). 
 
 
3.2.2 Reagents 
 
 
Dodecoxycarbonylvaline (DDCV), marketed under the name EnantioselectTM, was 
provided by Waters Corporation (Milford, MA, USA).  Highly sulfated cyclodextrin (HS-
β-CD) was provided by Beckman Coulter, Inc. (Fullerton, CA, USA).  
Tris(hydroxymethyl)aminomethane (TRIS) was purchased from BioRad Laboratories 
(Richmond, CA, USA).  Sodium phosphate, monobasic was purchased from J.T. Baker, 
Inc. (Phillipsburg, NJ, USA).  Sodium dodecylsulfate (SDS) was purchased from ICN 
Biomedicals, Inc. (Aurora, OH, USA).  Ethyl acetate was purchased from Aldrich 
(Milwaukee, WI, USA).  1-Butanol was purchased from Sigma (St. Louis, MO, USA).  
N-2-acetomido-2-aminoethanesulfonic acid (ACES), β-cyclodextrin, sulfated sodium salt 
(s-β-CD), hydroxypropyl-β-cyclodextrin (HP-β-CD) and tetrapropylammonium 
hydroxide (TPAH) were purchased from Aldrich (Milwaukee, WI, USA).  
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Pseudoephedrine, ephedrine, methylephedrine, norphenylephrine and propranolol were 
purchased from Aldrich (Milwaukee,WI, USA).  Metoprolol, indapamide, synephrine, 
octopamine, and chlorpheniramine were purchased from Sigma (St. Louis, MO, USA).   
 
 
3.2.3  Microemulsion Preparation 
 
 
Each microemulsion was prepared by combining the appropriate amount of surfactant 
and buffer component (Table 3.1) in a beaker and dissolving them in a volume of HPLC 
grade water equivalent to 75% of the final volume.  The resulting solutions were pH 
adjusted with either TPAH or HCl, depending on the preparation. Once the pH 
adjustment was complete, 0.5% (v/v) ethyl acetate and 1.2% (v/v) 1-butanol were added 
and the contents were subsequently sonicated, while covered, for approximately 30 
minutes.  Once sonicated, the microemulsions were transferred to volumetric flasks, 
diluted and allowed to rest for one hour prior to use. 
 
 
3.2.4  CD-Modified Microemulsion Preparation 
 
 
For the solid cyclodextrin additives (s-β-CD and HP-β-CD) the necessary amount of 
cyclodextrin was weighed, combined with microemulsion, sonicated for 3 minutes and 
then vortexed (see Table 3.1 for various CD-MEEKC preparations).  In the case of the 
20% (w/v) solution of Beckman HS-β-CD, the appropriate amount of HS-β-CD was 
pipetted into the microemulsion flask prior to final dilution.  The flask was then diluted to 
the mark, mixed well and allowed to rest. 
 
  
 
 
 
 
Table 3.1: Summary of microemulsion-sulfated-CD systems employed 
 
Microemulsion Buffer Type and Concentration (mM) CD Type and Concentration %(w/v) µeo (104) 
(cm2/Vs) 
DDCV ACES, 50 mM, pH 7.0 s-β-CD, 1.0% 3.28 ± 0.02 
DDCV ACES, 50 mM, pH 7.0 s-β-CD, 1.5% 3.25 ± 0.02 
DDCV phosphate, 50 mM, pH 7.0 HS-β-CD, 1.0% 3.05 ± 0.05 
DDCV phosphate, 50 mM, pH 7.0 HS-β-CD, 1.5% 2.60 ± 0.06 
SDS TRIS, 100 mM, pH 8.0 s-β-CD, 1.0% 3.43 ± 0.08 
SDS TRIS, 100 mM, pH 8.0 HS-β-CD, 1.0% 3.44 ± 0.11 
SDS phosphate, 50 mM, pH 8.0 HS-β-CD, 1.0% 3.79 ± 0.22 
SDS phosphate, 100 mM, pH 8.0 HS-β-CD, 1.0% 3.26 ± 0.03 
SDS phosphate, 100 mM, pH 8.0 s-β-CD, 1.0% 3.26 ± 0.03 
a) DDCV Microemulsion is comprised of 1.0% (w/v) DDCV: 0.5% (v/v) ethyl acetate: 1.2% (v/v) 1-butanol, dissolved in designated 
buffer. b) SDS Microemulsion is comprised of 0.6% (w/v) SDS: 0.5% (v/v) ethyl acetate: 1.2% (v/v) 1-butanol, dissolved in 
designated buffer. 
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3.2.5  Sample Preparation 
 
 
Each pharmaceutical enantiomer was dissolved in the appropriate microemulsion 
(without CD) at a concentration of 0.5 mg/mL, with the exception of indapamide (0.25 
mg/mL).  A negligible amount of methanol was added to each sample to serve as a t0 
marker.   
 
 
3.2.6  Calculations 
 
 
Whenever the resolution was sufficient, the efficiency (N) and resolution (Rs) were 
evaluated for each enantiomer or pair of enantiomers.  Because the resolution was less 
than baseline in some cases, both resolution and efficiency were calculated using the 
respective half-height equations via ChemStation software (v. A.08.03).  The less-than-
baseline resolution nearly always precluded the ChemStation's statistical moment method 
or the Foley-Dorsey equation [28] which requires the peak width and asymmetry factor at 
10%.  An analogous equation based on the peak width and asymmetry factor at 50% [28] 
was not utilized because the ChemStation software does not provide an asymmetry factor 
at 50%. 
Rs = 1.18(tr(b ) − tr(a ))
W0.5(b ) + W0.5(a )
     (3.1) 
N = 5.54 tr
W0.5
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟ 
2
    (3.2) 
where W0.5 is the peak width at half-height (min), tr is the peak retention time (min), and 
"a" and "b" denote peaks one and two respectively.   
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Electroosmotic flow (µeo) was calculated using the equation: 
µeo = Ld Ltt0V     (3.3) 
where Ld and Lt are the length to the detector and total column length respectively, t0 
signifies the retention time of the neutral marker (methanol) and V is the applied voltage.   
 
 
3.3  Results and Discussion 
 
 
3.3.1  Initial Results for the Dual CD-MEEKC Separations 
 
 
3.3.1.1  Dual CD-MEEKC Results using DDCV or SDS Microemulsions with 
Zwitterionic Buffer and HP-β-CD 
 
 
The main advantage of using a neutral cyclodextrin is that the addition of an uncharged 
species to the background electrolyte will not increase the Joule heat of the system.  
Subsequently, high separation voltages can still be utilized.  Unfortunately, a 
consequence of the cyclodextrin neutrality is that it has no electrophoretic mobility of its 
own and migrates with the EOF.  As such, the more time an analyte spends associated 
with the neutral cyclodextrin and not with the anionic microemulsion, the lower its 
overall migration time and hence, its time for separation. Shown in Figure 3.1 are the 
average resolution values for increasing concentrations of HP-β-CD with either R- or S- 
DDCV microemulsions.  As the cyclodextrin concentration is increased it is apparent that 
the resolution and retention time greatly decrease.   At the highest HP-β-CD 
concentration (50 mM), almost none of the enantiomers were separated.   
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Figure 3.1: Effect of HP-β-CD concentration on average compound resolution using either R- or S- DDCV microemulsion. 
Detection wavelength: 215 ± 5 nm, capillary dimensions: Ld = 23.6 cm, Lt = 32 cm, I.D. = 50 µm, injection: hydrodynamic (25 
mbar x 2 s.), voltage: 17 kV. 
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Similarly, addition of HP-β-CD to the SDS microemulsion provided essentially no chiral 
resolution of any of the compounds investigated, with the exception of pseudoephedrine 
which displayed a resolution of 0.7 at the highest HP-β-CD concentration (50 mM).  
Based on the widespread decrease in enantiomeric resolution when using HP-β-CD with 
the R-DDCV, S-DDCV or SDS microemulsions, the cause is most likely not due to a 
lack of stereoselective interaction and more likely due to a lack of optimal retention.  In 
EKC if retention factors (k) are outside of the optimal range which depends on the elution 
range, resolution will suffer [19, 29].  Since the structures of the compounds evaluated 
were moderately diverse and both enantiomers of DDCV microemulsion were utilized, if 
the decrease in resolution had been only due to a lack of stereoselective interaction, then 
either the (R)- or (S)- form of the DDCV microemulsion would most likely have 
provided a separation for at least some of the enantiomers.   
 
While the loss in migration time caused by the HP-β-CD makes it unsuitable for use as 
the sole additive in conjunction with the SDS or DDCV microemulsions, it may still 
show value in a mixed cyclodextrin (neutral and anionic) microemulsion application.  
Additionally, it may also find use in the MEEKC analyses of more hydrophobic 
compounds where large retention factors often pose a problem. 
 
 
3.3.1.2 Dual CD-MEEKC Results Using DDCV Microemulsion with ACES Buffer 
and a Randomly Sulfated β-CD 
 
 
The addition of s-β-CD to the DDCV microemulsion system increased the amount of 
current and as a result decreased the voltage that could be applied.  The DDCV 
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microemulsion system with 0% s-β-CD utilized a separation voltage of 17 kV.  At the 
highest s-β-CD concentration (1.5%) the separation voltage had to be decreased to 11 kV.  
All voltages were applied such that Joule heating did not exceed 1.5 W/m. 
 
Resolution data for both the R- and S- DDCV microemulsion using 0 to 1.5% (w/v) s-β-
CD are given in Table 3.2.  The resolution varies with the type of surfactant enantiomer 
used and the concentration of s-β-CD added.  They also vary from compound to 
compound depending on the complementary or antagonistic stereoselective interactions 
provided by the dual-PSP system.   
 
Of particular interest are some of the compounds that exhibited very limited separation 
using only the DDCV microemulsion.  These compounds include synephrine, 
propranolol, and chlorpheniramine. While the separation of these compounds utilizing 
DDCV microemulsion was limited, greater resolution of these compounds was achieved 
upon the addition of s-β-CD.  Synephrine and propranolol displayed a slight preference 
for the R-DDCV microemulsion. Synephrine exhibited almost baseline resolution (1.3) 
upon the addition of 1.0% s-β-CD and displayed greater than baseline resolution (1.9) 
when the concentration of s-β-CD was increased to 1.5%.  Propranolol, which had never 
before separated utilizing solely the DDCV microemulsion, exhibited a small amount of 
resolution (0.4 and 0.5 respectively) upon the addition of 0.5 and 1.0% s-β-CD.  
Furthermore, chlorpheniramine (also not previously separated by chiral MEEKC) 
exhibited greater than baseline resolution under 0.5% s-β-CD conditions (1.7 and 1.6 for 
 
  
 
 
 
Table 3.2: Effect of concentration of s-β-CD and DDCV surfactant enantiomer on resolution a)
Compound 0b) 0.5-Sc) 1.0-Sc) 1.5-Sc) 0.5-Rb) 1.0-Rb) 1.5-Rb)
pseudoephedrine      2.87 3.37 4.48 5.70* 0.52 2.01 3.20*
ephedrine 1.74       
       
       
        
      
      
      
      
1.61 2.13 2.27 0.00 0.46 0.98
methylephedrine
 
1.65 1.44 1.57 1.80 0.00 0.42 NDe)
metoprolol 1.35 0.94 0.96 0.91 0.87 0.76 0.76
indapamide 0.96 0.97 0.97 1.00 1.09 0.94 1.11
synephrine 0.80 0.98* 0.59 NDe) 0.61 1.28 1.90
octopamine 0.59 0.38 0.49 NDe) 0.19 0.41 NDe)
propranolol 0.00 0.00 0.00 NDe) 0.43 0.54 NDe)
chlorpheniramine 0.00 1.68 0.00 NDe) 1.56 0.00 NDe)
a) Standard deviations (n = 4) ranged from 0.00 to 0.86 (pseudoephedrine), with an average value of 0.07.  “*” 
Represents values with a standard deviation > 0.1.   b) DDCV microemulsion (1.0% (w/v) DDCV: 0.5% (v/v) ethyl 
acetate: 1.2% (v/v) 1-butanol, 50 mM ACES buffer, pH 7.0) with no added cyclodextrin.  c) Where "x"-S = "x"% (w/v) 
s-β-CD with S-DDCV microemulsion.  d) Where "x"-R = "x"% (w/v) s-β-CD with R-DDCV microemulsion.  e) ND:  
Not detected either due to excessive retention or baseline noise. 
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S- and R-DDCV respectively), however, a preference for either DDCV enantiomer was 
not clearly established. 
 
The ephedrine derivatives (ephedrine, pseudoephedrine and methylephedrine) exhibited a 
clear preference for S-DDCV, and the resolution of these compounds steadily increased 
with increasing s-β-CD concentration.  Pseudoephedrine exhibited a resolution increase 
from 2.9 with no s-β-CD to 5.7 upon the incorporation of 1.5% s-β-CD.  Similarly, 
ephedrine displayed an increase from 1.7 to 2.3 and methylephedrine from 1.6 to 1.8.  In 
contrast, when R-DDCV was used in the microemulsion, ephedrine and methylephedrine 
showed no separation at the lowest concentration (0.5%), while pseudoephedrine 
displayed a resolution of only 0.5.  The resolution of these compounds using R-DDCV 
did increase with increasing s-β-CD concentration, but the values achieved were always 
significantly less than those achieved using S-DDCV.  This would indicate that the 
stereoselective mechanisms of S-DDCV and s-β-CD are complementary, while those of 
R-DDCV and s-β-CD are antagonistic.  In the latter case, when the magnitudes of the 
opposing stereoselective mechanisms are comparable (e.g., at 0.5% s-β-CD), the 
enantioselectivity provided by each PSP cancels.  Beyond that point, as the concentration 
of s-β-CD increases, the greater magnitude of the s-β-CD enantioselective mechanism 
begins to dominate, and a moderate amount of resolution is obtained.   
 
Two compounds, metoprolol and indapamide, were relatively unaffected by either the 
stereochemical configuration of DDCV or the concentration of s-β-CD added.  
Metoprolol showed an initial reduction in resolution (from 1.3 to 0.9) upon the addition 
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of s-β-CD, but thereafter no further change occurred as the concentration of s-β-CD was 
varied.  Moreover, it displayed a very slight preference for S-DDCV over R-DDCV, 
exhibiting resolution of 0.9 to 1.0 with the S-DDCV and 0.8 to 0.9 with the R-DDCV 
over the entire range of s-β-CD  concentrations. Conversely, indapamide showed no real 
preference for either R- or S- DDCV with the resolutions ranging from 0.9 to 1.1 over the 
entire s-β-CD concentration range. 
 
Table 3.3 displays the efficiency values.  One obvious result is that the separation 
efficiency decreased significantly upon the addition of any s-β-CD.  Of particular note is 
the increase in baseline disturbance with increasing s-β-CD concentration (Figure 3.2).  
As the concentration of s-β-CD was increased, so did the level of baseline disturbance.  
Ultimately, at the highest concentration (1.5%) it was difficult to distinguish many of the 
peaks from the background noise.   
 
 
3.3.1.3  Dual CD-MEEKC Results Using SDS Microemulsion with TRIS Buffer and 
Randomly Sulfated CDs 
 
 
The SDS microemulsion (Table 3.1) used in these experiments was previously reported 
by Mahuzier et al. in the high-speed analysis of ethyl parahydroxybenzoate samples [27].  
This formulation was chosen because it employs a low-interfacial-tension oil, as well as a 
zwitterionic surfactant (TRIS), to enable the use of high voltages while minimizing Joule 
heat.  In contrast to the DDCV microemulsion, the SDS microemulsion is achiral.  
Consequently, the only way to elicit any capability of chiral differentiation is to 
incorporate an additive that is chiral in nature. The SDS microemulsion was evaluated 
 
  
 
 
 
 
Table 3.3: Effect of concentration of s-β-CD employing S-DDCV microemulsion on efficiency a)
88
 Compound 0.50%b)c
)
1.00%b)c
)
1.50%b)c
)
pseudoephedrine    6000 5000 5700
ephedrine 6000   
    
   
    
   
  
 
  
8000 8000
methylephedrine
 
5000 5000 6000
metoprolol 11000 12000 11000
indapamide 21000 19000 19000
synephrine 1400 300 NDc)
octopamine NDc) 800 NDc)
propranolol NDc) NDc) NDc)
chlorpheniramine 17000 NDc) NDc)
 
a) Standard deviations (n = 4) ranged from 100 to 2100, with an average value of 800.  b) S-DDCV microemulsion (1.0% (w/v) 
S-DDCV: 0.5% (v/v) ethyl acetate: 1.2% (v/v) 1-butanol, 50 mM ACES buffer, pH 7.0) c) Resulting efficiencies when 0.50, 
1.00 and 1.50 % (w/v) s-β-CD with S-DDCV microemulsion. Efficiencies represent the average of peaks 1 and 2 over four 
injections.  d) ND:  Not detected either due to excessive retention or baseline noise. 
 
 
 
  
Figure 3.2: Representative chromatograms for enantiomeric separations using the initial 1.5% s-β-CD – (S)-DDCV 
microemulsion separation conditions with 50 mM ACES buffer and randomly sulfated CDs (microemulsion and buffer 
composition as in Table 3.1). (A)  (±)-ephedrine, (B)  (±)-methylephedrine, (C)  (±)-pseudoephedrine.  Voltage: 11 kV. Other 
conditions as noted in Figure 3.1.
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with the addition of 0.25, 0.5 and 1.0% s-β-CD.  A lower CD concentration range was 
explored compared to that previously explored with the DDCV microemulsion because 
the SDS microemulsion is somewhat more conductive, and as a result, generates more 
Joule heat.  
 
Of the ten compounds investigated, the dual s-β-CD-SDS microemulsion system 
achieved a small degree of chiral separation with six compounds: pseudoephedrine, 
ephedrine, methylephedrine, norphenylephrine, synephrine and octopamine (Figures 3.3 
and 3.4).  Unfortunately, the resolution was very low, ranging from 0 to 0.83 at the 
highest s-β-CD concentration (1.0%).  Moreover, the efficiencies of the separated peaks 
ranged from 600 to 4800, with an average value of only 1900. 
 
An additional disadvantage noted with the CD-SDS microemulsions was that the 
retention times were extremely long.  Indeed, the retention times ranged from 4 to 75 
minutes, with a majority of the compounds eluting after 10 minutes. Since the 
electroosmotic flow noted in these analyses was moderate to high (Table 3.1), the large 
retention times are due solely to strong analyte-PSP interactions. 
 
 
3.3.2  Method Optimization – Buffer Selection and Highly Sulfated-β-CD (HS-β-CD) 
 
 
Several deficiencies were observed in the first series of CD-MEEKC experiments that 
warranted further investigation.  First and foremost were the low efficiencies and poor 
peak shapes obtained.  When working with cyclodextrin-modified PSP systems, there are 
additional sources of band broadening to consider.  First, surfactant monomers often 
 
  
Resolution vs s-β-CD % (w/v) in SDS Microemulsion 
for Separated Compounds
0.0
0.2
0.4
0.6
0.8
0 0.2 0.4 0.6 0.8 1
Concentration of s-β-CD % (w/v)
R
e
s
o
l
u
t
i
o
n
pseudoephedrine ephedrine methylephedrine
norphenylephrine synephrine octopamine
 
Figure 3.3: Effect of s-β-CD concentration on resolution for compounds separated using the initial 1.0% s-β-CD – SDS 
microemulsion separation conditions with 100 mM TRIS buffer and randomly sulfated CDs (microemulsion and buffer 
composition as in Table 3.1). Voltage: 10.5 kV. Other conditions as noted in Figure 3.1. 
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Figure 3.4: Representative chromatograms for enantiomeric separations using the initial 1.0% s-β-CD – SDS microemulsion 
separation conditions with 100 mM TRIS buffer and randomly sulfated CDs (microemulsion and buffer composition as in 
Table 3.1). Voltage: 10.5 kV(A)  (±)-ephedrine, (B)  (±)-norphenylephrine, (C)  (±)-pseudoephedrine, (D)  (±)-synephrine.  
Other conditions as noted in Figure 3.1.
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compete with analyte to complex with the cyclodextrin and this competition can affect 
both resolution and efficiency [19].  Second, derivatized cyclodextrins can exhibit a range 
in both the degree and placement of the substituents around the glucopyranose rings of 
the CD cavity rim.  The resultant polydispersity of both CD mass and charge will create a 
range of CD mobilities within a given separation [22].  Understandably, any analyte 
associated with the CD would also exhibit a range of mobilities, thus broadening the 
peak.  Furthermore, the mobility mismatch between the migration of the analyte and the 
analyte-CD complex can cause broadening due to electromigration dispersion [30, 31].  
Lastly, the dual PSP – analyte interactions can serve to greatly lengthen analysis times.  
As a result, there may also be an increase in band broadening simply due to increased 
longitudinal diffusion.  
 
In addition to the low efficiencies observed, there was a significant amount of baseline 
disturbance associated with these analyses, especially the DDCV analysis (Figure 3.2).  
In many labs there has been an increase in the use of zwitterionic buffers for voltage-
driven separations because they permit the use of high operating voltages due to their low 
conductivity, and resulting lower Joule heat generation.  While these buffers have proven 
extraordinarily useful in many applications, there are two key items that should be 
considered when deciding to use a zwitterionic buffer over an inorganic buffer such as 
phosphate or borate.  First, many zwitterionic buffers exhibit a significant degree of UV 
absorption, which serves to increase the background signal in a given separation.  
Secondly, and equally important in EKC, zwitterionic buffers are more hydrophobic than 
inorganic buffers; as a result, they too may partition into a given pseudostationary phase.   
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Based on the aforementioned sources of band broadening and the significant buffer UV 
absorption, several additional experiments were conducted.  A smaller compound subset 
was used to investigate the effect of changing parameters such as the quality of s-β-CD, 
the identity and concentration of the background buffer, and the use of higher applied 
voltages.  First, in terms of the quality of sulfated-β-CD, the use of highly sulfated β-
cyclodextrins (HS-β-CD) was investigated. These HS-β-CDs contain an average of 12 
sulfate groups per β-CD molecule [32], and a relatively small standard deviation to 
reduce polydispersity.  In terms of changing the background buffer, TRIS and phosphate 
were each compared for use in conjunction with the DDCV and SDS microemulsions.  
Finally, there has been an increasing popularity in the use of higher operating voltages 
that result in Joule heating levels above the linear range of an Ohm's law plot (i.e. > 1.5 
W/m).  Surprisingly, many of these separations have proven to be very robust and 
reproducible.  Consequently, higher voltages were employed in the second set of 
experiments than previously used in the first set. 
 
 
3.3.2.1  Dual CD-MEEKC Results Using DDCV Microemulsion with Phosphate 
Buffer and HS-β-CDs 
 
 
Using HPLC-grade water as the reference, 10 mM preparations of ACES, TRIS and 
phosphate buffer were scanned via UV/VIS from 190 to 320 nm.  At the analytical 
wavelength of 214 nm, ACES and TRIS displayed absorbances of 2.9 and 1.6 
respectively.  In contrast, phosphate exhibited essentially no absorbance, with a value of 
0.001 AU.  It was obvious that ACES needed to be replaced.  Even though TRIS 
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exhibited significant absorbance at 214, it was still evaluated along with phosphate as a 
possible replacement for ACES.  DDCV microemulsion (without cyclodextrin) was 
prepared in both 50 mM TRIS and 50 mM phosphate buffer (pH 7.0) and analyses of 
ephedrine were then conducted.  Surprisingly, there was a large difference in the resulting 
efficiencies.  The TRIS system displayed an average efficiency of only 7500 whereas the 
phosphate system displayed an average value of 18000.  There was a moderate difference 
in the retention times of the ephedrine enantiomers (4.5 and 7.2 minutes for phosphate 
and TRIS respectively) but not enough to result in large difference in the longitudinal 
diffusion.  Furthermore, both systems generated fairly equivalent electroosmotic flows 
(µeo), 3.5 x 10-4 and 3.9 x 10-4 for TRIS and phosphate respectively.  The increased 
retention times of the enantiomers in TRIS, despite the similar µeo, would indicate that 
the microemulsion was more retentive, or moving more strongly in opposition to the bulk 
flow in the TRIS system than in the phosphate system.  One possible reason for the 
difference in microemulsion migration is the presence of sodium ions in the phosphate 
buffer (NaH2PO4).  Since the microemulsion is negatively charged, sodium ions present 
in solution would associate with it.  This would subsequently reduce the negative 
effective charge of the aggregate, thus causing it to migrate less strongly up-stream.  
Furthermore, the reduction in charge may have decreased the electromigration dispersion 
from the analyte associating with the microemulsion[31]. 
 
Based on the above results with ACES and phosphate buffer, the latter was used 
exclusively in the experiments below.  The sulfated cyclodextrin experiments were 
repeated using the phosphate buffer and employing HS-β-CDs (Table 3.4, Figure 3.5).  
 
  
 
 
 
 
Table 3.4: Effect of buffer composition and % sulfated-β-CD in S-DDCV microemulsion on efficiency and resolution 
Buffer 50 mM ACES buffer, pH 7.0a) 50 mM phosphate buffer, pH 7.0a)
Compound 1% s-β-CD  
 
Rs  
1% s-β-CD  
 
Nb)  
1.5% s-β-CD 
 
Rs 
1.5% s-β-CD 
 
Nb)  
1% HS-β-
CD  
Rs 
1% HS-β-
CD  
Nb)  
1.5% HS-β-
CD  
Rs 
1.5% HS-β-
CD  
Nb)  
ephedrine 2.13 ± 0.07 8000 ± 700 2.27 ± 0.02 8000 ± 200 1.93 ± 0.03 11000 ± 300 2.66 ± 0.02 8000 ± 1000 
pseudoephedrine 4.48 ± 0.13 5000 ± 400 5.70 ± 0.86 6000 ± 1300 3.23 ± 0.08 6000 ± 400 4.82 ± 0.10 4000 ± 600 
methylephedrine 1.57 ± 0.08 5000 ± 500 1.80 ± 0.09 6000 ± 200 1.80 ± 0.08 9000 ± 500 2.25 ± 0.10 5000 ± 1200 
Average         2.73 6000 3.26 6000 2.32 9000 3.24 6000
a) S-DDCV microemulsion (1.0% (w/v) S-DDCV: 0.5% (v/v) ethyl acetate: 1.2% (v/v) 1-butanol, designated buffer, pH 7.0) b) 
Resulting efficiencies when 1.00 and 1.50 % (w/v) sulfated-β-CD (either random or highly sulfated) with S-DDCV microemulsion. 
Efficiencies represent the average of peaks 1 and 2 over four injections. 
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Figure 3.5: Representative chromatograms for enantiomeric separations using the optimized 1.5% HS-β-CD – (S)-DDCV 
microemulsion separation conditions with 50 mM phosphate buffer and highly sulfated CDs (microemulsion and buffer 
composition as in Table 3.1).  Voltage: 9 kV. Compounds and other conditions as noted in Figure 3.2.
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This time a smaller subset of compounds was investigated: ephedrine, pseudoephedrine 
and methylephedrine.   Most notably, the reduction in baseline noise is readily apparent 
(Figure 3.5 vs. Figure 3.2).  While the values for efficiency and resolution remained 
approximately the same, the likely increase in separation robustness and reproducibility 
resulting from the improvement in baseline stability are of paramount importance. 
 
 
3.3.2.2 Dual CD-MEEKC Results Using SDS Microemulsion with Phosphate Buffer 
and HS-β-CDs  
 
 
The original SDS-s-β-CD results were obtained using TRIS buffer, and the initial 
hypothesis was that it was largely the polydispersity of the randomly sulfated CDs that 
was the source of the poor resolution and efficiency.  Consequently, the first set of 
optimization experiments were conducted using the same TRIS buffer, but incorporating 
the better quality HS-β-CD.  Again, a smaller set of compounds was investigated: 
pseudoephedrine, norphenylephrine and synephrine.   
 
Surprisingly, although some improvement in efficiency and resolution was observed 
(Table 3.5 and Figure 3.6A), the efficiency did not improve as dramatically as desired. 
Moreover, the retention times were still long.  Based on the insight gained from the 
previous DDCV experiments, the SDS experiments were conducted again, this time using 
50 mM phosphate buffer.  Experiments were also conducted using 100 mM phosphate 
and comparing both the random and highly sulfated CDs.  The most improved efficiency 
and resolution resulted from using 100 mM phosphate in conjunction with the randomly 
sulfated cyclodextrins. These improvements depended mostly on buffer identity and 
 
  
 
 
 
Table 3.5: Effect of buffer composition and % sulfated-β-CD in SDS microemulsion on efficiency and resolution 
 
Buffer 
 
100 mM TRIS buffer, pH 8.0a)
50 mM 
phosphate buffer, 
pH 8.0a)
 
 
100 mM phosphate buffer, pH 8.0a)
 
Compound 
1% s-
β-CD 
Rs  
1% s-
β-CD 
Nb)  
1% HS-
β-CD 
Rs  
1% HS-
β-CD 
Nb)  
1%HS-
β-CD 
Rs 
1%HS-
β-CD 
Nb)  
1% HS-
β-CD  
Rs  
1% HS-
β-CD  
Nb)  
1% s-
β-CD 
Rs  
1% s-
β-CD 
Nb)  
pseudoephedrine           0.83 800 1.14 4000 2.57 14000 2.38 16000 2.87 19000
norphenylephrine           0.79 600 1.64 2000 1.41 2000 1.47 3000 1.59 5000
synephrine 0.83          2000 1.29 5000 1.02 5000 1.05 9000 1.22 10000
Average           0.82 1000 1.36 3000 1.67 7000 1.63 9000 1.89 11000
a) SDS microemulsion (0.6% (w/v) SDS: 0.5% (v/v) ethyl acetate: 1.2% (v/v) 1-butanol, in designated buffer, pH 8.0).  
Standard deviations (n = 4) were ≤ 0.2 or 3000 with an average of 0.09 and 900 for resolution and efficiency, respectively. b) 
Resulting efficiencies when 1.00% (w/v) sulfated-β-CD (either random or highly sulfated) is combined with SDS 
microemulsion using either phosphate or TRIS buffer. Efficiencies represent the average of peaks 1 and 2 over four injections. 
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Figure 3.6: Representative chromatograms of the separation of (±)-pseudoephedrine comparing the use of either 100 mM TRIS 
or 100 mM phosphate buffer with 1.0% HS-β-CD and SDS microemulsion (microemulsion and buffer composition as in Table 
3.1).  Voltage: 8 kV.  (A)  (±)-pseudoephedrine employing TRIS buffer (B)  (±)-pseudoephedrine employing phosphate buffer. 
Other conditions as noted in Figure 3.1.
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concentration and varied only slightly with the type of sulfated CD used (Figures 3.6A 
and 3.6B).  Additionally, the use of higher voltages (corresponding to 2.5 W/m) may 
have increased efficiency by reducing longitudinal diffusion via shorter analysis times.  
Further, the µeo obtained using these voltages was still very reproducible, yielding a value 
of 3.26 ± 0.03 x 10-4 over 32 injections. 
 
Once the optimum buffer and cyclodextrin choices had been made, the dual SDS-s-β-CD 
PSP was re-applied to ephedrine and methylephedrine which had previously been poorly 
resolved.  Indeed, resolution of both ephedrine and methylephedrine greatly improved, as 
did the analysis time and efficiency (Table 3.6 and Figures 3.7A and 3.7B).  Where the 
retention time of ephedrine using the old method was greater than 15 minutes, the 
improved method yields an analysis time of only 6 minutes.  Similarly the resolution 
improved from 0.36 to 1.04, and the efficiency (although not previously measurable) 
increased to a value of 26000.   
 
This method was also applied to levetiracetam (Keppra), a chiral derivative of an S-
enantiomer pyrrolidine that has proven to be a broad-spectrum anti-epileptic drug for 
both partial onset and primarily generalized epilepsies [33].  A CE-based method of 
chiral analysis is very desirable for levetiracetam due to the lower relative cost, and 
capability for efficient yet rapid enantiomeric separations when compared with HPLC.  A 
chiral CE separation of levetiracetam has yet to be reported, and until this point, our own 
attempts to develop a chiral CE method for levetiracetam, using both conventional and 
 
  
 
 
 
Table 3.6: Efficiency and resolution of additional compounds separated using optimized CD-SDS microemulsion 
 
Buffer 
100 mM TRIS buffer, pH 
8.0a)
100 mM phosphate buffer, pH 8.0a)
Compound Rs  Nb)  Rs  Nb)  
ephedrine 0.36 ± 0.01 N/A 1.04 ± 0.12 26000 ± 3000 
methylephedrine 0.36 ± 0.04 N/A 0.83 ± 0.02 23000 ± 700 
levetiracetum  N/A N/A 0.93 /1.11c) 26000/15000c)
Average   0.36 N/A 0.93d) 25000d)
a) SDS microemulsion (0.6% (w/v) SDS: 0.5% (v/v) ethyl acetate: 1.2% (v/v) 1-butanol, in designated buffer, pH 8.0) b) 
Resulting efficiencies when 1.0% (w/v) s-β-CD is combined with SDS microemulsion using either phosphate or TRIS buffer. 
Efficiencies represent the average of peaks 1 and 2 over four injections.  Plate counts were unavailable for the non-optimized 
method conditions due to insufficient resolution. c) Utilizing 1.0 and 1.5% s-β-CD, respectively.  Standard deviations for these 
measurements were 3000 and 500, respectively.  d) Represents the average of the 1.0% s-β-CD addition only. 
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Figure 3.7: Separation of (A)  (±)-ephedrine, (B)  (±)-methylephedrine enantiomers previously unresolved, using the optimized 100 
mM phosphate, s-β-CD-SDS conditions (microemulsion and buffer composition as in Table 3.1).  Voltage: 8 kV. Other conditions as 
noted in Figure 3.1.
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Figure 3.8: Separation of (R,S)-levetiracetam, using the optimized 100 mM phosphate, s-β-CD-SDS conditions 
(microemulsion and buffer composition as in Table 3.1).  Voltage: 8 kV. (A)  (R/S)-levetiracetam using 1.0% s-β-CD, (B)  
(R/S)-levetiracetam using 1.5% s-β-CD.  Other conditions as noted in Figure 3.1.  
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unconventional methodologies, had proven unsuccessful (investigations by M.X. Zhou 
and J.P. Foley).      
 
Using the optimized dual SDS-s-β-CD approach noted above (50 mM SDS and 1% s-β-
CD), Levetiracetam was enantioresolved for the first time via CE methodology (Table 3.6 
and Figure 3.8), with a resolution of 0.93 and an average efficiency of 26000.  Moreover, 
when the amount of s-β-CD was increased from 1.0 to 1.5% (Figure 3.8A vs. 3.8B), the 
resolution of levetiracetam increased to 1.11. 
 
 
3.4  Concluding Remarks 
 
 
Microemulsion electrokinetic chromatography is only now beginning to come into its 
own as a chromatographic technique. Its greatest strengths continue to lie in its ability to 
solubilize a wide array of analytes and additives, as well as its increased flexibility in 
both method optimization and elution range.  Specifically, we have shown the potential 
strengths of chiral CD-MEEKC as a future analytical technique.  By varying simple 
parameters such as buffer system, applied voltage, surfactant enantiomer and type of 
cyclodextrin dramatic improvements in enantiomeric separations were noted. 
Importantly, this facilitated the first ever chiral CE analysis of levetiracetam.  Indeed, 
chiral MEEKC analyses could prove beneficial in a wide array of applications, most 
notably in the chiral analysis of hydrophobic compounds, for which CE methods are not 
currently a preferred methodology. 
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Chapter 4: The Effect of Surfactant Concentration and Buffer Selection on 
Chromatographic Figures of Merit in Chiral Microemulsion Electrokinetic 
Chromatography 
 
 
4.1 Introduction 
 
 
Three of the four previous chiral MEEKC publications dealt specifically with a chiral 
microemulsion based on a chiral surfactant, dodecoxycarbonylvaline (DDCV), a low 
interfacial tension oil (ethyl acetate), 1-butanol as the co-surfactant and a zwitterionic 
background buffer (ACES) [1-3]. The DDCV-based chiral microemulsion provided many 
rapid, highly selective separations.  Most notably, when compared to an analogous 
DDCV-based micellar system, the microemulsion separations exhibited equal or slightly 
larger enantioselectivities, a greater than 2-fold increase in the elution range, and analysis 
times that were more than 3-fold lower [1].  Unfortunately, while separations using the 
DDCV microemulsion were successful, the efficiencies noted were consistently lower 
than those observed with the MEKC system.  Furthermore, to truly compete with the 
current state of chiral technology (namely SFC, GC and HPLC) the resolution obtained 
via chiral MEEKC should be improved. 
 
Experiments have been performed to at least partially address the aforementioned issues.  
The first study dealt specifically with the effect of oil substitution on the chiral DDCV-
MEEKC separations [2]. A closely related series of oils was evaluated, in addition to 
ethyl acetate, and their effect on efficiency, resolution and enantioselectivity were 
reported.  Unfortunately, while differences were indeed noted, ethyl acetate still provided 
the best results and no changes to the original method were made.   
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In contrast, the second study evaluated the use of cyclodextrin-modified MEEKC (CD-
MEEKC) as a means of increasing the resolving power of the original DDCV 
microemulsion [3].  During this series of experiments, the ACES zwitterionic buffer was 
replaced with phosphate buffer (also pH 7, 50 mM), to reduce background absorbance 
and investigate the possibility that the more hydrophobic ACES species was competing 
with analyte to interact with cyclodextrin or microemulsion. This was similarly 
performed with a CD modified, achiral SDS microemulsion.  By varying simple 
parameters such as buffer system, applied voltage, and the quality of sulfated 
cyclodextrin, dramatic improvements in the chiral separations were noted. Surprisingly, 
resolution and efficiency were found to be highly dependent on buffer identity and 
concentration, and only somewhat dependent on whether the cyclodextrins used were 
randomly or highly sulfated.  Prior to method optimization, the CD-MEEKC resolution 
values were minimal, with few enantiomers resolved.  Moreover, the number of 
theoretical plates ranged from only the hundreds to low thousands.  In contrast, using the 
optimized conditions resolution values greatly increased, such that many compounds 
unresolved under the previous conditions subsequently displayed baseline resolution.  
Similarly, the efficiencies increased by approximately 4 to 25 times their original values.  
Importantly, this facilitated the first ever chiral CE separation of R- and S- levetiracetam, 
which were separated in less than 8 minutes, with a resolution of 1.1. 
 
Utilizing the recent insights regarding the importance of buffer choice, described herein 
are the results of work that was conducted to re-evaluate the DDCV microemulsion in the 
absence of the zwitterionic ACES buffer.  Importantly, supplemental to the switch to 
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phosphate buffer, experiments were performed in which only the amount of surfactant 
was increased.  These results were then compared to those obtained by increasing the 
overall phase ratio (or number of microemulsion aggregates) in the BGE.  Finally, the 
microemulsions are evaluated based on efficiency, resolution, retention, enantioselectivty 
and elution range. 
 
 
4.2 Materials and Methods 
 
 
4.2.1  Instrumentation 
 
 
All separations were performed on an Agilent 3DCE electrophoresis system (Agilent 
Technologies, Waldbronn, Germany) at a constant temperature of 25° C.  The detection 
wavelength was 215 nm, although detection wavelengths of 236, 254 and 280 nm were 
also stored and monitored.  Each microemulsion was evaluated on a fresh, fused silica 
capillary (Ld = 23.6 cm, Lt = 32 cm, I.D. = 50 µm) (Polymicro Technologies, Phoenix 
AZ, USA).  The fresh capillaries were rinsed with 1 M NaOH for 10 minutes, 0.1 M 
NaOH for 5 minutes, HPLC grade water for 3 minutes and microemulsion for 15 
minutes.  In between analyses, capillaries were rinsed with HPLC grade water for 10 
minutes, 0.1 M NaOH for 10 minutes, HPLC grade water for 3 minutes and 
microemulsion for 15 minutes.  Sample injection was performed hydrodynamically by 
applying 25 mbar of pressure for 2 seconds.  All sample injections were performed in 
quadruplicate. Voltages were applied such that a power of 0.9 W was observed, resulting 
in Joule heat values of 2.8 W/m. Voltages applied for the phosphate analyses ranged from 
11.5 to 12.5 kV and the voltage for the ACES analysis was 17 kV.  Analytical data from 
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the Agilent 3DCE were collected and processed on a Hewlett Packard Kayak XA system 
using ChemStation software (v. A.08.03). 
 
 
4.2.2  Reagents 
 
 
Dodecoxycarbonylvaline (DDCV), marketed under the name EnantioselectTM, was 
provided by Waters Corporation (Milford, MA, USA).  Ethyl acetate, 
tetrapropylammonium hydroxide (TPAH), octanophenone, pseudoephedrine, ephedrine, 
methylephedrine, norphenylephrine and atenolol were purchased from Aldrich 
(Milwaukee, WI, USA).  1-Butanol, metoprolol, indapamide, synephrine, octopamine, 
epinephrine  and arterenol were purchased from Sigma (St. Louis, MO, USA).  Methanol 
was purchased from Fisher Scientific (Fairlawn, NJ, USA). 
 
 
4.2.3 Microemulsion Preparation 
 
 
Each microemulsion was prepared by weighing and combining the appropriate amount of 
surfactant and buffer (Table 4.1) in a beaker and dissolving them in a volume of HPLC-
grade water equivalent to 75% of the final volume.  The resulting solutions were then pH 
adjusted with 1.0 M tetrapropylammonium hydroxide (TPAH). Once the pH adjustment 
was complete, the ethyl acetate and 1-butanol were added and the contents were 
subsequently sonicated, while covered, for approximately 30 minutes.  Once sonicated, 
the microemulsions were transferred to volumetric flasks, diluted to volume and allowed 
to rest for one hour prior to use.
 
  
 
 
 
Table 4.1.  Electrophoretic parameters and elution range for DDCV microemulsions  
Microemulsion η (cP) e)
Voltage 
(kV)  
µep,me (104) 
cm2/Vs c) e)
η ∗ µep,me 
(104) 
µeo (104) 
cm2/Vs d)
η ∗ µeo 
(104) 
tme/teo = 
µeo/µme
1% DDCV – ACES a) 1.04 17.0 -3.09 ± 0.01 -3.21 3.18 ± 0.07 3.31  11.4
1% DDCV - phosphate a) 0.98 12.5 -2.99 ± 0.01 -2.94 3.78 ± 0.17 3.72  
  
  
  
  
4.0
2% DDCV – phosphate a) 1.06 12.5 -2.91 ± 0.01 -3.09 3.93 ± 0.05 4.17 4.7
3% DDCV – phosphate a) 1.14 12.0 -2.85 ± 0.01 -3.26 3.56 ± 0.10 4.07 6.1
4% DDCV - phosphate a) 1.28 11.5 -2.74 ± 0.03 -3.52 3.51 ± 0.04 4.50 6.5
4x phase ratio - phosphate 
b) 1.49 
11.5 -2.07 ± 0.02 -3.07 3.06 ± 0.01 4.54 3.6
a) Designated buffer concentration is 50 mM, pH 7.  In the case of phosphate buffer, solid NaH2PO4 was used.  Other 
microemulsion components include 1.2% (v/v) 1-butanol and 0.5% (v/v) ethyl acetate. b) Designated buffer concentration is 50 
mM, pH 7.  Microemulsion components include 4% (w/v) DDCV, 4.8% (v/v) 1-butanol and 2.0% (v/v) ethyl acetate. c) 
Octanophenone was used as a tme marker. d) Values based on the average of 24 - 50 injections.  e) Values based on the average of 
four injections.
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4.2.4 Sample Preparation 
 
 
Each pharmaceutical enantiomer was dissolved in the appropriate microemulsion at a 
concentration of 0.5 mg/mL, with the exception of indapamide (0.25 mg/mL).  A 
negligible amount of methanol was added to each sample to serve as a t0 marker.  The tme 
marker (migration time of the microemulsion) was prepared by dissolving 1 µL of 
octanophenone in 3 mL of the appropriate microemulsion.  A negligible amount of 
methanol was also added to each tme marker solution to serve as a t0 marker. 
 
 
4.2.5 Calculations 
 
 
Each set of results was evaluated for peak efficiency (N), resolution (Rs), retention factor 
(k) and enantioselectivity (αenant).  Because the resolution was less than baseline in some 
cases, both resolution and efficiency were calculated using the respective half-height 
equations (equations 1 and 2 below) via ChemStation software (v. A.08.03).  The less-
than-baseline resolution nearly always precluded the ChemStation's statistical moment 
method or the Foley-Dorsey equation [4] which requires the peak width and asymmetry 
factor at 10%.  An analogous equation based on the peak width and asymmetry factor at 
50% [4] was not utilized because the ChemStation software does not provide an 
asymmetry factor at 50%. 
Rs = 1.18(tr( b ) − tr(a ))
W 0.5(b ) + W 0.5( a )
  (4.1) 
N = 5.54 tr
W0.5
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟ 
2
  (4.2) 
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where W0.5 is the peak width at half-height (min), tr is the peak retention time (min), and 
"a" and "b" denote peaks one and two respectively. Electroosmotic flow (µeo) was 
calculated using the equation: 
µeo = Ld Ltt0V    (4.3) 
where Ld and Lt are the length to the detector and total column length respectively, t0 
signifies the retention time of methanol and V is the applied voltage.  When calculating 
retention factors in EKC, both the electrophoretic mobility of the analytes and the 
retention characteristics must be taken into account.  The electrophoretic mobility of the 
analytes (µep) in the microemulsion was estimated by obtaining the electrophoretic 
mobilities under CZE conditions (phosphate buffer, pH 7.0) and applying a correction 
factor to adjust for viscosity differences between the CZE buffer and the 
microemulsion[5].  The viscosity correction factor was calculated for each of the 
microemulsions investigated.  The retention factor of each enantiomer was then 
calculated by the equation: 
k = tr 1− µr( )− t0
t0 − µ eo − µep, meµeo
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟ tr
 (4.4) 
where µ me is calculated using equation (4.3) with the substitution of tme for t0, µ ep,me = µ 
me -µ eo, and the relative electrophoretic mobility (µr) is defined as the ratio µep,analyte/µeo.  
From the retention factors, the enantioselectivity can then be determined: 
αenant = k2k1    (4.5) 
where k2 and k1 are the retention factors of the second and first enantiomers respectively.  
Optimal retention was then calculated using the equation [6]: 
 
 117
kopt = µeoµme 1+ µr( )  (4.6) 
 
 
4.3  Results and Discussion 
 
 
4.3.1 Initial Comparison of DDCV Microemulsion Utilizing 50 mM ACES or 
Phosphate Buffer 
 
 
 
Several differences were readily apparent upon the substitution of phosphate for ACES 
buffer.  When ACES had been employed it typically took a significant amount of time for 
the system to equilibrate.  Multiple test solute injections were performed until the 
electropherograms obtained overlaid reproducibly.  Moreover, the system was also 
sensitive to rinsing and storage conditions, such that the best results were obtained when 
the capillary was rinsed and stored with microemulsion only.  As a result, the capillaries 
were never intermittently rinsed with hydroxide or water, as is common practice when 
reconditioning a capillary.  In contrast, using phosphate buffer the ruggedness and 
robustness of the system improved dramatically.  Indeed, test solute injections exhibited 
immediate reproducibility.  Moreover, capillary rinsing with hydroxide and water was 
performed between analyses without ill effect. 
 
In terms of overall separation performance, the transition to phosphate resulted in a slight 
increase in efficiency (Table 4.2), a decrease in the migration times and a decrease in 
resolution (Table 4.3).  As shown in Table 4.1, the elution range decreased from 11.4 to 
 
  
 
Table 4.2. Effect of microemulsion preparation Efficiency a)          
Compound 1% DDCV - ACES a) 1% DDCV
 a) 2% DDCV a) 3% DDCV a) 4% DDCV a) 4x Phase Ratio a)
epinephrine c) b) b) b) 53000 c)
arterenol c) b) b) b) 55000 c)
ephedrine* 17000      
  
      
      
    
    
      
      
      
      
20000 33000 45000 60000 112000
atenolol c) c) c) 64000 140000 c)
methylephedrine* 18000 17000 32000 45000 60000 84000
metoprolol* 16000 19000 45000 79000 72000 98000
synephrine* 19000 c) 21000 49000 66000 93000
octopamine 15000 c) b) b) 58000 71000
norphenylephrine* 13000 18000 27000 38000 50000 74000
indapamide* 11000 28000 56000 77000 67000 79000
pseudoephedrine* 14000 19000 31000 40000 65000 79000
Average* 15000 20000 35000 53000 63000 88000
a) Microemulsion preparations as noted in Table 4.1. Represents the average efficiency of enantiomer peaks 1 and 2 over four 
injections.  Standard deviation ranged from 300 to 6000.  The average standard deviation was 4000 for the 4x Phase Ratio and 
2000 for all others. b) No data for this compound under these conditions. c) Not resolved adequately for measurement.  
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Table 4.3. Effect of microemulsion composition on resolution 
Compound 1% DDCV - ACES a) 1% DDCV
 a) 2% DDCV a) 3% DDCV a) 4% DDCV a) 4x Phase Ratio a)
epinephrine    0.56 b) b) b) 0.90 0.58
arterenol    
      
      
      
      
    
    
      
      
      
      
0.44 b) b) b) 0.92 0.75
ephedrine* 1.74 1.18 1.83 2.09 2.30 2.10
atenolol 0.62 c) 0.60 0.83 1.18 0.59
methylephedrine* 1.65 1.36 1.69 2.09 2.28 1.74
metoprolol* 1.35 1.15 1.33 1.69 1.52 1.28*
synephrine* 0.80 c) 0.83 1.23 1.46 1.03
octopamine 0.59 c) b) b) 1.05 0.73
norphenylephrine* 1.26 1.01 1.25 1.49 1.83 1.35
indapamide* 0.96 0.98 1.05 1.04 0.91 0.71
pseudoephedrine* 2.87* 2.56 3.08 3.55 4.71 3.07
Average* 1.52 1.37 1.46 1.75 2.02 1.48
a) Microemulsion preparations as noted in Table 4.1.  Standard deviation (n = 4) ≤ 0.2 for all values, with an average of 0.03.  
Standard deviations of 0.2 are denoted with an asterisk.  All others were ≤ 0.1.  b) No data for this compound under these 
conditions. c) Not resolved adequately for measurement.
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4.0, due to a concomitant increase in EOF and decrease in the electrophoretic mobility of 
the microemulsion droplets in phosphate buffer. While the increase in EOF may seem 
counterintuitive with respect to the increased ionic strength and comparable viscosity, the 
capillary conditioning regimen between the ACES and phosphate analyses was entirely 
different.  The intermittent sodium hydroxide rinsing when phosphate was employed 
(discussed in the previous paragraph) most likely provided a more negatively charged 
capillary surface, resulting in a higher zeta potential and faster EOF.  With respect to the 
decrease in the magnitude of the electrophoretic mobility of the microemulsion 
aggregate, one possible reason is the presence of sodium ions from one of the phosphate 
buffer components (NaH2PO4).  Since the microemulsion is negatively charged, sodium 
ions present in solution would partially associate with it [7, 8], subsequently reducing the 
effective negative charge of the aggregate, thus causing it to migrate less strongly up 
stream. 
 
While the substitution of phosphate for ACES improved sensitivity and provided a small 
increase in efficiency, the loss in resolution and elution range was undesirable.  
Consequently, experiments were performed in which the concentration of surfactant was 
increased.  Increasing the surfactant (other variables held constant) serves to increase the 
negative charge density on the microemulsion droplet, thus increasing the electrophoretic 
mobility of the microemulsion and expanding the elution range of a given MEEKC 
separation [9].  Moreover, the greater surfactant density also increases the hydrophobicity 
of the microemulsion by increasing the concentration of hydrophobic moieties within the 
aggregate.  This provides greater compound retention and a possible shift of retention 
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factors into a more optimal range. In EKC, if retention factors (k) are outside of the 
optimal range, which depends on the elution range and the analytes’ relative 
electrophoretic mobilities, resolution will suffer [10]. Table 4.4 shows a comparison of 
the resolution and retention factors obtained versus the optimal retention factors for 
several of the compounds investigated.  With the exception of indapamide and 
metoprolol, all of retention factors are well below their calculated optimal value using 1% 
DDCV.  As a result, many of the compounds exhibit limited resolution under these 
conditions. 
 
 
4.3.2  Efficiency 
 
 
The increase from 1 to 4% DDCV resulted in a nominal increase in current compared to 
the initial switch from ACES to phosphate buffer.  Voltages were adjusted for each 
DDCV concentration, such that a power of 0.9 W was maintained. The results for 
efficiency, resolution, retention and enantioselectivity, are displayed in Tables 4.2, 4.3, 
4.4 and 4.5 respectively. With the exception of metoprolol and indapamide, the overall 
trend with increasing surfactant concentration is an increase in elution range (Table 4.1), 
efficiency, retention, and resolution.  When the ACES buffer was employed, efficiencies 
(averaged over pairs of enantiomers) ranged from only 1l,000 – 19,000.  In contrast, 
when phosphate buffer was employed, in conjunction with maintaining higher W/m 
values and increased surfactant concentration, efficiencies ranging from 50,000 to 
140,000 were observed (Table 4.2 and Figure 4.1). 
 
  
 
 
Table 4.4.  Effect of microemulsion preparation a) on retention factor, optimum retention factor and resolution  
 1% DDCV 2% DDCV 3% DDCV 4% DDCV 4x phase ratio 
Compound Rs  k kopt Rs  k kopt Rs  k kopt Rs  k kopt Rs  k kopt
epinephrine b) b) b) b) b) b) b) b) b) 0.90      1.14 2.88 0.58 0.60 2.17
arterenol b) b) b) b) b) b) b) b) b) 0.92      1.27 2.92 0.75 0.61 2.17
ephedrine               1.18 1.52 2.39 1.83 2.72* 2.58 2.09 3.21 2.93 2.30 3.47 2.99 2.10 2.19 2.24
atenolol c) 0.52              2.33 0.60 0.85 2.47 0.83 1.06 2.83 1.18 1.15 2.87 0.59 0.69 2.15
methylephedrine                1.36 1.50 2.44 1.69 2.51 2.58 2.09 2.75 2.96 2.28 3.25 2.99 1.74 2.08 2.24
metoprolol 1.15               3.12 2.33 1.33 5.65 2.47 1.69 4.63 2.83 1.52 6.23 2.87 1.28 4.44 2.15
synephrine c) 0.57              2.39 0.83 0.93 2.53 1.23 1.18 2.90 1.46 1.31 2.95 1.03 0.74 2.21
octopamine c) 0.58        2.40 b) b) b) b) b) b) 1.05 1.38 2.95 0.73 0.76 2.21
norphenylephrine               1.01 0.97 2.39 1.25 1.62 2.53 1.49 1.91* 2.89 1.83 2.26 2.94 1.35 2.20 2.20
indapamide 0.98               2.31 2.01 1.05 5.27 2.16 1.04 5.67 2.47 0.91 7.02 2.54 0.71 9.02 1.91
pseudoephedrine                2.56 1.53 2.43 3.08 2.56 2.57 3.55 2.99 2.93 4.71 3.26 2.99 3.07 2.06 2.24
 a) Phosphate microemulsion preparations as noted in Table 4.1. Standard deviation (n = 4) of retention factors ≤ 0.2 with an average 
of 0.02. Standard deviations of 0.2 are denoted with an asterisk.  All others were ≤ 0.07.    b) No data for this compound under these 
conditions. c) Not resolved adequately. 
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Table 4.5.  Effect of microemulsion composition on enantioselectivity  
Compound 1% DDCV - ACES a) 1% DDCV
 a) 2% DDCV a) 3% DDCV a) 4% DDCV a) 4x Phase Ratio a)
epinephrine    1.04 b) b) b) 1.05 1.04
arterenol    
      
      
      
      
    
    
      
      
      
      
1.03 b) b) b) 1.04 1.03
ephedrine* 1.09 1.10 1.11 1.10 1.10 1.08
atenolol 1.03 c) 1.04 1.04 1.04 1.02
methylephedrine* 1.09 1.11 1.10 1.09 1.09 1.08
metoprolol* 1.07 1.08 1.09 1.06 1.07 1.06
synephrine* 1.05 c) 1.08 1.06 1.06 1.05
octopamine 1.04 c) b) b) 1.05 1.04
norphenylephrine* 1.08 1.09 1.09 1.08 1.08 1.07
indapamide* 1.06 1.06 1.07 1.05 1.05 1.07
pseudoephedrine* 1.18 1.20 1.20 1.19 1.19 1.14
Average* 1.08 1.11 1.10 1.08 1.09 1.07
a) Microemulsion preparations as noted in Table 4.1. Standard deviation (n = 4) ≤ 0.01 with an average of 0.002.   b) No data 
for this compound under these conditions. c) Not resolved adequately. 
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Figure 4.1: Representative comparison of (A) unoptimized and (B) optimized separation of (±)-norphenylephrine 
(microemulsion and buffer composition as in Table 4.1). (A)  (±)-norphenylephrine employing 1% DDCV microemulsion in 
ACES buffer.  Resolution = 1.26, average efficiency = 13,000.  Voltage: 17 kV (B)  (±)-norphenylephrine employing 4% 
DDCV microemulsion in phosphate buffer. Resolution = 1.83, average efficiency = 50,000.  Voltage:  11.5 kV.  Detection 
wavelength: 215 ± 5 nm, capillary dimensions: Ld = 23.6 cm, Lt = 32 cm, I.D. = 50 µm, injection: hydrodynamic (25 mbar x 2 
s.), separation voltage: 17 kV.
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To properly examine the increase in efficiency, it is important to address all possible 
sources of band broadening.  In free solution capillary electrophoresis (or CZE) the 
contributions to band broadening include longitudinal diffusion, excess Joule heat, 
differences in conductivity between sample diluent and BGE, differences in mobility 
between analyte and buffer co-ions, and instrumental or external sources [7, 11, 12].  In 
addition to these sources of band broadening, EKC with surfactant aggregates introduces 
a few others.  These include resistance to mass transfer, pseudostationary phase (PSP) 
overload, and surfactant aggregate polydispersity [7, 11, 12].  Three of the above sources 
of band broadening can be eliminated without difficulty: external/instrumental sources of 
band broadening, differences in conductivity between sample diluent and BGE, and Joule 
heat.  First, the external/instrumental sources of band broadening were constant for all of 
the acquired data.  Second, in all of the experiments the BGE and sample diluent were 
one and the same, thereby eliminating dispersion due to differences in conductivity.  
Finally, if Joule heat had been the cause of the initial ACES- 1% DDCV poor efficiency, 
the efficiency would have worsened rather than improved with the higher W/m values 
employed for the current set of experiments.  
 
The initial transition from ACES to phosphate buffer, using 1% DDCV, produced only a 
minor increase in the average efficiency.  This increase can be readily assigned to two 
specific causes.  First, the change in buffer resulted in a dramatic decrease in both 
retention and migration time.  This would notably decrease longitudinal diffusion.  
Second, the switch to phosphate resulted in a microemulsion that was more robust with 
respect to small changes in environment.  A more stable aggregate system would 
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understandably decrease the amount of dispersion observed by providing a more 
reproducible retention mechanism. 
 
While the increase in efficiency with change in buffer was somewhat small, a much 
greater increase in efficiency was observed as the surfactant concentration was increased 
from 1 to 4 percent.  Again, there are several possibilities to consider.  First, PSP 
overload cannot be completely ruled out. In evaluating PSP overload, the concentration 
of analyte relative to the concentration of PSP must be known.  Whereas the calculation 
of analyte concentration is straightforward, calculating the concentration of 
microemulsion aggregates in a given system is far more complex.  To calculate the 
concentration of microemulsion aggregates, the surfactant concentration, critical 
aggregation concentration (cac) and aggregation number (N) are required [7, 8]. Due to 
the complexity in assigning cac and N for a novel microemulsion system, the relative 
concentration of analytes and DDCV microemulsion aggregates is currently unknown, 
making the assessment of PSP overload understandably difficult.  It would make sense, 
however, that if the number of aggregates remained the same and the microemulsion 
droplets became somewhat larger with increasing surfactant concentration, there would 
be more surface area per microemulsion droplet available for analyte interaction.  
Moreover, it would provide a greater number of chiral moieties to participate in analyte – 
microemulsion interactions.  Both phenomena would serve to decrease aggregate 
overload, and a resulting increase in efficiency would be observed. 
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Another possibility for the increase in efficiency may have to do with an increase in the 
surfactant packing density around the microemulsion droplet.  More surfactant monomers 
per fixed microemulsion droplet would most likely yield a microemulsion droplet that is 
more tightly packed.  This, in turn may affect the diffusive mass transfer in the 
microemulsion by affecting the depth with which the analyte is allowed to penetrate.   
 
There is a third possibility for this increase, previously discussed by Davis [11],  who 
recognized the retention dependence of efficiency under low field strengths in micellar 
EKC.  In effect, provided that migration time does not greatly lengthen, as analytes are 
increasingly retained by the micelle, their apparent diffusion coefficient is decreased, 
consequently decreasing longitudinal diffusion.  Our results do show an increase in 
efficiency with increasing retention factor, but they are acquired under high-field 
strengths (34 kV/m as opposed to the < 16 kV/m reported by Davis). However, if the 
Joule heat generated during the separation did not have a dominant effect on the 
efficiency, then the aforementioned argument would most likely still remain valid, and 
efficiency would increase with increasing retention. 
 
A final consideration is that of electromigration dispersion.  The original DDCV chiral 
microemulsion paper [1] commented specifically on the use of tetrapropylammonium 
hydroxide (TPAH) to improve the efficiency by providing a co-ion with a mobility much 
closer to the mobilities of the various analytes.  Since DDCV does affect the pH of a 
given solution, increasing the amount of DDCV in the microemulsion additionally 
requires an increase in the amount of TPAH necessary to arrive at pH 7.   Understandably 
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then, the increase in the concentration of TPAH in the BGE may have also contributed to 
the increase in efficiency by further decreasing electromigration dispersion. 
 
In terms of the increase in efficiency observed with the 4x phase ratio microemulsion, a 
similar rationale can be applied [11, 12].  First, the migration time and retention factor 
greatly decreased, consequently reducing the longitudinal diffusion.  Further, by 
increasing all components (surfactant, co-surfactant and oil) by a factor of 4, there should 
be an analogous increase in the phase ratio, or number of microemulsion droplets.  This 
serves to decrease microemulsion overload, and also lessen the distance between 
droplets, aiding in mass transfer. 
 
 
4.3.3  Resolution, Enantioselectivity and Retention  
 
 
In addition to an increase in efficiency, the overall average of the resolution of separated 
compounds similarly increased, from 1.17 to 1.73 (Table 4.3).  In fact, the only compound 
for which resolution did not increase from its initial 1% DDCV- ACES value was 
indapamide. The most dramatic improvements in resolution were observed with atenolol, 
synephrine, octopamine, arterenol (Figure 4.2) and epinephrine.  Previously, these poorly 
separated compounds displayed an average resolution of only 0.60, whereas the average 
resolution almost doubled (1.10) utilizing the optimized conditions.  
 
The change from 1% DDCV-ACES to 4% DDCV-phosphate resulted in a modest 
increase in enantioselectivity (Table 4.5) for seven out of the eleven compounds.  Out of 
the remaining four compounds, three displayed no change, whereas one compound 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: Representative chromatograms of the separation of (±)-arterenol comparing the use of either 1% DDCV 
microemulsion in ACES buffer or 4% DDCV microemulsion in phosphate buffer (microemulsion and buffer composition as in 
Table 4.1). (A)  (±)-arterenol employing 1% DDCV microemulsion in ACES buffer. Resolution = 0.44, average efficiency = 
N/A.  Voltage: 17 kV (B)  (±)-arterenol employing 4% DDCV microemulsion in phosphate buffer. Resolution = 0.92, average 
efficiency = 55,000.  Separation voltage:  11.5 kV.  Other conditions as noted in Figure 4.1.
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(indapamide) exhibited a modest decrease.  A similar trend is noted in going from 1 to 
4% DDCV in phosphate.  While the increase in enantioselectivity is not as universal as 
noted with efficiency and resolution, it should be noted that if enantioselectivity either 
improves or remains constant, resolution will still increase with increasing efficiency.  
Although enantioselectivity generally increased with increasing DDCV concentration, 
there were a few situations where the enantioselectivity was higher at a lower DDCV 
concentration for a given compound.  In these situations, however, the slightly higher 
enantioselectivity at lower DDCV concentration was more than offset by the much lower 
efficiency and less-optimal retention. 
 
Table 4.4 shows a comparison of the resolution and retention factors obtained versus the 
optimal retention factors for several of the compounds investigated.  Using 1% DDCV all 
of the retention factors are lower than the calculated optimal value, except for indapamide 
and metoprolol.  As a result, the resolution of the latter two compounds is affected the 
least by the transition to phosphate buffer, which resulted in a general decrease in 
retention.  When the DDCV concentration was increased to 2%, the retention factors of 
pseudoephedrine, ephedrine and methylephedrine were closer to kopt and the resolution of 
these compounds was subsequently slightly higher than those achieved in the presence of 
ACES.  In contrast, the retention factors of atenolol and synephrine were significantly 
lower than optimal, and their enantiomers were not baseline resolved.  Indapamide and 
metoprolol both displayed k values higher than optimal, but not yet to the point where 
resolution suffered.  Using 3% DDCV, norphenylephrine, synephrine and atenolol 
exhibited k values closer to kopt and their resolution improved.  In contrast, indapamide 
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displayed a decrease in resolution under these conditions, with a k that was greater than 
twice the value of kopt.  Finally, when 4% DDCV was employed, both indapamide and 
metoprolol exhibited k values that were greater than twice kopt and in both cases, 
resolution decreased.  In contrast, 4% DDCV provided retention factors much closer to 
optimal for the remainder of the compounds and the highest resolutions were indeed 
observed under those conditions.  This was similarly true for epinephrine, arterenol and 
octopamine (Tables 4.2 and 4.4), which displayed resolution values between 0.9 – 1.1 
using the optimized 4% DDCV conditions.  
 
 
4.3.4  A comparison of the 4x phase ratio increase and the 4% DDCV results 
 
 
Increasing the surfactant, co-surfactant and oil by a factor of four (4x phase ratio 
increase) resulted in a large decrease in elution range.  In fact, the observed elution range 
of 3.6 was the smallest of any of the microemulsions (Table 4.1).  This preparation was 
also the most viscous (Table 4.1) and consequently yielded the slowest EOF.  While there 
was an improvement in efficiency (Table 4.2) over the 4% DDCV conditions, the 
improvement came at a great cost to the overall resolution obtained, as well as the 
number of compounds resolved (Table 4.3).  As per Table 4.4, the 4x microemulsion 
provided retention factors for ephedrine, methylephedrine, pseudoephedrine and 
norphenylephrine closest to kopt, and therefore the greatest resolution is observed for 
these compounds.  In contrast, the retention factors provided for the remainder of the 
compounds were either too high or too low for an improvement in resolution to be 
observed.  Furthermore, not only did the 4x microemulsion provide inadequate 
resolution, but there was also an increase in baseline noise.  This was most likely due to 
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the four-fold increase in the 1-butanol and ethyl acetate concentrations, compounds 
which both exhibit UV absorbance at 215 nm. 
 
 
4.4  Concluding Remarks 
 
 
The dependence of microemulsion electrokinetic chromatography on the concentration 
and identity of surfactant, co-surfactant and oil, as well as the pH and concentration of 
the background electrolyte continue to be explored as ways to optimize MEEKC 
separations.  Herein we have demonstrated the fundamental importance of buffer identity, 
a variable often taken for granted.  The transition from ACES to phosphate buffer 
improved sensitivity, ruggedness and efficiency of the enantiomeric separations.  More 
importantly, the effectiveness of using surfactant concentration to tailor the elution range 
in MEEKC to enhance and/or achieve chiral resolution was also demonstrated.  By 
increasing the concentration of surfactant, the average enantiomeric resolution increased 
from 1.17 to 1.73.  Moreover, it doubled in going from non- optimized to optimized 
conditions for five of the eleven compounds. The 4% DDCV-phosphate microemulsion 
provided efficiencies ranging from 50,000 to 140,000 (160,000 to 400,000 N/m) with 
resolution values ranging from 0.90 to 4.71.  Ultimately, these conditions resulted in an 
overall increase in the resolution, elution range and efficiency and provided retention 
factors that were closer to the optimal retention for all but two of the eleven the 
compounds. 
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Chapter 5: Temperature Effects on Chiral Microemulsion Electrokinetic 
Chromatography Employing the Chiral Surfactant Dodecoxycarbonylvaline 
 
 
5.1  Introduction 
 
 
Several studies have been conducted to better understand the DDCV microemulsion and 
which variables are the most important with respect to chiral discrimination and 
chromatographic figures of merit.  The effect of the identity and concentration of the oil, 
the identity and concentration of the background buffer, the incorporation of 
cyclodextrins as a secondary separation mechanism, separation voltage, and the effect of 
surfactant concentration have all been explored in great detail.  These experiments have 
resulted in the knowledge that parameters such as oil identity play a somewhat minor role 
with respect to analytical performance, whereas background buffer, separation voltage 
and surfactant concentration all play a much more significant role in providing optimal 
separation conditions.   
 
One variable that has yet to be explored with the DDCV microemulsion is temperature. 
In chiral separations, small differences in the enthalpy or entropy of solute transfer play 
an important role in chiral selectivity.  The easiest way to elucidate these quantities is via 
van’t Hoff analysis, where a linear plot of the natural logarithm of the distribution 
coefficient versus inverse temperature provides the enthalpy and entropy of transfer via 
the slope and intercept, respectively.  While there have been a few publications [1-5] 
which have examined the effects of temperature on resolution, selectivity and efficiency 
in MEEKC, there have been relatively few which have performed a more rigorous van’t 
Hoff analysis [6, 7]. Due to the complex nature of microemulsion aggregates, it is 
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important to gain an understanding of how the mechanism of solute-aggregate interaction 
changes with temperature and whether or not this relationship is linear.  Further, this 
relationship was previously investigated for DDCV micelles [8] and it would be valuable 
to compare the micellar results to those obtained using an analogous DDCV 
microemulsion system.  In this work, a 1% and 4% DDCV microemulsion are used to 
separate a variety of pharmaceutical compounds over a temperature range of 15 to 35° C. 
 
 
5.2  Materials and Methods 
 
 
5.2.1  Instrumentation 
 
 
All separations were performed on an Agilent 3DCE electrophoresis system (Agilent 
Technologies, Waldbronn, Germany) over a temperature range of 15 to 35° C.  The 
detection wavelength was 215 nm, although detection wavelengths of 236, 254 and 280 
nm were also stored and monitored.  Each microemulsion was evaluated on a fresh, fused 
silica capillary (Ld = 23.6 cm, Lt = 32 cm, I.D. = 50 µm) (Polymicro Technologies, 
Phoenix AZ, USA).  The fresh capillaries were rinsed with 1 M NaOH for 10 minutes, 
0.1 M NaOH for 5 minutes, HPLC grade water for 3 minutes and microemulsion for 15 
minutes.  In between analyses, capillaries were rinsed with HPLC grade water for 10 
minutes, 0.1 M NaOH for 10 minutes, HPLC grade water for 3 minutes and 
microemulsion for 15 minutes.  Sample injection was performed hydrodynamically by 
applying 25 mbar of pressure for 2 seconds.  All sample injections were performed in 
triplicate. Voltages were applied such that a power of 0.3 W was observed, resulting in 
Joule heat values of 1.0 W/m. These voltages ranged from 7.5 to 8.0 kV.  Analytical data 
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from the Agilent 3DCE were collected and processed on a Hewlett Packard Kayak XA 
system using ChemStation software (v. A.08.03). 
 
 
5.2.2  Reagents 
 
 
Dodecoxycarbonylvaline (DDCV), marketed under the name EnantioselectTM, was 
provided by Waters Corporation (Milford, MA, USA).  Ethyl acetate, 
tetrapropylammonium hydroxide (TPAH), octanophenone, valerophenone, 
butyrophenone, acetophenone, pseudoephedrine, ephedrine, methylephedrine, 
norphenylephrine and atenolol were purchased from Aldrich (Milwaukee, WI, USA).  1-
butanol, propiophenone, metoprolol, indapamide, synephrine and epinephrine were 
purchased from Sigma (St. Louis, MO, USA).   
 
 
5.2.3  Microemulsion Preparation 
 
 
Each microemulsion was prepared by weighing and combining the appropriate amount of 
surfactant and buffer (Table 5.1) in a beaker and dissolving them in a volume of HPLC 
grade water equivalent to 75% of the final volume.  The resulting solutions were then pH 
adjusted with 1.0 M tetrapropylammonium hydroxide (TPAH). Once the pH adjustment 
was complete, the ethyl acetate and 1-butanol were added and the contents were sonicated, 
while covered, for approximately 30 minutes.  Once sonicated, the microemulsions were 
transferred to volumetric flasks, diluted to volume and allowed to rest for one hour prior to 
use.
 
  
 
 
Table 5.1.  Comparison of electrophoretic parameters and elution range for DDCV surfactant aggregatesa)  
 
Microemulsion µep,me (104) cm2/Vs d)
η ∗ µep,me 
(104) 
µeo (10 ) 4
cm /Vs2  e)
η ∗ µeo 
(104) 
tme/teo = 
µeo/µme
DDCV micelle b) -3.98 ± 0.02 -3.54 5.76 ± 0.03 5.13  3.2
1% (w/v) DDCV microemulsion c) -2.99 ± 0.01 -2.94 3.78 ± 0.17 3.72  
  
4.0
4% (w/v) DDCV microemulsion c) -2.74 ± 0.03 -3.52 3.51 ± 0.04 4.50 6.5
a) Based on results obtained at 25° C. b) 25 mM DDCV, 100 mM CHES buffer, pH 8.5 [8] c) Microemulsion components in 
addition to surfactant include 1.2% (v/v) 1-butanol and 0.5% (v/v) ethyl acetate in 50 mM phosphate buffer, pH 7.0 d) 
Octanophenone was used as a tme marker. Values based on the average of four injections. e) Values based on the average of 24 - 
50 injections.  
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5.2.4  Sample Preparations 
 
 
Each pharmaceutical enantiomer was dissolved in the appropriate microemulsion at a 
concentration of 0.5 mg/mL, with the exception of indapamide (0.25 mg/mL).  At the 
pH’s employed in this study, all analytes are cationic with the exception of indapamide 
which was neutral.  A negligible amount of methanol was added to the tme marker, as well 
as to each sample to serve as a t0 marker.  The tme marker (migration time of the 
microemulsion) was prepared by dissolving 1 µL of octanophenone in 3 mL of the 
appropriate microemulsion. A solution of homologous alkylphenones (acetophenone, 
propiophenone, butyrophenone and valerophenone) was similarly created by mixing 1 µL 
of each alkylphenone in 3 mL of the appropriate microemulsion. 
 
 
5.2.5  Calculations 
 
 
Each set of results was evaluated for resolution (Rs), retention factor (k), distribution 
coefficient (Keq) and enantioselectivity (αenant).  Because the resolution was less than 
baseline in some cases, resolution was calculated using the respective half-height 
equation (equation 1) via ChemStation software (v. A.08.03).  
Rs = 1.18(tr( b ) − tr(a ))
W 0.5(b ) + W 0.5( a )
   (5.1) 
where W0.5 is the peak width at half-height (min), tr is the peak retention time (min), and 
"a" and "b" denote peaks one and two respectively. Electroosmotic flow (µeo) was 
calculated using the equation: 
µeo = Ld Ltt0V   (5.2) 
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where Ld and Lt are the length to the detector and total column length respectively, t0 
signifies the retention time of methanol and V is the applied voltage.  When calculating 
retention factors in EKC, both the electrophoretic mobility of the analytes and the 
retention characteristics must be taken into account.  The electrophoretic mobility of the 
analytes (µep) in the microemulsion was estimated by obtaining the electrophoretic 
mobilities under CZE conditions (phosphate buffer, pH 7.0) and applying a correction 
factor to adjust for viscosity differences between the CZE buffer and the microemulsion 
[9].  The viscosity correction factor was calculated for each of the microemulsions 
investigated.  The retention factor of each enantiomer was then calculated by the 
equation: 
k = tr 1− µr( )− t0
t0 − µ eo − µep, meµeo
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟ tr
 (5.3) 
where µme is calculated using equation (5.2) with the substitution of tme for t0, µep,me = µme 
- µeo, and the relative electrophoretic mobility (µr) is defined as the ratio µep,analyte/µeo.  
From the retention factors, the enantioselectivity can then be determined: 
αenant = k2k1    (5.4) 
where k2 and k1 are the retention factors of the second and first eluting peaks 
respectively.  The retention factor can be related to the distribution coefficient (Keq) by 
equation (5.5): 
k = Keq VpspVaq
⎛ 
⎝ 
⎜ ⎜ 
⎞ 
⎠ 
⎟ ⎟     (5.5) 
where (Vpsp/Vaq) is the phase ratio (β) and can be determined as per equation (5.6): 
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β = Σi
nV i(ci − ccrit ,i)
1− ΣinV (ci − ccrit,i)
  (5.6) 
where V i  is the partial molar volume of the ith microemulsion component, ccrit,i is the 
critical aggregate concentration of ith microemulsion component (assumed to be zero for 
1-butanol and ethyl acetate), and ci is the concentration of the ith microemulsion 
component.   
 
The phase ratio of the DDCV microemulsion is somewhat difficult to ascertain, in part 
due to lack of information with respect to the partial molar volume of DDCV and the cac 
of the DDCV microemulsion aggregate.  For these purposes, an estimate of the partial 
molar volume of DDCV was calculated based on the McGowan’s characteristic volume 
(0.327 L/mol).  This value, in conjunction with the volumes of 1-butanol and ethyl 
acetate in the microemulsion preparation, was then used to estimate the volume of 
microemulsion pseudostationary phase and the corresponding phase ratio.  In addition, a 
cac value of 0.5 mM was utilized, corresponding to the cmc of DDCV micelles [8].  
Ultimately, the phase ratio for the 1% DDCV microemulsion was calculated to be 0.028 
and the phase ratio for the 4% DDCV microemulsion was calculated to be 0.060.   
Once the distribution coefficient was calculated, a plot of ln Keq versus inverse 
temperature (1/T) was used to acquire the enthalpy and entropy of transfer through the 
van’t Hoff equation (5.7): 
lnKeq = − ∆HRT +
∆S
R
   (5.7) 
where the enthalpy is calculated from the slope (-∆H°/R), and the entropy is calculated 
from the y-intercept (∆S°/R).  
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5.3  Results and Discussion 
 
 
5.3.1  Changes in Resolution, Enantioselectivity and Retention with Temperature 
for analyses using 1 and 4% DDCV microemulsion 
 
 
As expected, resolution (Table 5.2) and retention (Figures 5.1 and 5.2) decreased with 
increasing temperature.  Using 1% DDCV, resolution ranged from 0.62 to 3.17 at 15° C 
and 0.00 to 2.02 at 35° C.  In contrast, while a similar trend was noted with the 4% 
DDCV microemulsion, the compounds exhibited resolution values no lower than 0.84 
over the range of temperatures studied. Using 4% DDCV, resolution ranged from 1.29 to 
6.20 at 15° C and 0.84 to 4.11 at 35° C.    
 
In terms of enantioselectivity (Table 5.3), the decrease in values with increasing 
temperature was similar. Moreover, using 1% DDCV the enantioselectivity (with 
increasing temperature) decreased to 1.00 for three out of nine compounds, resulting in a 
complete loss of resolution.  Employing the 1% DDCV microemulsion, enantioselectivity 
ranged from 1.04 to 1.25 at 15°C and 1.00 to 1.19 at 35°C. In contrast, employing the 4% 
DDCV microemulsion always provided some degree of enantioselectivity for each of the 
compounds investigated over the entire temperature range.  Using 4% DDCV, 
enantioselectivities ranged from 1.05 to 1.31 at 15°C and 1.05 to 1.18 at 35°C. 
 
The bottom of Table 5.2 displays results for the elution range calculated via two different 
methods: the iterative homolog approach [10] and employing octanophenone as a tme 
 
  
 
Table 5.2.  Effect of temperature on resolution, elution range and methylene selectivity using 1 and 4% DDCV microemulsions 
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  1% DDCV a) 4% DDCV a)
Compound 15° C 20° C 25° C 30° C 35° C 15° C 20° C 25° C 30° C 35° C 
epinephrine 0.62 0.45 0.45 0.00 0.00 1.34 1.19 0.98 1.08 0.97 
ephedrine 1.65 1.51 1.39 1.37 1.29 3.22 2.91 2.46 2.86 2.21 
atenolol 0.63 1.04 0.30 0.40∗ 0.00 1.65 1.37 1.07 1.19 0.96 
methylephedrine 1.56 1.46 1.32 1.35 1.07 3.03 2.67 2.38 2.73 2.14 
metoprolol 1.40 1.27 1.05 0.99 0.74 2.43 2.12 1.38 2.03 1.42 
synephrine 0.83 0.68 0.62∗ 0.00 0.00 2.21 1.90 1.61 1.79 1.01 
norphenylephrine 1.38 1.22 1.02 0.76 0.74 2.60 2.32 1.96 2.05 1.68 
indapamide 1.07 0.95 0.93 0.82 0.79 1.29 1.29 0.62 1.25 0.84 
pseudoephedrine 3.17 2.84 2.52 2.14 2.02 6.20∗ 5.61∗ 4.77 5.02∗ 4.11 
Elution Range b) 36.5 14.0 10.6 8.5 7.5 55.7 10.5 8.9 7.9 6.9 
Elution Range c) 5.1 5.3 4.7 4.3 3.9 6.1 5.5 6.6 5.5 5.1 
αCH2 2.314 2.334 2.349 2.360 2.370 2.237 2.301 2.308 2.318 2.339 
a) Microemulsion preparations as noted in Table 5.1. Standard deviation (n = 4) of resolution all ≤ 0.1 with an average of 0.02. 
Standard deviations close to 0.1 are denoted with an asterisk.  All others were ≤ 0.04.     b) Elution range obtained using the iterative 
homolog method (acetophenone through valerophenone). c) Elution range obtained using octanophenone as a tme marker.  
 
  
 
Figure 5.1: Van’t Hoff plot for low-to-moderately retained solutes using 4% DDCV microemulsion over a temperature range 
of 15 to 30°C. Microemulsion preparation noted in Table 5.1.  Standard deviation (n = 4) of retention factors all ≤ 0.06.  
Voltage ranged from 7.5 to 8.0 kV.  Detection wavelength: 215 ± 5 nm, capillary dimensions: Ld = 23.6 cm, Lt = 32 cm, I.D. = 
50 µm, injection: hydrodynamic (25 mbar x 2 s.). 
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Figure 5.2: Van’t Hoff plot for moderate-to-highly retained solutes using 1% DDCV microemulsion over a temperature range 
of 15 to 30°C. Microemulsion preparation noted in Table 5.1. Standard deviation (n = 4) of retention factors all ≤ 0.03.  
Voltage 8.0 kV.  Detection wavelength: 215 ± 5 nm, capillary dimensions: Ld = 23.6 cm, Lt = 32 cm, I.D. = 50 µm, injection: 
hydrodynamic (25 mbar x 2 s.).
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Table 5.3.  Effect of temperature on enantioselectivity employing 1 and 4% DDCV microemulsions 
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  1% DDCV a) 4% DDCV a)
Compound 15° C 20° C 25° C 30° C 35° C 15° C 20° C 25° C 30° C 35° C 
epinephrine 1.08 1.04 1.04 1.00 1.00 1.06 1.06 1.06 1.05 1.07 
ephedrine 1.12 1.11 1.11 1.10 1.10 1.13 1.14 1.13 1.10 1.10 
atenolol 1.04 1.08 1.02 1.03 1.00 1.05 1.05 1.04 1.04 1.05 
methylephedrine 1.11 1.11 1.11 1.10 1.10 1.12 1.13 1.12 1.10 1.09 
metoprolol 1.09 1.09 1.08 1.08 1.07 1.11 1.13 1.12 1.07 1.07 
synephrine 1.09 1.10 1.07 1.00 1.00 1.09 1.08 1.07 1.06 1.05 
norphenylephrine 1.12 1.11 1.10 1.09 1.08 1.13 1.12 1.11 1.08 1.08 
indapamide 1.08 1.07 1.07 1.06 1.06 1.17 1.16 1.21 1.06 1.05 
pseudoephedrine 1.25 1.23 1.21 1.20 1.19 1.31 1.28 1.27 1.20 1.18 
a) Microemulsion preparations as noted in Table 5.1. Standard deviation (n = 4) of enantioselectivities all ≤ 0.01, with an average of 
0.001.
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marker. Previous work with the DDCV microemulsion [11] found the iterative approach 
to be non-linear, resulting in the subsequent use of a tme marker.  It was later discovered 
[12, 13] that the background buffer used in those experiments (ACES) was the cause of 
the non-linearity, and the situation was subsequently corrected by replacing ACES with 
phosphate buffer.  In this study, the iterative approach was re-examined to yield 
information on both the elution range and the methylene selectivity (αCH2) of the 
microemulsions.  Interestingly, the elution range is significantly larger when calculated 
using the iterative approach. It should be further noted that the correlation for each of the 
iterative results was very good (r2 no less than 0.9999 and F values > 18,000) and the 
precision was similarly high with respect to the uncertainty of the slope (relative 
uncertainty of 0.1 %).  Because αCH2 is directly proportional to the slope, this precision is 
reflected in the methylene selectivity as well. To err on the side of caution, however, the 
migration time observed employing the tme marker was used for all subsequent 
calculations.  While this value may represent a worst-case scenario (by being smaller than 
the true value), it would be more prudent than employing a value that might be falsely 
inflated.  A cautious stance of this nature is further supported by reports that the iterative 
approach can result in an overestimation of PSP migration times [14] when lower carbon 
homologs are used in the iteration, as was the case here. 
 
 
5.3.2 Van’t Hoff Plots for 1% and 4% DDCV Microemulsions 
 
 
A plot of ln Keq vs. 1/T will be linear provided that the analyte-selectand interaction 
occurs via a single mechanism over the entire temperature range studied.  Understandably 
then, this further requires that the heat capacity change upon transfer is zero and the 
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phase ratio is independent of temperature [8].  Typical van’t Hoff plots for the test 
analytes are displayed in Figures 5.1 and 5.2 and the thermodynamic results for the 1% 
DDCV microemulsion are displayed in Table 5.4. Of particular interest is the lack of 
linearity when employing the 4% DDCV microemulsion (Figure 5.1).  The r2 values 
ranged from 0.71 to 0.97 over the temperature range studied and the correlation improved 
only slightly (0.82 to 0.96) when the 15° C data was excluded.  Since the 4% DDCV 
contained a large concentration of surfactant compared to the 1% DDCV microemulsion 
(without a proportional increase in oil and/or co-surfactant), the temperature change most 
likely had a much more dramatic effect with respect to either the phase ratio or the 
respective microemulsion conformation.  Due to the observed lack of fit, these data were 
not used to elucidate thermodynamic quantities.  
 
In contrast, the 1% DDCV microemulsion exhibited linearity superior to the 4% DDCV 
microemulsion (Figure 5.2), and the linearity was further improved when the temperature 
range was narrowed to 15 to 30° C.  The r2 values exhibited an average of 0.79 when the 
entire temperature range was examined, and subsequently improved to an average of 0.99 
when the highest temperature (35° C) was excluded. For the latter set of data, the most 
linear relationships were observed with moderate to highly retained compounds (Table 
5.4), whereas the correlation was somewhat less for compounds which were only slightly 
retained (epinephrine, atenolol and synephrine).  The lack of fit in this case may have 
more to do with the assignment of migration times via Chemstation software than a 
change in the mechanism of interaction.  This is because the lesser-retained enantiomers 
transitioned from being moderately resolved (Rs ≥ 0.62) to being unresolved (Rs = 0.00) 
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as the temperature increased.  In chromatography, as peaks increasingly overlap their 
center of gravity will shift inward and the actual peak maximum will be shifted from its 
true value [15, 16].  This discrepancy in integration would have understandably affected 
the retention factors and resulting van’t Hoff data analysis. 
 
As displayed in Table 5.4, the values for ∆H are all negative, indicating an enthalpic 
preference of the enantiomers for the microemulsion pseudostationary phase.  The values 
themselves ranged from –4.01 to –17.14 kJ/mol, with the less-negative values 
corresponding to solutes which were strongly retained (metoprolol and indapamide).  In 
contrast, ∆S displayed both positive and negative values, with the most favorable values 
(large, positive values) corresponding to metoprolol and indapamide, the compounds 
which had previously exhibited less favorable enthalpies.   
 
The entropy of transfers ranged from –27.7 to 22.3 J/mol K, with all enantiomeric pairs 
displaying the same relative sign except synephrine and pseudoephedrine.  
Understandably, the larger the magnitude of the entropy value, the greater the difference 
in “order” that the solute has experienced in transferring from the aqueous environment 
to the microemulsion environment.  The positive entropy values can be explained through 
the hydrophobic effect.  When a comparatively hydrophobic solute is present in the 
aqueous phase, water molecules will orient themselves around the solute via a network of 
hydrogen bonds to compensate for the energetically unfavorable interaction.  However, 
upon solute transfer into the microemulsion phase the converse is true because water 
 
  
 
Table 5.4.  Enthalpies and entropies of transfer for chiral compounds using 1% DDCV microemulsion a) 
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  Enthalpy Entropy 
Solute 
 
Enantiomer 
 
r2 ∆H° (kJ/mol) Uncertainty ∆S° (J/mol K) Uncertainty 
Epinephrine       1 0.9421 -7.42 0.22 -1.64 0.76
 2      
       
       
        
        
       
      
       
       
        
       
       
      
       
       
      
      
0.9794 -10.66 0.19 -12.28 0.63
Ephedrine 1 (1R,2S) 0.9980 -9.23 0.05 1.93 0.17
2 (1S,2R) 0.9992 -9.95 0.03 0.35 0.11
Atenolol 1 (S) 0.9982 -7.87 0.04 -2.58 0.14
2 I 0.9499 -8.37 0.32 -3.91 1.07
Methylephedrine
 
1 1.0000 -9.26 0.00 1.34 0.02
2 0.9998 -9.68 0.02 0.78 0.06
Metoprolol 1 0.9868 -5.37 0.08 20.14 0.25
2 0.9890 -5.96 0.08 18.84 0.26
Synephrine 1 0.9574 -6.64 0.17 2.30 0.58
2 0.9882 -11.29 0.15 -12.87 0.50
Norphenylephrine
 
1 0.9990 -15.86 0.06 -24.21 0.21
2 0.9991 -17.14 0.06 -27.71 0.21
Indapamide 1 0.9998 -4.01 0.01 22.31 0.03
2 0.9999 -4.80 0.01 20.20 0.02
Pseudoephedrine
 
 1 (1R,2R) 0.9997 -9.14 0.02 1.48 0.06
2 (1S,2S) 0.9998 -11.26 0.02 -3.99 0.06
a) Microemulsion preparations as noted in Table 5.1.   Data represents the linear range of 15 to 30°C.  
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molecules have no appreciable presence within the microemulsion droplet, allowing for 
less rigid order and a subsequent increase in the entropy of the system.   
 
In contrast, the solutes that displayed a negative ∆S transitioned into an environment 
where they were forced into a more ordered state than the aqueous surroundings.  If an 
analyte is significantly polar in nature, then the hydrophobic effect in the aqueous phase 
will not be as strong, resulting in the analyte actually assuming an increased order in the 
microemulsion phase than the aqueous phase.  Further, more polar, cationic analytes will 
most likely be more attracted to the polar, anionic surfactant head groups than into the 
microemulsion core.  This would lead to an interaction that was more adsorbed onto the 
microemulsion droplet than absorbed within the microemulsion droplet.   Consequently, 
the increased rigidity caused by the more polar/electrostatic interactions would result in 
reduced and/or negative entropic values.  Two of the compounds that displayed negative 
entropy values, epinephrine and norphenylephrine, are indeed polar analytes.  In fact, 
similar behavior was noted for these two compounds during van’t Hoff analysis using 
DDCV micelles [8].  With respect to the negative entropy values for synephrine, the 
aforementioned micellar study observed positive entropies for synephrine but negative 
entropies for octopamine.  For this particular study, octopamine was not evaluated, 
however in previous work [11-13] it had been found that both octopamine and synephrine 
behaved almost identically in all microemulsion experiments performed.  So similar, in 
fact, that synephrine was chosen for evaluation over the octopamine in this work to 
narrow the scope of compounds. The two compounds differ only by a beta amino methyl 
group, so it is possible that this slight difference in structure had more of an impact when 
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using the micellar phase than noted with the microemulsion phase.  In terms of atenolol, 
the negative entropy value may have been a combination of the increased hydrogen 
bonding capability and steric bulkiness of the molecule preventing it from penetrating 
deeply into the microemulsion. 
 
The previous two scenarios argue for the hydrophobic effect or lack thereof and serve 
only to elucidate the driving force behind achiral solute/PSP interactions.  Importantly, 
there must be a difference in Gibb’s free energy of transfer (∆∆G°) between enantiomers 
for chiral differentiation to occur.  Further, the change in Gibb’s free energy between 
enantiomeric pairs must be brought about by differences in enthalpy and/or entropy.  
Table 5.5 displays a compilation of the selectivity (αCH2), resolution (Rs), distribution 
coefficients (Keq), Gibb’s free energy (∆G°) and the change in Gibb’s free energy (∆∆G°) 
at 25° C.  Importantly, it also shows the differences in enthalpy (∆∆H°) and entropy 
(∆∆S°) of transfer between enantiomeric pairs.  The entropy of transfer contribution is 
indeed significant, averaging approximately 72% of the enthalpic contribution.   This 
makes sense if one considers the 3-point interaction rule of chiral discrimination [17]:  
both enantiomers will share two common achiral points of favorable interaction when 
interacting with a favorable chiral species.  In contrast, only one of the two enantiomers 
will interact through a third preferential point which will result in the overall chiral 
discrimination.  Essentially, this dictates that if chiral differentiation is observed then one 
enantiomer must be interacting more strongly than the other, and thus must be held more 
rigidly, resulting in the larger observed differences in entropy over enthalpy.
 
  
 
Table 5.5.  Comparison of selectivities, resolution, distribution coefficients, and thermodynamic parameters at 25°C using the 1% 
DDCV microemulsiona)  
 
Solute 
 
Enantiomer 
 
αenant
 
Rs 
 
Keq
 
 ∆G°  
(kJ/mol) 
 
-∆∆G°  
(kJ/mol) 
 
 -∆∆H°  
(kJ/mol) 
 
-T(∆∆S°) 
(kJ/mol) 
Epinephrine    1 16.0 -6.93
         
    
        
          
    
        
    
         
     
         
    
        
    
         
          
2 1.04 0.45 16.7 -7.00 0.07 3.24 3.17
Ephedrine 1 (1R,2S) 51.9 -9.80
2 (1S,2R) 1.11 1.39 57.7 -10.06 0.28 0.72 0.47
Atenolol 1 (S) 17.4 -7.10 
2 I 1.02 0.30 17.8 -7.20 0.10 0.50 0.40
Methylephedrine
 
1 49.4 -9.66
2 1.11 1.32 54.5 -9.91 0.25 0.42 0.17
Metoprolol 1 98.1 -11.38
2 1.08 1.05 106 -11.57 0.19 0.59 0.17
Synephrine 1 19.3 -7.32
2 1.07 0.62 20.7 -7.45 0.13 4.65 4.52
Norphenylephrine
 
1 33.1 -8.65
2 1.10 1.02 36.3 -8.88 0.23 1.28 1.04
Indapamide 1 73.7 -10.66
2 1.07 0.93 78.8 -10.82 0.16 0.79 0.63
Pseudoephedrine
 
1 (1R,2R) 47.9 -9.58
2 (1S,2S) 1.21 2.52 58.1 -10.07
0.49 2.12 1.63
a) Microemulsion preparations as noted in Table 5.1.
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5.3.3  Enthalpy/entropy compensation 
 
 
Enthalpy/entropy compensation behavior is exhibited when the Gibb’s free energy is 
equal for all solutes at a temperature known as the compensation temperature (Tc).  
Importantly, the existence of a relationship of this kind supports the idea of a similar 
retention mechanism for all of the solutes involved.  Compensation behavior is signified 
by a linear correlation between ∆H° and ∆S°, where the slope of the line provides the 
compensation temperature (Tc), or the temperature around which the relationship holds 
true and ∆G° for all compounds is similar.  Figure 5.3 displays a graph of ∆H° versus 
∆S° for all of the enantiomers studied using the 1% DDCV microemulsion.  The 
correlation coefficient (r2) was 0.87, somewhat lower than anticipated but still a good 
indication that enthalpy/entropy compensation occurred. Examination of these data yields 
a slope, or compensation temperature, of 227 ± 22 K.  A previous report of Peterson and 
Foley [8] about DDCV micelles noted slightly higher values for Tc (295 and 288 for the 
two groupings respectively), however, it should be pointed out that the compounds used 
in that set of experiments were somewhat different.  Further, the compensation plots were 
segregated according to hydrophobic and hydrophilic analyte groupings, whereas in this 
case they were left a single group.  Similar to the micellar results, however, our 
compensation temperature is significantly lower than what would typically be observed 
in reversed-phase liquid chromatography (e.g. between 500 to 750 K) [18].  While the 
∆G° values noted in Table 5.5 were calculated above the compensation temperature (298 
vs 227 K), a similarity in magnitude is still apparent, indicating with high probability that 
these compounds undergo a comparable retention mechanism.
 
   
 
 
 
 
Figure 5.3: Compensation plot for enantiomers analyzed using 1% DDCV microemulsion over a temperature range of 15 to 30°C.  
1A, 1B – epinephrine enantiomers, 2A, 2B – ephedrine enantiomers, 3A, 3B – atenolol enantiomers, 4A, 4B – methylephedrine 
enantiomers, 5A, 5B – metoprolol enantiomers, 6A, 6B – synephrine enantiomers, 7A, 7B – norphenylephrine enantiomers, 8A, 8B – 
indapamide enantiomers, 9A, 9B – pseudoephedrine enantiomers. Voltage ranged from 7.5 to 8.0 kV.  Detection wavelength: 215 ± 5 
nm, capillary dimensions: Ld = 23.6 cm, Lt = 32 cm, I.D. = 50 µm, injection: hydrodynamic (25 mbar x 2 s.).
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5.3.4 Comparison of DDCV MEKC and MEEKC thermodynamic data for like 
compounds 
 
 
Table 5.6 displays a comparison of thermodynamic data acquired for the compounds that 
were analyzed using both the DDCV micellar and microemulsion aggregates.  In terms of 
∆H°, a comparison of the results reveal that the data are evenly split, with half of the 
more favorable enthalpy values obtained with the DDCV microemulsion and half 
obtained with the DDCV micelle.  In contrast, both ∆S° and ∆G° clearly favor the 
micellar phase.  Again, these values show the overall achiral preference of the analyte for 
the aggregate.  From that standpoint this particular set of analytes is more attracted 
(exhibits a greater increase in Gibb’s free energy) to the DDCV micelles. This may have 
to do with the difference in background buffer employed with the two different phases.  
The micellar experiments were conducted using a zwitterionic background buffer 
(CHES), whereas the microemulsion experiments were conducted using an inorganic 
buffer (phosphate).  Previous microemulsion experiments employing a zwitterionic buffer 
(ACES) exhibited greater analyte retention and migration times, as well as a larger 
elution range [11-13].  This was largely attributed to (i) penetration of the ACES buffer 
species into the microemulsion aggregate and (ii) a lesser degree of microemulsion 
counterion association.  The penetration of zwitterionic species can create a 
comparatively more hydrophobic aggregate overall.  In fact, this was similarly 
recognized by Peterson and Foley in a separate manuscript evaluating counterion effects 
[9].  Had the microemulsion data been acquired using a zwitterionic buffer, the retention 
factors and subsequent magnitude of the thermodynamic data may have been more 
comparable.  Unfortunately, the lack of reproducibility encountered when using the
 
  
 
 
Table 5.6.  Comparison of thermodynamic data between DDCV micellar (MC) and microemulsion (ME) surfactant aggregates 
Average ∆H° c)
(kJ/mol) 
∆∆H° 
(kJ/mol) 
Average ∆S° c)
(J/mol K) 
∆∆S° 
(J/mol K) 
Average ∆G° c)
(kJ/mol) 
∆∆G° 
(kJ/mol) Compound 
MC b)  a) MC b)  a) MC b)  a) MC b)  a) MC b)  a) MC b)  a)
ephedrine −7.33 −9.59 1.88 0.72 33.3 1.14 5.40 1.58 −17.4 −9.93 0.24 0.28 
atenolol −6.52 −8.28 3.35 0.82 28.1 −3.82 12.0 2.48 −15.0 −7.14 0.10 0.08 
metoprolol −7.07 −5.67 1.89 0.59 39.9 19.5 1.89 1.30 −19.1 −11.5 0.17 0.19 
synephrine −10.2 −8.97 1.00 4.65 15.0 −5.29 0.17 15.2 −14.8 −7.39 0.17 0.13 
norphenylephrine −18.3 −16.5 2.09 1.28 −9.3 −26.0 0.21 3.50 −15.6 −8.77 0.21 0.23 
pseudoephedrine −9.98 −10.2 3.26 2.12 27.2 −1.26 0.51 5.47 −18.2 −9.83 0.51 0.49 
a) Microemulsion preparations as noted for 1% DDCV microemulsion in Table 5.1. b) Micelle preparation as noted in Table 5.1. c) The 
average of enantiomer peaks one and two.
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DDCV microemulsion in conjunction with zwitterionic buffers precluded a direct 
comparison of this nature. 
 
With respect to chiral differentiation, one must compare ∆∆H°, ∆∆S° and ∆∆G° between 
the two systems.  From this standpoint, it appears that entropy is the deciding factor 
between the two.  The ∆∆H° values largely favor the micellar phase, whereas the ∆∆S° 
and ultimately ∆∆G° values are evenly split between the two phases.  In contrast, while 
the magnitude of ∆S° was lower in all cases for the microemulsion results, the 
microemulsion was still able to provide a large enough difference in entropy (∆∆S°) 
between enantiomers to elicit separation.  
 
 
5.4 Concluding Remarks 
 
 
Van’t Hoff data analysis provides a valuable insight into both chiral and achiral analyte-
selectand interaction mechanisms.  While a linear van’t Hoff relationship was not 
observed with the 4% DDCV microemulsion, the 1% DDCV microemulsion exhibited 
linearity over the range of 15 to 30° C. For the 1% DDCV microemulsion, the enthalpic 
contribution to retention was consistently favorable (∆H < 0), whereas the entropic 
contribution varied from compound to compound.  Specifically, this work highlights that 
there are important differences to consider when using a micellar or microemulsion 
phase. While the achiral attraction of the analytes was greater for the micellar phase, the 
microemulsion provided a suitable difference in entropy (and Gibb’s free energy) 
between enantiomers to achieve chiral discrimination. 
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Chapter 6: Comparison of DDCV Microemulsion, Solvent-Modified Micellar and 
Micellar Pseudostationary Phases for the Chiral Analysis of Pharmaceutical 
Compounds 
 
 
6.3 Introduction 
 
 
Microemulsion electrokinetic chromatography (or MEEKC) has become both 
increasingly utilized and investigated as a chromatographic technique. The uniqueness in 
MEEKC lies in the fact that where micellar or vesicular aggregates are only comprised of 
surfactant monomers, an oil-in-water microemulsion additionally requires oil and/or co-
surfactant in a ratio such that a single, optically transparent, thermodynamically stable 
liquid is formed. The chemicals typically used for these purposes include short-chain 
linear alcohols as co-surfactants and hydrocarbons or moderately polar organic 
compounds as water immiscible oils.   The result is a structure exhibiting a surfactant-
enveloped oil core, with the co-surfactant acting to ease interfacial tension and 
electrostatic repulsion.  
 
In terms of the advantages in using a microemulsion, first there are a greater number of 
parameters that can be manipulated during preparation.  Variations in the concentration 
and identity of surfactant, co-surfactant and oil, as well as the pH and concentration of 
the background electrolyte have all proven to be important parameters in MEEKC [1-7]. 
In addition, it has been theorized that the microemulsion structure offers increased 
fluidity, aiding in analyte penetration and mass transfer [1, 8]. Moreover, the presence of 
the oil core in microemulsions results in an aggregate that is better able to solubilize a 
wide array of analytes and additives.  In effect, this extends CE towards more 
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hydrophobic compounds for which it is not usually a preferred methodology. 
Hydrophobic compounds for which separations were either difficult or unachievable 
using conventional micellar EKC have been successfully separated via MEEKC [9, 10].  
Last, and of great importance, is the ability to extend the elution range of the separation 
by changing the surfactant concentration and subsequently altering the charge density of 
the aggregate[11].  This is usually not an option with other PSPs, where elution ranges 
are largely fixed. 
 
As the amount of research on microemulsions has increased, the scientific community 
has continually gained valuable insight towards understanding what parameters are the 
most important in MEEKC in terms of analytical performance.  For example, it has 
become increasingly well established that the oil core generally does not play a 
significant role in selectivity [1, 6, 12, 13] although there is at least one obvious 
exception [14].  In contrast, altering the identity of the surfactant and/or co-surfactant will 
greatly affect it [1, 3, 5, 6, 12, 13, 15, 16].  Further, we have noted in our laboratory the 
importance of the identity of the background buffer with respect to stability, robustness, 
ease of equilibration, elution range, retention, resolution and efficiency [17, 18].  The 
growth in the amount of research performed to systematically probe these unique systems 
has served to established guidelines for working with and fine-tuning them.  
Unfortunately, one area in which there are still many unanswered questions is how 
exactly the mechanism of solute-microemulsion interaction differs with respect to other 
PSPs, specifically micelles.  Questions have been raised regarding whether the lipophilic 
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phase is truly necessary [12].  They have also been raised over the merits of MEEKC 
versus MEKC for a variety of applications. 
 
Regarding this, there have been a few MEKC and MEEKC comparisons, however, many 
are somewhat inequitable because they compare different surfactant concentrations, 
background buffers and sometimes even co-surfactants [10, 19-21].  The few that have 
controlled those parameters [8, 12, 22, 23] have indeed observed differences between the 
two techniques in the areas of efficiency, resolution, retention, elution window, log Pow 
predictions and even selectivity.  Unfortunately, the number of fair comparisons is 
limited and there is still a great deal of knowledge to be gained. 
 
The research conducted recently in our laboratory has centered around using 
microemulsions to achieve chiral separations, most of it specifically involving the chiral 
surfactant dodecoxycarbonylvaline (DDCV), a low interfacial tension oil (ethyl acetate) 
and 1-butanol as the co-surfactant [17, 18, 24, 25]. The DDCV-based chiral 
microemulsion has provided many rapid, highly selective separations. More recently, 
studies were conducted which examined the effect of surfactant concentration, voltage 
and buffer composition on chromatographic figures of merit [18].  It was noted that by 
changing the surfactant concentration of the microemulsion that retention, resolution and 
elution window could essentially be custom tuned.  There was also a dramatic 
improvement in efficiency with increasing surfactant concentration, such that many of the 
efficiencies increased by a factor of five.  Further, this particular microemulsion could be 
used under higher Joule heat values, without any loss in analytical performance. 
 
 164
 
Research using DDCV micelles has been performed by our research group in the past 
[26-28], however the buffer conditions, surfactant concentration and pH were different 
than what was used in the aforementioned microemulsion system.  Ideally it would be 
useful to be able to compare the two systems using identical conditions.  Further, it would 
be similarly helpful to evaluate the impact of the co-surfactant (1-butanol) without the 
lipophilic phase (ethyl acetate) present.  In this work, three different aggregate systems 
are compared using two different surfactant concentrations:  (1) a DDCV microemulsion, 
(2) a DDCV micelle modified with 1.2% (v/v) 1-butanol, and (3) a DDCV micelle with 
no organic modifier.  Each aggregate type was prepared with both 2 and 4% (w/v) DDCV 
surfactant (60 and 120 mM DDCV).   When comparing the three different aggregates, the 
preparation techniques, instrumentation and analytical parameters used were identical so 
that the only differences noted were the presence or absence of the oil and/or co-
surfactant. 
 
 
6.4 Materials and Methods 
 
 
6.5 Instrumentation 
 
 
All separations were performed on an Agilent 3DCE electrophoresis system (Agilent 
Technologies, Waldbronn, Germany) at a constant temperature of 25° C.  The detection 
wavelength was 215 nm, although detection wavelengths of 236, 254 and 280 nm were 
also stored and monitored.  Each microemulsion was evaluated on a fresh, fused silica 
capillary (Ld = 23.6 cm, Lt = 32 cm, I.D. = 50 µm) (Polymicro Technologies, Phoenix 
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AZ, USA).  The fresh capillaries were rinsed with 1 M NaOH for 10 minutes, 0.1 M 
NaOH for 5 minutes, HPLC grade water for 3 minutes and microemulsion for 15 
minutes.  In between analyses, capillaries were rinsed with HPLC grade water for 10 
minutes, 0.1 M NaOH for 10 minutes, HPLC grade water for 3 minutes and 
microemulsion for 15 minutes.  Sample injection was performed hydrodynamically by 
applying 25 mbar of pressure for 2 seconds.  All sample injections were performed in 
triplicate. Voltages were applied such that a power of 0.9 W was observed, resulting in 
Joule heat values of 2.8 W/m. The applied voltage was 11.5 kV. Analytical data from the 
Agilent 3DCE were collected and processed on a Hewlett Packard Kayak XA system 
using ChemStation software (v. A.08.03). 
 
 
6.6 Reagents 
 
 
Dodecoxycarbonylvaline (DDCV), marketed under the name EnantioselectTM, was 
provided by Waters Corporation (Milford, MA, USA).  Ethyl acetate, 
tetrapropylammonium hydroxide (TPAH), pseudoephedrine, ephedrine, methylephedrine, 
norphenylephrine and atenolol were purchased from Aldrich (Milwaukee, WI, USA).  1-
Butanol, metoprolol, indapamide, synephrine, octopamine, epinephrine  and arterenol 
were purchased from Sigma (St. Louis, MO, USA).   
 
 
6.7 DDCV Aggregate Preparations 
 
 
For all three surfactant aggregate systems, the appropriate amount of surfactant and 
buffer (Table 6.1) was weighed into a beaker and dissolved in a volume of HPLC-grade 
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water equivalent to 75% of the final volume.  The resulting solutions were then pH 
adjusted with 1.0 M tetrapropylammonium hydroxide (TPAH). Once the pH adjustment 
was complete, ethyl acetate and 1-butanol were added to the microemulsion flask, 1-
butanol was added to the butanol-modified flask and nothing was added to the micelle 
preparation.  The contents of each flask were subsequently sonicated, while covered, for 
approximately 30 minutes.  Once sonicated, each aggregate solution was transferred to a 
volumetric flask, diluted to volume and allowed to rest for one hour prior to use. 
 
6.8 Sample Preparations 
 
 
Each pharmaceutical enantiomer was dissolved in the appropriate surfactant aggregate 
system at a concentration of 0.5 mg/mL, with the exception of indapamide (0.25 mg/mL). 
The tpsp marker (migration time of the aggregate) was prepared by dissolving 1 µL of 
octanophenone in 3 mL of the appropriate microemulsion.  A negligible amount of 
methanol was employed as a t0 marker in both the sample solutions and the tpsp marker 
solution. 
 
6.9 Calculations 
 
 
Each set of results was evaluated for peak efficiency (N), resolution (Rs), retention factor 
(k) and enantioselectivity (αenant).  Because the resolution was less than baseline in some 
cases, both resolution and efficiency were calculated using the respective half-height 
equations (equations 1 and 2 below) via ChemStation software (v. A.08.03).  The less-
than-baseline resolution nearly always precluded the ChemStation’s statistical moment 
method or the Foley-Dorsey equation [29] which requires the peak width and asymmetry  
 
  
 
 
 
Table 6.1:  Comparison of electrophoretic parameters and elution range for DDCV aggregates b)  
 
DDCV Aggregate a) %  DDCV 
% (v/v) 1-
butanol 
% (v/v) 
ethyl 
acetate  
µep,psp (104) 
cm2/Vs c)
η∗µep,psp 
(104) µeo (10
4) 
cm2/Vs d)
η∗µeo 
(104) 
tpsp/teo = 
µeo/µpsp
Microemulsion 2.0     1.2 0.5 -2.91 ± 0.01 -3.56 3.93 ± 0.04 4.81 4.7
Butanol-Modified MC  2.0 1.2 N/A -2.97 ± 0.04 -3.77 3.91 ± 0.06 4.97  
     
     
5.3
Micelle 2.0 N/A N/A -3.24 ± 0.01 -3.89 3.79 ± 0.03 4.55 7.8
Microemulsion 4.0 1.2 0.5 -2.74 ± 0.04 -4.06 3.48 ± 0.08 5.16 6.5
Butanol-Modified MC e) 4.0     
     
1.2 N/A -2.76 ± 0.02 -5.35 2.91 ± 0.13 5.65 9.7
Micelle e) 4.0 N/A N/A -2.86 ± 0.04 -4.42 3.39 ± 0.16 5.24 10.2
a) Dissolved in 50 mM phosphate buffer, pH 7.0. b) 4% data acquired using a voltage of 11.5 kV.  2% data acquired using a voltages of 
12.0 kV.  Detection wavelength: 215 ± 5 nm, capillary dimensions: Ld = 23.6 cm, Lt = 32 cm, I.D. = 50 µm, injection: hydrodynamic 
(25 mbar x 2 s.),  c) Octanophenone was used as a tpsp marker. Values based on the average of four injections.  d) Values based on the 
average of 24 – 40 injections. e) A stable baseline was not obtained with these PSPs. 
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Factor at 10%.  An analogous equation based on the peak width and asymmetry factor at 
50% [29] was not utilized because the ChemStation software does not provide an 
asymmetry factor at 50%. 
Rs = 1.18(t r( b ) − tr (a ))
W50( b ) + W50(a )
   (6.1) 
N = 5.54 tr
W50
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟ 
2
   (6.2) 
where W50 is the peak width at half-height (min), tr is the peak retention time (min), and 
“a” and “b” denote peaks one and two respectively. Electroosmotic flow (µeo) was 
calculated using the equation: 
µeo = Ld Ltt0V     (6.3) 
where Ld and Lt are the length to the detector and total column length respectively, t0 
signifies the retention time of methanol and V is the applied voltage.  When calculating 
retention factors in EKC, both the electrophoretic mobility of the analytes and the 
retention characteristics must be taken into account.  The electrophoretic mobility of the 
analytes (µep) in the microemulsion was estimated by obtaining the electrophoretic 
mobilities under CZE conditions (phosphate buffer, pH 7.0) and applying a correction 
factor to adjust for viscosity differences between the CZE buffer and the microemulsion 
[27].  The viscosity correction factor was calculated for each of the microemulsions 
investigated.  The retention factor of each enantiomer was then calculated by the 
equation: 
k = tr 1− µr( )− t0
t0 − µ eo − µep, meµeo
⎛ 
⎝ ⎜ 
⎞ 
⎠ ⎟ tr
  (6.4) 
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where µ me is calculated using equation (6.3) with the substitution of tme for t0, µ ep,me = µ 
me -µ eo, and the relative electrophoretic mobility (µr) is defined as the ratio µep,analyte/µeo.   
From the retention factors, the enantioselectivity can then be determined: 
αenant = k2k1     (6.5) 
where k2 and k1 are the retention factors of the second and first eluting peaks 
respectively.   
 
 
6.10 Results and Discussion 
 
 
6.10.1 Overall Chromatographic Appearance 
 
 
The initial intent of this study was to focus on investigating the aggregates using only the 
4% DDCV surfactant concentration.  This was because it was the concentration of DDCV 
that had provided the most optimal results in a previous MEEKC study [18].  
Unfortunately, employing such a high surfactant concentration in a non-microemulsion 
format resulted in an aberrant baseline (Figures 6.1A and 6.1B).  Despite repeated 
attempts to re-run the analyses and/or re-prepare the aggregates, the poor and fluctuating 
baseline was always present. This would indicate that the aggregate formed under these 
conditions was unstable.  In fact similar instability has been noted with DDCV when 
ACES buffer was used in conjunction with cyclodextrins [17], and also when attempts 
were made to formulate a microemulsion using methyl formate as the lipophilic phase 
[24]. 
 
To provide a more reasonable comparison of chromatographic performance between the 
three systems, the concentration of DDCV was reduced to 2%.  This ultimately yielded
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Figure 6.1: Representative chromatograms of the separation of (±)-methylephedrine comparing the use of 4% DDCV (A) micelles, (B) 
butanol-modified micelles or (C) microemulsion. Aggregate preparations as noted in Table 6.1.  Voltage:  11.5 kV.  Detection 
wavelength: 215 ± 5 nm, capillary dimensions: Ld = 23.6 cm, Lt = 32 cm, I.D. = 50 µm, injection: hydrodynamic (25 mbar x 2 s.). 
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stable baselines for all of the analyses (Figure 6.2).  Both sets of results will be discussed, 
however, it should be understood that the baseline and aggregate instability directly 
impacted the results for the 4% DDCV butanol-modified micellar and micellar analyses.  
 
 
6.10.2 Comparison of µep,psp, EOF and Elution Range 
 
 
Table 6.1 displays the results for µep,psp(migration time of the aggregate), EOF 
(electroosmotic mobility) and elution range (ER) for the six systems investigated. 
Importantly, the trend is the same for both the 4 and 2% series of experiments.  In each 
case (4 and 2% respectively), the elution ranges are different, with the largest elution 
range provided by the micelle (10.2 and 7.8), followed by the butanol-modified micelle 
(9.7 and 5.3) and lastly the microemulsion (6.5 and 4.7).  
 
To understand the variation in elution range from system to system it is important to 
examine the migration characteristics of the surfactant aggregate, as well as the 
electroosmotic flow.  First, the electrophoretic mobility of the aggregate follows the same 
trend as the elution range, with the micelle exhibiting the fastest mobility, followed by 
the butanol-modified micelle and the microemulsion respectively.  Also, in both the 2 and 
the 4% analyses the greatest difference in mobility is noted with the micelle, whereas the 
microemulsion and butanol-modified micelle mobilities are very comparable.  This result 
may have more to do with the relative size of the aggregates.  The micelle, in the absence 
of any organic modifiers, is most likely the smallest in size and consequently the most 
mobile for a given charge density.  In contrast, if 1-butanol was indeed solubilized by the 
micelle, as is in agreement with theory, then it would have resulted in a more “swollen” 
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Figure 6.2: Representative chromatograms of the separation of (±)-pseudoephedrine comparing the use of 2% DDCV (A) micelles, 
(B) butanol-modified micelles or (C) microemulsion. Aggregate preparations as noted in Table 6.1.  Voltage:  12 kV.  Detection 
wavelength: 215 ± 5 nm, capillary dimensions: Ld = 23.6 cm, Lt = 32 cm, I.D. = 50 µm, injection: hydrodynamic (25 mbar x 2 s.). 172 
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PSP.  Resultingly, this increase in size would slow down the overall mobility of the 
aggregate for a given amount of surface charge, allowing it to be pulled past the detector 
window more readily by the EOF.  With respect to the microemulsion, because these 
droplets have an increased ability to pack surfactant around the oil core, there may even 
be a greater net charge surrounding the surface, but this increase in net charge may have 
been offset by the increase in size due to the presence of both co-surfactant and oil.  
Consequently, even though the net charge is greater in comparison to the other two 
aggregates, so is the size, resulting in an electrophoretic mobility that is not 
proportionally larger. 
 
While the trend in aggregate mobility was comparable for both systems, the trend in 
electroosmotic flow varied between the 2 and 4% sets of data.  In both cases the fastest 
EOF was exhibited with the microemulsion, however, the EOF noted employing the other 
two aggregates varied with surfactant concentration. Variations in the EOF can be caused 
by a number of variables.  First and foremost, is the presence or absence of organic 
constituents (i.e. butanol and/or ethyl acetate) in the BGE. Organic solvents in the 
system, especially if not completely solubilized by the aggregate, would subsequently 
alter the EOF by altering the viscosity and zeta potential. In contrast, if there are no 
organics present, or they are present yet highly solubilized within the aggregate, the 
effect on EOF would be minimal. These effects are highlighted when the viscosity-
corrected EOF values are examined.  The viscosity correction highlights what the EOF 
might have been had the viscosity not been as high.  Because the butanol-modified 
system exhibited a proportionally greater viscosity value than the other two systems, 
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performing a viscosity correction results in the former having a faster EOF than the latter 
two. 
 
 
6.11 Comparison of Efficiency, Resolution, Enantioselectivity and Retention 
 
 
The results for retention factor, resolution, enantioselectivity and efficiency are reported 
in Tables 6.2, 6.3, 6.4 and 6.5, respectively.  In addition, both the average and geometric 
average are reported for each set of results.  While the two different mean values vary 
slightly in magnitude, the trends are still largely the same, with the exception of the 2% 
resolution results.  In that case, the geometric mean highlights a slight difference between 
the microemulsion and butanol-modified micelle (resolution values of 1.3 vs. 1.4 
respectively as opposed to a previous average of 1.5 for both).   
 
The retention data are displayed in Table 6.2.  Notably, both the 2 and 4% experiments 
employing the micellar system provided the greatest retention, whereas the retention was 
somewhat more comparable for the microemulsion and butanol-modified micelle. With 
respect to the later two systems, the presence of any excess 1-butanol in the surrounding 
aqueous phase would have resulted in an aqueous phase that was better able to solubilize 
the analytes, resulting in a decrease in affinity of the analytes for the PSP and reduced 
retention.  In addition, 1-butanol is a class I organic modifier with respect to surfactant 
aggregates.  These modifiers interact with the internal phase of micelles, causing them to 
swell (becoming more fluid in structure) and also resulting in a reduction in the level of 
counterion binding [12, 30].  Lesser counterion binding would yield a more highly 
charged /less hydrophobic aggregate overall, resulting in a decrease in analyte affinity 
 
  
 
Table 6.2:  Effect of aggregate structure and composition a) on retention factor 
2% DDCV 4% DDCV 
Microemulsion Butanol-Modified Micelle  Microemulsion
Butanol-
Modified c) Micelle
 c)
Compound k    kopt k kopt k kopt k kopt k kopt k kopt
epinephrine b) b) b) b) b) b) 1.14      2.88 1.04 3.53 1.56 3.63
arterenol b) b) b) b) b) b) 1.27      2.92 1.09 3.53 1.63 3.63
ephedrine             2.72 2.58 2.59 2.72 3.20 3.35 3.47 2.99 3.53 3.62 5.00 3.69
atenolol             0.85 2.47 0.81 2.62 0.99 3.21 1.15 2.87 1.05 3.49 1.46 3.60
methylephedrine             2.51 2.58 2.40 2.74 2.88 3.36 3.25 2.99 3.19 3.62 4.50 3.75
metoprolol 5.65            2.47 5.20 2.62 6.70 3.21 6.23 2.87 7.15 3.49 13.6 3.60
synephrine             0.93 2.53 0.89 2.69 1.12 3.30 1.31 2.95 1.20 3.59 1.74 3.70
octopamine b) b) b) b) b) b) 1.38      2.95 1.28 3.62 1.85 3.70
norphenylephrine             1.62 2.53 1.57 2.70 2.05 3.30 2.26 2.94 2.11 3.60 3.26 3.69
indapamide 5.27            2.16 4.96 2.31 5.54 2.80 7.02 2.54 10.8 3.12 18.7 3.19
pseudoephedrine             2.56 2.57 2.42 2.74 2.99 3.34 3.26 2.99 3.28 3.65 4.37 3.75
kave 2.8            N/A 2.6 N/A 3.2 N/A 2.9 N/A 3.3 N/A 5.2 N/A
kave, geometric 2.3            N/A 2.1 N/A 2.6 N/A 2.9 N/A 3.1 N/A 4.7 N/A
a)Aggregate preparations and analytical conditions as noted in Table 6.1. Standard deviation (n = 4) of retention factors all ≤ 0.1, 
with the exception of the indapamide 4% micellar results (2.23).   b) No data for this compound under these conditions. c) A stable 
baseline was not obtained with these PSPs. 
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 Table 6.3:  Effect of aggregate structure and composition a) on resolution  
 2% DDCV 4% DDCV 
Compound    Microemulsion Butanol-Modified Micelle Microemulsion
Butanol-
Modified c) Micelle
 c)
epinephrine b) b) b) 0.90   0.92 0.86
arterenol b) b) b) 0.92   0.83 0.68
ephedrine       1.83 1.93 2.03 2.30 2.90 2.11
atenolol       0.60 0.90 0.91 1.18 1.17 0.99
methylephedrine       1.69 2.02 1.95 2.28 2.86 2.06
metoprolol       1.33 1.52 1.59 1.52 2.08 1.03
synephrine       0.83 1.00 1.10 1.46 1.40 1.41
octopamine b) b) b) 1.05   1.22 1.08
norphenylephrine       1.25 1.33 1.48 1.83 2.11 1.72
indapamide       1.05 0.68 1.32 0.91 0.59 0.00
pseudoephedrine       3.08 2.94 3.67 4.71 5.30 3.26
Rsave  1.5      1.5 1.8 1.7 1.9 1.4
Rsave, geometric 1.3      1.4 1.6 1.8 1.9 1.5
a)Aggregate preparations and analytical conditions as noted in Table 6.1. Standard deviations (n = 4) of resolution values all ≤ 0.1, 
with the exception of the pseudoephedrine 4% micellar results (0.50).   b) No data for this compound under these conditions. c) A stable 
baseline was not obtained with these PSPs. 
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 Table 6.4.  Effect of aggregate structure and composition a) on enantioselectivity  
 2% DDCV 4% DDCV 
Compound    Microemulsion Butanol-Modified Micelle Microemulsion
Butanol-
Modified c) Micelle
 c)
epinephrine b) b) b) 1.05   1.06 1.06
arterenol b) b) b) 1.04   1.04 1.04
ephedrine       1.11 1.11 1.11 1.10 1.11 1.12
atenolol       1.04 1.04 1.05 1.04 1.04 1.05
methylephedrine       1.10 1.11 1.11 1.09 1.11 1.12
metoprolol       1.09 1.08 1.09 1.07 1.08 1.13
synephrine       1.08 1.08 1.07 1.06 1.07 1.08
octopamine b) b) b) 1.05   1.05 1.06
norphenylephrine       1.09 1.08 1.09 1.08 1.08 1.10
indapamide       1.07 1.07 1.07 1.05 1.07 1.00
pseudoephedrine       1.20 1.20 1.23 1.19 1.22 1.24
αenant,ave  1.10      1.10 1.10 1.07 1.08 1.09
αenant,ave, geometric 1.10      1.10 1.10 1.08 1.10 1.12
a)Aggregate preparations and analytical conditions as noted in Table 6.1. Standard deviation (n = 4) of enantioselectivities all ≤ 0.01, 
with an average of 0.003. b) No data for this compound under these conditions. c) A stable baseline was not obtained with these PSPs.  
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 Table 6.5:  Effect of aggregate structure and composition a) on efficiency d)  
 2% DDCV 4% DDCV 
Compound    Microemulsion Butanol-Modified Micelle Microemulsion
Butanol-
Modified f) Micelle
 f)
epinephrine b) b) b) 53000   25000* 21000
arterenol b) b) b) 55000   30000* 23000
ephedrine       33000 41000 23000 60000 34000 27000
atenolol c) 105000*     52000 137000 73000 48000
methylephedrine       32000 41000 23000 60000 38000 28000
metoprolol       45000 56000 30000 72000 38000 13000
synephrine       21000 33000 25000 66000* 29000* 31000
octopamine b) b) b) 58000   33000 33000
norphenylephrine       27000 30000 19000 50000 25000 24000
indapamide       56000* 21000 41000 67000 11000 5000*
pseudoephedrine       31000 24000 22000 65000 23000 23000*
N e)ave  35000      35000 26000 68000 32000 25000
N e)ave, geometric 33000      33000 25000 69000 30000 24000
a) Aggregate preparations and analytical conditions as noted in Table 6.1. Standard deviation (n = 4) of efficiencies ranged from 500 to 
8000, with an average of 2000. Standard deviations of ≥ 3000 are denoted with an asterisk.   b) No data for this compound under these 
conditions. c) Not resolved adequately for measurement. d) Represents the average efficiency of enantiomer peaks 1 and 2 over three 
injections. e) Average excluding atenolol. f) A stable baseline was not obtained with these PSPs. 
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And ultimately, retention.  In contrast, since the micellar system contains no butanol, the 
level of counterion binding would be greater, decreasing the polarity of the aggregate and 
resulting in greater retention overall. 
 
When the microemulsion and butanol-modifed micelle retention data are compared, it 
appears that the presence of 1-butanol typically provided similar retention for both these 
systems.  In the 2% experiments, the microemulsion provided slightly greater retention in 
all cases, and in the 4% experiments it similarly provided greater retention for seven out 
of eleven compounds. With respect to the butanol-modified case, it would follow that 
without a lipophilic phase present there may be an increase in the amount of 1-butanol 
not solubilized by the aggregate and thus outside in the aqueous region.  As noted in the 
previous discussion, this would comparatively reduce the retention.   
 
The results for resolution are displayed in Table 6.3.  Importantly, greater retention is not 
always beneficial for greater resolution.  In EKC, the elution range of a system and the 
electrophoretic mobility of an analyte establish a range of retention factors that will 
provide optimal resolution [31].  Consequently, if retention factors are outside of this 
optimal range, resolution will suffer. While the micelle provided the largest retention 
factors using either 2 or 4% DDCV, in the case of the latter results the retention was 
sometimes prohibitively large, contributing, in part, to the decrease in resolution noted 
for all but one of the compounds (octopamine).  The optimal retention factor (kopt) for all 
systems fell within the range of 2.2 to 3.8.  Understandably, retention values that were 
more than three times their optimal value (e.g. 13.6 and 18.7 for metoprolol and 
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indapamide using the 4% DDCV micelle) would contribute significantly to the observed 
deterioration in resolution.  In fact, the decrease in resolution was the greatest for those 
two compounds, 0.9 to 0.0 and 1.5 to 1.0 for indapamide and metoprolol, respectively.   
 
In contrast to the 4% DDCV micellar results, the 2% DDCV micellar results indicate 
superior resolution when compared to the corresponding microemulsion and butanol-
modified micelles. Retention using 2% DDCV micelles was not as great as that observed 
using 4% DDCV micelles and was positioned in a more optimal range, contributing to an 
improvement in resolution.  With respect to the microemulsion and butanol-modified 
systems, use of the latter typically provided improved resolution overall, but the extent of 
improvement varied between compounds and surfactant concentration. In the case of the 
2% DDCV experiments, use of the butanol-modified micelle provided slightly greater 
resolution for all but two of the compounds (indapamide and pseudoephedrine).  A more 
dramatic improvement in resolution was noted with atenolol, which displayed a 
resolution of 0.9 when the butanol-modified system was used, but only exhibited a 
resolution of 0.6 using the microemulsion.  Similarly, use of the micelle also provided a 
resolution of 0.9 for atenolol.  Use of the butanol-modified micelle similarly provided 
greater resolution for seven out of eleven compounds when 4% DDCV was used. 
 
The enantioselectivity and efficiency results are displayed in Tables 6.4 and 6.5 
respectively. With respect to the 4% results, in many cases the enantioselectivity of the 
butanol-modified micelle is just slightly better than what was noted with respect to the 
microemulsion.  In contrast, with the exception of indapamide, the micelle provided 
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either equal or superior selectivity overall.  In contrast, the results for enantioselectivity 
using the 2% DDCV aggregate systems do not show a discernable trend, with each set of 
results displaying an average enantioselectivity value of 1.10.  
 
An additional area that has been highlighted with respect to selectivity concerns the 
fluidity of the aggregate. For example, Terabe et al. Noted the superior selectivity of 
micelles over microemulsions in the separation of isomeric cresols and xylenols [8].  The 
rationale that has been used by he and others concerns the rigidity of the micellar 
structure compared to that of the microemulsion.  Indeed, it does make sense that a more 
rigid structure would accentuate the recognition of subtle shape differences based on 
steric fit. As the contents within the aggregate (by incorporating co-surfactant and/or oil) 
are increased, the fluidity of the structure most likely also increases and a decrease in 
selectivity may be observed.  The exception in this case might be more hydrophobic 
compounds for which the presence of a lipophilic and/or co-surfactant phase serves as the 
driving force for solute-aggregate interaction. In reality, the observed enantioselectivities 
may highlight the combined effects of retention and aggregate rigidity.  An example of 
this may be the results noted with atenolol employing the 2% DDCV aggregates.  
Atenolol is a somewhat bulky, polar molecule, such that the manner in which it is 
oriented with respect to hydrogen bonding and electrostatic interaction (as provided by 
polar surfactant head groups) may play a key role in determining enantioselectivity.  In 
fact, it is has been previously hypothesized in a DDCV micellar analysis that atenolol 
most likely adsorbs onto the surface of the aggregate rather than partitioning into it [26].  
In this respect, an increase in aggregate rigidity may have improved the 
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enantioselectivity, resulting in slightly better resolution with the micelle compared to the 
microemulsion (0.6 vs. 0.9).   
 
In terms of efficiency (Table 6.5), with respect to the 4% aggregates, the values provided 
by the microemulsion are double those provided by the butanol-modified micelle, and 
typically more than double those provided by the micelle.  When evaluating differences 
in efficiency between the three systems, key parameters include longitudinal diffusion 
and the sorption-desorption kinetics during solute-aggregate partitioning. First and 
foremost to consider with these results is the aberrant baseline and underlying aggregate 
instability. The presence of an aggregate that may be transiently polydisperse in shape, 
charge and size would understandably deteriorate efficiency.  Compounding this issue, in 
the case of the micelle, is the fact that its use resulted in longer migration times than 
either the microemulsion or the butanol-modified micelle for all of the compounds 
evaluated. Understandably, an increase in migration time often results in a decrease in 
efficiency via a subsequent increase in longitudinal diffusion. In contrast, in the case of 
the butanol-modified micelle, in spite of exhibiting migration times that were comparable 
to the microemulsion, the efficiencies were still significantly lower.  This is most likely 
solely due to the instability of the aggregate. 
 
In contrast, the 2% results were acquired with a very stable baseline and a more logical 
comparison can be made.  Similar to the 4% results, the efficiency noted when using the 
micelle was consistently lower than noted with the other two systems.  Since the outcome 
in both cases was so consistent, it may indicate a fundamental difference in solute-
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aggregate partitioning mechanism.  It may be that the increased fluidity of the 
microemulsion and butanol-modified systems facilitates the mass transfer process 
compared to the more rigid micellar structure. In contrast, the butanol-modified 
efficiency results (with the exception of indapamide and pseudoephedrine) were all 
slightly higher than those noted with the microemulsion, however the microemulsion 
provided better efficiency and greater resolution for the most hydrophobic analyte 
(indapamide). While the butanol-modified micelle always exhibited slightly higher 
efficiencies, it also always exhibited slightly lower retention factors.  Consequently, the 
increase in efficiency in this case was may have been due to the slight decrease in 
longitudinal diffusion. 
 
 
6.12 Concluding Remarks 
 
 
The aforementioned results highlight the necessity of pairing proper choice of analytical 
methodologies with the analytical needs at hand.  Whenever possible, it is always better 
to err on the side of simplicity.  If the analytical needs can be met without the use of a 
more complicated preparation scheme (as is necessary with microemulsions and solvent-
modified microemulsions), then that is the logical method choice.  Micellar systems 
provide adequate and/or superior results for a variety of analytes.  What this work 
highlights, however, is when it may be more logical to choose a more complicated 
aggregate system over that of a micelle.  
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Using 2% DDCV, all three aggregate analyses yielded similar values for 
enantioselectivity, resolution that was slightly better using the micellar phase, retention 
factors were larger using the micellar phase, but efficiencies that were consistently better 
using either the microemulsion or butanol-modified micellar phases.  Largely, the 
microemulsion and butanol-modifed micellar phases behaved fairly similar, although use 
of the butanol-modified micelle provided resolution and efficiency that was slightly 
better for all but two of the compounds.   
 
While reasonable separations were achieved using 2% DDCV, the results using 4% 
DDCV for the microemulsion system were far superior.  Analyses using analogous 
micellar and butanol-modified micellar aggregates were unstable, making them 
unsuitable for use at that surfactant concentration. Importantly, the strength of using a 
microemulsion system continues to lie in the ability to further extend the surfactant 
concentration than would be accessible in other aggregate systems.   This allows room to 
custom tune a given separation, a very valuable asset to any separation scientist.  
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Chapter 7:  Chiral MEEKC Conclusions and Future Directions 
 
 
Chiral MEEKC offers (i) increased method development flexibility, (ii) the ability to 
custom tune chiral resolution via elution range and retention factor optimization and (iii) 
a superior solubility range for both analytes and additives when compared to typical 
capillary electrophoretic techniques.  Importantly, the greatest potential of this technique 
is with respect to the chiral separation of more hydrophobic compounds for which CE is 
not currently a preferred methodology.  A key example in this case is the chiral analysis 
of pesticides, most notably organophosphorous and methyl ester phenoxy acid pesticides.  
Metolachlor, in particular, exists as four stereoisomers and would be a difficult and 
valuable analytical challenge. 
 
Further, there is still an enormous amount of research to be done with respect to 
optimizing these systems, including an improved understanding of how they work in 
comparison to other EKC systems. Since it has become increasingly well established that 
the surfactant and co-surfactant play the largest role with respect to selectivity, it is 
important to explore those parameters in greater detail. Other chiral surfactants should be 
investigated, especially those that might not be as pH dependent as DDCV.  An example 
would be either CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-
propanesulphonate) or CHAPSO (3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-
1-propanesulphonate).   A mixed surfactant microemulsion system should also be 
investigated.   In this case a neutral chiral surfactant could be combined with a charged 
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secondary surfactant (i.e. SDS), or vice versa.  A suppressed EOF format would also be a 
valuable approach with respect to extending the elution range and improving resolution. 
 
It would be similarly beneficial to explore the possibility of a chiral microemulsion 
formulated using a chiral co-surfactant.  A chiral co-surfactant could be incorporated with 
either a chiral or achiral microemulsion aggregate.  With respect to the former, both 
complementary and antagonistic interactions could be explored.  The chiral co-surfactant 
should have a similar linear structure to 1-butanol, but it should also contain greater 
functionality and rigidity to help provide the stereoselective mechanism.  Class I organic 
modifiers may offer promise in this area. 
 
With respect to the microemulsion lipophilic phase, a comparison should be made 
between typical hydrocarbon oils (hexane, heptane or octane) and the low-interfacial 
tension oil, ethyl acetate.  It may, at some point, prove more beneficial to utilize a 
hydrocarbon oil with respect to the analysis of more hydrophobic analytes. 
 
In addition, the DDCV microemulsion systems should be better characterized.  This 
characterization should involve both a factorial approach to method optimization and also 
the physical characterization of the aggregate.   With respect to the physical 
characterization, the use of a more sensitive dynamic light scattering instrument, capable 
of accurately measuring the extremely small aggregate size, may be necessary.   
Fluorimetric methods of determining the cac should also be investigated.  
 
 Appendix A: Microemulsion Compositions by Chapter 
 
 
 
Chapter 2:  Microemulsion Compositions 
 
 
MEa) Surfactant % (w/v) 
Surfactant 
(mM) 
Co-surfactant 
% (v/v) 
Co-surfactant 
(mM) 
Oil % 
(v/v) 
Oil 
(mM)
Buffer (concentration, 
identity, pH) 
ethyl acetate - control 1.0 30 1.2 131 0.50 51 50 mM ACES, pH 7.0 
methyl acetate -CV 1.0 30 1.2 131 0.50 63 50 mM ACES, pH 7.0 
methyl acetate -CM 1.0 30 1.2 131 0.40 51 50 mM ACES, pH 7.0 
methyl formate -CV 1.0 30 1.2 131 0.50 81 50 mM ACES, pH 7.0 
methyl formate -CM 1.0 30 1.2 131 0.32 51 50 mM ACES, pH 7.0 
methyl propionate -CV 1.0 30 1.2 131 0.50 47 50 mM ACES, pH 7.0 
methyl propionate -CM 1.0 30 1.2 131 0.54 51 50 mM ACES, pH 7.0 
a) CV = oil employed using the same volume as ethyl acetate in the control microemulsion, or “constant volume”. CM = oil employed 
at the same molar concentration as ethyl acetate in the control microemulsion, or “constant molarity”.  
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Chapter 3:  Microemulsion Compositions 
 
ME β-CD Type c) CD % (w/v) CD Concentration (mM) Buffer (concentration, identity, pH) 
DDCV a) HP 0.02 10 50 mM ACES, pH 7.0 
DDCV a) HP 0.03 20 50 mM ACES, pH 7.0 
DDCV a) HP 0.07 50 50 mM ACES, pH 7.0 
DDCV a) s 0.50 27 50 mM ACES, pH 7.0 
DDCV a) s 1.00 54 50 mM ACES, pH 7.0 
DDCV a) s 1.50 81 50 mM ACES, pH 7.0 
DDCV a) HS 1.00 48 50 mM ACES, pH 7.0 
DDCV a) HS 1.00 48 50 mM phosphate, pH 7.0 
DDCV a) HS 1.50 72 50 mM phosphate, pH 7.0 
SDS b) HP 0.02 10 100 mM TRIS, pH 8.0 
SDS b) HP 0.03 20 100 mM TRIS, pH 8.0 
SDS b) HP 0.07 50 100 mM TRIS, pH 8.0 
SDS b) s 0.25 14 100 mM TRIS, pH 8.0 
SDS b) s 0.50 27 100 mM TRIS, pH 8.0 
SDS b) s 1.00 54 100 mM TRIS, pH 8.0 
SDS b) HS 1.00 48 100 mM TRIS, pH 8.0 
SDS b) HS 1.00 48 50 mM phosphate, pH 8.0 
SDS b) HS 1.00 48 100 mM phosphate, pH 8.0 
a) Additional microemulsion components include 1.0% (30 mM) DDCV surfactant (either R- or S- configuration), 1.2% (v/v) (131 
mM) 1-butanol, 0.5% (v/v) (51 mM) ethyl acetate. b) Additional microemulsion components include 0.6% (21 mM) SDS surfactant, 
1.2% (v/v) (131 mM) 1-butanol, 0.5% (v/v) (51 mM) ethyl acetate. c) “HP” = hydroxypropyl. “s” = randomly sulfated (range 7-11), 
assumed an average degree of sulfation of 9 for concentration calculations.  “HS” = highly sulfated.  Average degree of sulfation of 
12.  
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Chapter 4:  Microemulsion Compositions 
 
ME* Surfactant % (w/v) 
Surfactant 
(mM) 
Co-surfactant 
% (v/v) 
Co-surfactant 
(mM) 
Oil % 
(v/v) 
Oil 
(mM) 
Buffer (concentration, 
identity, pH) 
1% DDCV - 
ACES 1.0 30 1.2 131 0.50 51 50 mM ACES, pH 7.0 
1% DDCV 1.0 30 1.2 131 0.50 51 50 mM phosphate, pH 7.0 
2% DDCV 2.0 60 1.2 131 0.50 51 50 mM phosphate, pH 7.0 
3% DDCV 3.0 90 1.2 131 0.50 51 50 mM phosphate, pH 7.0 
4% DDCV 4.0 120 1.2 131 0.50 51 50 mM phosphate, pH 7.0 
4x phase ratio 4.0 120 4.8 524 2.00 204 50 mM phosphate, pH 7.0 
*  For pH adjustment, approximately 1.25 mL of 1.0 M tetrapropylammonium hydroxide (TPAH) was used per gram DDCV. 
 
 
Chapter 5:  Microemulsion Compositions 
 
ME Surfactant % (w/v) 
Surfactant 
(mM) 
Co-surfactant 
% (v/v) 
Co-surfactant 
(mM) 
Oil % 
(v/v) 
Oil 
(mM) 
Buffer (concentration, 
identity, pH) 
1% DDCV 1.0 30 1.2 131 0.50 51 50 mM phosphate, pH 7.0 
4% DDCV 4.0 120 1.2 131 0.50 51 50 mM phosphate, pH 7.0 
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Chapter 6:  Aggregate Compositions 
 
Aggregate Surfactant % (w/v) 
Surfactant 
(mM) 
Co-
surfactant 
% (v/v) 
Co-
surfactant 
(mM) 
Oil % 
(v/v) 
Oil 
(mM) 
Buffer (concentration, 
identity, pH) 
Microemulsion 2.0 60 1.2 131 0.50 51 50 mM phosphate, pH 7.0 
Butanol-modified 
microemulsion 2.0 60 1.2 131 N/A N/A 50 mM phosphate, pH 7.0 
Micelle 2.0 60 N/A N/A N/A N/A 50 mM phosphate, pH 7.0 
Microemulsion 4.0 120 1.2 131 0.50 51 50 mM phosphate, pH 7.0 
Butanol-modified 
microemulsion 4.0 120 1.2 131 N/A N/A 50 mM phosphate, pH 7.0 
Micelle 4.0 120 N/A N/A N/A N/A 50 mM phosphate, pH 7.0 
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Appendix B: Physical Properties of Microemulsion Constituents 
 
 
Chemical 
Grouping Chemical Relevant Properties
a)
DDCV MW = 329.52 g/mol Molecular formula: C18H35O4N, pKa = 6.5. Surfactant 
SDS MW = 288.38 g/mol Molecular formula: C11H25OSO3Na 
ethyl acetate 
Molecular formula: C4H8O2 MW = 88.10 g/mol, 
d20/4 = 0.9003, n20 = 1.3723. Solubility in water at 
25° C ~ 0.1% (v/v).  Interfacial tension with water 
= 6.8 dyne/cm  
heptane 
Molecular formula: C7H16.  Molecular weight = 
100.20 g/mol. d20/4 = 0.684, n25 = 1.3855.  
Interfacial tension with water = 51.1 dyne/cm. 
methyl acetate 
Molecular formula: C3H6O2 MW = 74.08 g/mol, 
d20/4 = 0.9342, n20 = 1.3614. Solubility b) in water 
at 25° C ~ 0.3% (v/v).   
methyl propionate 
Molecular formula: C4H8O2 MW = 88.10 g/mol, 
d20/4 = 0.915, n19 = 1.3769. Solubility in water at 
25° C ~ 0.1% (v/v). 
Oil 
methyl formate 
Molecular formula: C2H4O2 MW = 60.05 g/mol, 
d20/4 = 0.9742, n20 = 1.3433. Solubilityb) in water 
at 25° C ~ 0.4% (v/v). 
Co-Surfactant 1-butanol 
Molecular formula: C4H10O MW = 74.12 g/mol, 
d20/4 = 0.810, n19 = 1.3993. Solubility in water at 
25° C  ~ 9% (v/v). 
a)Data as per the Merck Index, 11th Edition, Copyright 1989 by Merck and Co., Inc, 
except for the DDCV data, which was obtained through the Waters Corporation.  
Interfacial tension data from Good, C.J., Chemistry and Physics of Interfaces, Ross, S., 
Ed., American Chemical Society, Washington, D.C., 1965. b) Fisher Scientific U.K. 
online catalog, www.catalogue.fisher.co.uk, accessed 21 July 2004.   
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